Investigations into the synthesis of heterocyclic compounds with biological applications by Abid, Huda Ahmed
This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be 
duplicated by you for research, private study, criticism/review or educational 
purposes. Electronic or print copies are for your own personal, non-
commercial use and shall not be passed to any other individual. No quotation 
may be published without proper acknowledgement. For any other use, or to 
quote extensively from the work, permission must be obtained from the 
copyright holder/s. 
  
 
 
 
 
 
 
 This work is protected by copyright and other intellectual property rights and 
duplication or sale of all or part is not permitted, except that material may be duplicated 
by you for research, private study, criticism/review or educational purposes. Electronic 
or print copies are for your own personal, non-commercial use and shall not be passed 
to any other individual. No quotation may be published without proper 
acknowledgement. For any other use, or to quote extensively from the work, permission 
must be obtained from the copyright holder/s 
 
 
Investigations into the synthesis of 
heterocyclic compounds with biological 
applications 
 
 
 
 
 
A thesis submitted to Keele University in 
partial fulfilment for the requirements for the 
degree of Doctor of Philosophy in Chemistry 
By 
Huda Ahmed Abid 
 
 
October 2018 
 
 ii | P a g e  
 
Abstract 
There is a growing body of literature that recognises the importance of tandem 
reactions, where a number of transformations are carried out in a one-pot 
process. Such reactions offer considerable benefits such as: a reduction in 
time, and the sequence of synthetic processes that subsequently improve in 
efficiency. Particularly useful is the one-pot cascade of transforming alcohols to 
alkenes using an Oxidation-Wittig sequence. Although, the Wittig reaction is a 
dominant and powerful olefination method, sometimes the isolation of, 
instability of, toxicity of, or volatility of the carbonyl compounds that are 
applied in a Wittig reaction is limiting. However, a tandem oxidation processes 
(TOP) in the presence of a number of oxidants can be employed to overcome 
these shortcomings. Herein, a variety of starting materials were used to 
construct six and five membered rings that possibly could be annulated later. 
Chapter 2 describes the attempted development of novel methodology for the 
construction of carbon-carbon bonds from diols in two routes. Firstly, a 
domino oxidation-Wittig olefination reaction was attempted to convert diols 
into extended alkene products through reacting with different ylides. The 
electrocyclisation of those alkenes (trienes) has been examined using thermal 
and microwave irradiation. In the second route, work on the intramolecular 
annulation of alkenes via 6π-electrocyclisation and then oxidation is described. 
No ring closure was observed under thermal or photochemical promotion of 
the 6π-electrocyclisation. 
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The attempted application of acid-catalysed Nazarov reaction of divinyl 
ketones and TOP reaction of diol is described in Chapter 3 using divinyl ketone 
302 and dihydroxyacetone 294 as key intermediates but only limited success 
was achieved. The Nazarov cyclisation could not be promoted on the TOP 
derivatives obtained.  
Chapter 4 explores the development of tandem oxidation/Diels-Alder reactions 
through potential inter- or intra-molecular Diels-Alder reactions. Firstly, two 
alcohols were used for the synthesis allyl and homo allyl esters via TOP 
reaction of cinnamyl alcohol and cyclohexenmethanol. Secondly, six vicinal 
diols and diketones were examined under the same conditions to synthesise 
dienes that might act as dienophiles. Unfortunately, no success was achieved. 
The final chapter, describes the successful preparation, via Pictet-Spengler 
cyclisation, and evaluation of a number of novel 1,2,3,4-tetrahydro-β-
carbolines that have anti-malarial activity. Although active, the compounds 
prepared did not show any significant increase in the growth inhibitory activity 
of compared to the existing collections, but they did successfully confirm the 
SAR model proposed.  
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Chapter 1 Introduction 
1 Tandem reactions 
The past thirty years have seen increasingly rapid advances in the field of the 
development of novel tandem reactions. These reactions aim to create several 
bonds in a single process and can lead to the rapid construction of molecules, 
which are often complex. Synthetic chemistry has long searched for easy 
methods to synthesise complex organic molecules. A tandem reaction is a 
reaction in which several bonds are formed in sequence without isolating 
intermediates, changing reaction conditions, or adding reagents. Such methods 
are often referred to by different names like domino, cascade, sequential and 
‘zipper’ that are all linked to performing multiple transformations in a single 
step.(1) 
Ideally the development of tandem reaction methodologies could lead to many 
benefits; for example; a reduction in the amount of solvent waste, by-product 
waste produced and shorter reaction times.(2) In addition to this, intermediates 
do not require purification and potentially higher yields can be obtained, when 
compared to stepwise processes. However, this ideal target is often impossible 
to achieve. These processes are important in both academia and industry, and 
ideally the synthesis of any target would proceed in the shortest number of 
steps from readily available starting materials. One of the earliest reported 
sequential reactions, a classic example of a domino reaction is Robinson’s 
synthesis of Tropinone 4 in 1917. It reported that the combination of 
succinaldehyde 1, methylamine 2 and 1,3-acetone dicarboxylic acid 3 afforded 
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tropinone 4, using the Mannich reaction that includes the nucleophilic addition 
of an amine to a carbonyl group followed by dehydration step to give the Schiff 
base, as shown in Scheme 1.(3) 
 
Scheme 1: Robinson’s domino synthesis of Tropinone 4 
Significant improvements in tandem reactions are being reported daily. To 
provide a recent example, Bhadraiah and co-workers reported the synthesis of 
1,3,4,5-tetra-substituted pyrazoles 8 rapidly and regioselectively in a one-pot, 
three-step sequence consisting of condensation, nitrilimine generation, and 
cycloaddition using mercuric acetate, as shown in Scheme 2.(4) 
 
Scheme 2: Tandem reaction for synthesis substituted triazole 
The use of tandem reactions is not however limited to synthesising rings. For 
example, Scheidt et al developed a one-pot process of tandem oxidation 
reaction of allylic and benzylic alcohols to esters 10, and saturated aldehydes 
to saturated esters 12 using a simple triazolium salt as the pre-catalyst as 
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shown in Scheme 3.(5) This is an example of how tandem reactions can also be 
used powerfully to accomplish otherwise challenging reactions.  
 
Scheme 3: Using catalysts to prepare esters 10 and 12 
Tandem reactions also do not always need expensive or complex catalysts. Liu 
et al (2016) developed an effective one-pot method for the synthesis of 
pyrazolo[3,4-d]pyrimidin-4-one 16 from the reaction of 2-
(ethoxymethylene)malononitrile 14, phenylhydrazine 13, and benzaldehyde 
15.(6) In addition, Kumar and co-workers used a potassium hydroxide mediated 
protocol to achieve the tandem cyclocondensation and rapid aromatization of 
1H-pyrazol-3-amines and chalcones (Scheme 4). This protocol observed 
excellent improvement in yields. It was noted that the basicity and solubility of 
potassium hydroxide in DMF was responsible for these high yields, as shown in 
Scheme 4.(7a)  
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Scheme 4: Using mild catalysts for the attempted tandem reactions 
Palladium-catalysed Heck and cross-coupling reactions are a major area of 
interest within the field of synthetic organic chemistry.(7b) Despite its long 
success, Pd-catalysed coupling reactions have a number of problems such as 
the growing requirement of starting materials and formation of halide salts 
waste. Langer et al(8) reported twofold Heck reactions of 2,3-dibromo-N-
methylindoles 20 with various acrylates, where it was proven as a successful 
reaction to synthesise the 2,3-di(alkenyl)indoles 21 from moderate to good 
yields, as shown in Scheme 5. These yields were obtained when it was carried 
out under Buchwald's conditions, using palladium (II) acetate [Pd(OAc)2] and 
the biaryl monophosphine ligand in DMF. Alternatively for one substrate  
triethanolamine was used instead conveniently replacing the  base, ligand, and 
solvent for the Heck reaction.  
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Scheme 5: The synthesis of 2,3-di(alkenyl)indoles 21 using Pd-catalysed 
coupling reaction 
1.1 Classification of tandem reactions: 
Chemists have classified tandem reactions into three groups.(1) The first is 
“sequential” reactions in which additional reagents must be added in order for 
the second reaction to occur, secondly, “consecutive” reactions in which 
another reagent is added after the first transformation without isolation of the 
first formed product and finally, “cascade or domino” reactions in which all 
reactions take place without the need for additional reagents or a change in 
reaction conditions (Scheme 6). 
 
Scheme 6: Illustration of tandem reactions  
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Domino reactions themselves can be classified according to the basis of the 
steps involved. Electrophilic, nucleophilic, pericyclic, radical, and transition 
metal catalysed processes have been grouped by Nicolaou and co-workers 
(2006).(9) In contrast, Tietze classifies these domino reactions into cationic, 
anionic, radical, pericyclic, photochemical, oxidative or reductive, and 
transition-metal induced transformations.(1)   
1.1.1 Cationic tandem reactions 
Cationic tandem reactions are considered the oldest known tandem reactions. 
A carbocation is generated either by elimination or by addition of a proton. 
Further reaction of the carbocation then produces a new carbocation.(10) The 
development of cationic tandem reactions has played an extensive role in the 
synthesis of natural products. An excellent example of cationic reactions is the 
synthesis of 3-acyl-5-substituted tetrahydrofurans, prepared from 
methoxymethyl (MOM) or (methylthio)methyl (MTM) derivatives of allylic diols 
with good to moderate yields. However, Overman demonstrated that the 
functionality and stereochemistry of Lewis acid-promoted pinacol can be 
useful in this reaction to construct different oxacyclic products, depicted in 
Scheme 7.(11)  
 
Chapter 1                                                                                                Introduction 
7 | P a g e  
 
 
Scheme 7: Lewis acid-promoted pinacol-terminated Prins cyclisation 
1.1.2 Anionic tandem reactions 
Anionic tandem reactions are also common in the literature. Carbanion 
formation involves a deprotonation of a CH group, and then this carbanion will 
attack an electrophile to create an anion that reacts with another electrophile 
to complete the desired reaction. There are a wide range of examples that 
include anionic–anionic processes like Michael-initiated or -terminated 
process. These examples are particularly utilised in organic syntheses.(12) An 
elegant example of an anionic-cyclisation domino reaction is Ley’s synthesis of 
tetronasin 28, which is of commercial importance as an antibiotic, 
antiparasitic, and growth-promoting agent for ruminants. Reaction of 26 with 
potassium hexamethyldisilazide (1.1 equiv.) in toluene at 0  ͦC, afforded 
tetronasin 28  in 67% yield as a single diastereoisomer, the key step being a 
domino-cyclisation to proceed via potassium salt 27 (Scheme 8).(12)  A large 
number of other anionic tandem reactions in various synthetic contexts have 
been reported with undeniable benefits. (13-15)   
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Scheme 8: An anionic-cyclisation cascade in the synthesis of tetronasin 28 
1.1.3 Pericyclic tandem cascades  
Many tandem routes to afford natural compounds targets, make use of 
pericyclic reactions, including cycloadditions, sigmatropic rearrangements and 
electrocyclic reactions. Gibbs and Okamura (1988) showed the total 
stereochemistry of the (+)-sterpurene (32, Scheme 9) through asymmetric 
tandem [2,3]-sigmatropic shift and intramolecular Diels-Alder reaction.(16) 
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Scheme 9: The enantioselective synthesis of (+)-sterpurene 32 
2 TOP Reactions  
The TOP strategy is a combination of an oxidation reaction with other synthetic 
transformations, termed by Taylor as a "Tandem Oxidation Process" (TOP).  
Such reactions can be very beneficial in terms of reducing the number of 
synthetic steps with maximization of complexity, being much less time 
consuming, and avoiding individual synthesis, isolation, and purification of the 
required intermediates. The conversion of alcohols into their corresponding 
oxidized forms is one of the fundamental transformations in organic synthesis 
as carbonyl derivatives can be transformed into many other functional 
groups.(17) 
The origins of this work are in the first sequential oxidation-olefination 
process. Ireland and co-workers prepared ethyl 3-(trimethylsilyl) methacrylate 
36 by successfully using a consecutive Swern oxidation-Wittig olefination 
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sequence, the unstable aldehyde was prepared and then treated in situ with 
stabilised phosphorane as a trapping reagent, which was added after the 
oxidation. This afforded a 54% yield of the desired product (Scheme 10). This 
process is however not ideal as the ylide cannot be added until the oxidation is 
complete because of incompatibility.(18) 
 
Scheme 10: Ireland’s consecutive reaction synthesis of 36 
Substituted alcohols can also undergo tandem oxidation/Wittig olefination to 
afford α,β-unsaturated esters without the requirement for protecting group 
strategies. Taylor and co-workers reported a tandem oxidation reaction 
between (E)-3-bromo-propen-1-ol 37 and 
(carboethoxymethylene)triphenylphosphorane 38 in the presence of MnO2 
and CH2Cl2, as shown in Scheme 11. Many examples of tandem oxidation 
process methodology have been reported by Taylor using a whole host of 
diverse conditions such as starting materials, solvents and temperature.(17) 
These reactions work well for activated alcohols such as allylic, propargylic, α-
hydroxyketones and benzylic alcohols and MnO2 is readily available, stable and 
also easily removed by filtration from reaction. 
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Scheme 11: A typical TOP reaction 
Many oxidants including metal and non-metal based reagents and others can 
be applied in the oxidation reaction to give their oxidised form. Barrett 
employed Dess-Martin periodinane (DMP) in the oxidation of diols such as 2-
butyne-1,2-diol 40 and 1,2-ethanediol 42 in the presence of 
(carboethoxymethylene)-triphenylphosphorane 38 to afford diester derivatives 
41 and 43. Although expensive, Dess-Martin periodinane is commercially 
available and widely utilized for the selective oxidation of alcohols to 
aldehydes containing sensitive functional groups. DMP is also good for alcohols 
that MnO2 cannot oxidise such as those which are unactivated (Scheme 12).(19) 
 
Scheme 12: Barrett’s tandem oxidation-Wittig reaction with DMP as the 
oxidant 
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Recently, the wide scope of TOP processes has been demonstrated in the 
development of systems with variation of the reagents, oxidants as well as the 
conditions of reaction. For example, Mojtahedi and co-workers reported a 
protocol involving a novel one-pot synthesis of bisarylmethylidene 46 from 
cyclic alcohols. These reactions take place at room temperature to produce the 
corresponding compounds in high yields through aldol reaction-elimination of 
the in situ aldehyde to effect olefination (Scheme 13).(20)  
 
Scheme 13: TOP of cycloalcohols 
New protocols are being increasingly used in tandem oxidation-anionic 
reactions utilizing other reactants such as amines instead of ylides. In 2001, a 
one-pot oxidation-imine formation-reduction sequence was developed for the 
conversion of activated alcohols into secondary and tertiary amines as well as 
imines (Scheme 14). Typically, the oxidation of alcohol 47 to the corresponding 
amine 49 and imine 50 yielded 33-95 %. This system proved to be more 
efficient by the combination of manganese dioxide as an in situ oxidant with 
polymer supported cyanoborohydride (PSCBH) as a compatible reductant for 
the preparation of amines.(21)  
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Scheme 14: The rapid synthesis of amines using TOP chemistry 
An interesting TOP approach has been described by Taylor et al using the 
reaction of various alcohols with a combination of phosphorus- and sulfur- 
ylide at the same time in the presence of MnO2-mediated oxidant that includes 
three separated transformations in a single manipulation to synthesise 
polysubstituted cyclopropanes affording good yields, as depicted in Scheme 
15.(22)  
 
Scheme 15: TOP-cyclopropanes 
Further to catalyst applications in organic synthesis, the presence of transition 
metals, such as caesium-mesoporous manganese oxide catalyst (meso 
Cs/MnOx) have been reported as an efficient methodology for the construction 
of various esters from alcohols in one step under aerobic conditions by Suib 
and co-workers. They found the efficiency of the catalyst can be retained for 
the next usage without loss of its performance. The scope of this method 
provides a potential synthetic route to afford new compounds using TOP.(23) In 
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this context, the motive to research TOP reactions is comprehensible and more 
reasonable and it sounds inescapable that those reactions will play a 
considerable role in the future of the synthetic chemistry. 
3 Olefination  
Alkenes are often important intermediates or synthetic targets and an impressive 
array of techniques have been assembled to prepare them. It is noteworthy that 
there are three predominate ways to synthesise alkenes, namely alkyne reduction, 
metathesis and olefination (Scheme 16). These methods are the reduction of alkyne 
by (Pd/H2 or Na/NH2), a reaction between two molecules of alkene in the presence 
of a catalyst, called alkene metathesis,(24) or the combination a carbonyl compound 
and a suitable olefinating agent together to generate alkene, which is known as 
olefination.  
 
Scheme 16: Synthesis of alkenes 
Generally, many processes for the construction of drugs and natural products 
via alkenes have been developed, including three widely used methodologies 
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for the trustworthy formation of olefins: the Wittig reaction,(25) the Peterson 
reaction,(26) and the Julia-Lythgo(27) / Julia Kocienski(28) olefinations. The 
olefination reactions in Scheme 17 illustrate the diverse olefination methods, 
each named after their discoverers. 
 
Scheme 17: Olefination reactions 
3.1 The Wittig reaction 
The Wittig reaction developed by Georg Wittig (1897-1987), remains one of 
the most effective reactions to form a C=C bond from a C=O bond and the 
ingenuity of this synthetic method is demonstrated by its extensive use in the 
chemistry of natural products.(29) Wittig olefination is the reaction between 
carbonyl compounds (aldehydes and ketones) and a phosphorane ylide known 
as the Wittig reagent. It is noteworthy that carbonyl components react with 
phosphorane ylide to afford olefins,(30a) whereas sulfurane ylide give either 
olefins or epoxides depending on the stabilisation of ylides.(31) The first record 
of a reaction between diphenyl ketene 56 and diphenyl ylide 57 was made by 
Staudinger in 1919, leading to the preparation of tetraphenylallene 58, well 
before the work of Wittig.(32) In any case, this report stayed in isolation until in 
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1953 Wittig and Geissler(29) revealed that benzophenone and methylene ylide 
react to deliver 1,1-diphenylethene 61 and triphenylphosphine oxide in an 84% 
yield (Scheme 18). Through the considerable endeavors of Wittig and his 
colleagues this technique was developed into to a general synthesis of alkenes 
from carbonyl compounds, and the reaction named after its developer.  
 
Scheme 18: Olefination reactions 
Fortunately, and within a brief timeframe, the importance of this discovery 
was not ignored; researchers at the neighbouring BASF plant in Ludwigshafen 
utilised a new reaction of retinoic acid from the phosphoranylidene and the 
aldehyde (Scheme 19).(33a) Industry now produces natural and synthetic 
carotenoids and vitamins that are based on the Wittig reaction, such as the 
production of 600 tons annually of Vitamin A.  
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Scheme 19: Olefination reactions 
In addition, Wittig reactions have been used in the preparation of the trienes 
core of indoles in the presence of palladium catalyst, by Pindur and Adam 
(1990).(33b) It was  noted that two different starting materials can be employed 
to synthesise N-methyl-2,3-divinyl-indole 72 using N-methyl-3-vinyl-indole-2-
carbaldehyde 70 and N-methyl-indole-2,3-dicarbaldehyde 71. Compound 70 
was first prepared from the reaction of N-methyl-indole-2-carbaldehyde 68 in 
the presence of palladium acetate and acrylate 69 in toluene under thermal 
conditions. Both product 70 and product 71 can be used in the following step 
which is based on the Wittig reaction in toluene to afford the final product 72 
in moderate yields of 54% and 30% respectively (Scheme 20).   
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Scheme 20: The synthesis of N-2,3-divinylindole 
3.2 Phosphorane ylides 
During the twentieth century, the development of phosphorous ylides(32) has 
been widely studied. Many researchers such as Bestmann, Corey, Schlosser, 
Trippett and others helped in the development of prominent improvements in 
phosphorane chemistry.(34) Phosphoranes have been classified into three 
classes depending on their delocalisation of the negative charge of carbon, 
which are: stabilised, semi-stabilised, and non-stabilised ylides.  
One of the most common reagents in organic chemistry are phosphorane 
ylides; “a substance in which a carbanion is attached directly to a heteroatom 
carrying a high degree of positive charge”. For phosphorane ylides, the 
phosphorus atom formally carries a positive charge, and bonds with five 
groups in which carbon is the adjacent atom and has a negative charge.  
The key factor in the reactivity of phosphorane is the presence of substituents 
(R1, R2) at the ylidic carbon atom. However, these ylides can be categorised 
according to the substituents on the carbon atom, where electron releasing 
Chapter 1                                                                                                Introduction 
19 | P a g e  
 
groups such as alkyl will increase their reactivity of the phosphorane. However, 
aromatic rings on the phosphorus atom will lessen their nucleophilicity to 
carbonyl compounds. In general, the unstabilised or semi-stabilised ylides are 
more active than stabilised ones. Keto-ylides are strongly enolised due to the 
localisation of negative charge on the oxygen atom rather than carbon atom of 
the ylide.     
 
By far the most significant synthetic process for the preparation of 
phosphorane ylides is the salt method which is one of three major preparative 
routes:- 
(1) - The ''salt-method'' (2) - Transylidation (3) - Umpolung "substitution" 
For example, the preparation of methyl (triphenylphosphoranylidene) acetate 
52 is demonstrated in Scheme 21. The same Scheme shows other methods in 
addition to the salt-method respectively.(34a, 34b, 34c) 
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Scheme 21: The preparation of ylides 
3.3 The mechanism of the Wittig reaction 
Many researchers have comprehensively studied the mechanism of the Wittig 
reaction. However, even today this mechanism is not completely understood 
and some its characteristics still prove contentious. In particular several 
reviews about the mechanism of the Wittig reaction have been reported by 
Schlosser,(35) Maryanoff,(36) and Kolodiozhni.(37) However, the outcome of 
Wittig stereochemistry in most alkenes are generally accepted to proceed via 
one of two cases depending on the ylide used. Despite all the attempts to 
suggest a suitable mechanism, it has proved unfeasible to isolate, or even 
detect betaine intermediates spectroscopically. Basically, two-steps are 
involved in the Wittig reaction. The first stage comprises the nucleophilic 
addition of the carbon of the ylide to the (C=O) group, leading to the formation 
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of a betaine. In this step, the presence of resonance stabilisation will reduce 
the nucleophilicity of the phosphorane between the carbanion and the groups 
on the carbon. Secondly, this intermediate is postulated to be converted to 
phosphine oxide and alkenes through a four-membered cyclic transition state.  
The identification of the oxaphosphetanes structure 81 was made by Vedejs 
using NMR, confirming them as a key intermediates, and at that it time was 
held to be pivotal to this mechanism (Scheme 22).(38) However, betaine 82 is 
the only the intermediate that has been identified either in the presence of 
lithium salts or chelating ligands on phosphorus in which to stabilise its 
charges.(39)  
 
Scheme 22: Traditional Wittig mechanism 
As can be seen, the Wittig reaction with unstabilised ylides is (Z)-selective 
which consists of a stereoselective first step by keeping the large substituents 
apart to form the syn oxaphosphetane, followed by an elimination step from 
this intermediate to afford a (Z)-alkene (Scheme 23).(40) 
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Scheme 23: The stereochemistry of (Z) - alkene formation (cis) 
In contrast, the (E)-selectivity is favourable for stabilised ylides in the Wittig 
reaction, where the presence of electron withdrawing groups, such as an ester 
group, can stabilise the ylide carbanion via resonance delocalisation. The 
stereochemistry of the alkene product is settled by the stereochemistry of 
intermediate, which is shown in Scheme 24. The addition occurs to minimise 
the dipoles by placing the EWG and the ylide opposite to each other.   
 
Scheme 24: The stereochemistry of (E)-alkene formation (trans) 
The process of construction of the oxaphosphetane intermediate 83 or 84 have 
been identified by many studies(37, 41) via an asynchronous (2+2) cycloaddition. 
Despite intermediate 84 being more thermodynamically stable than 
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oxaphosphetane 83, it still dominates for unstabilised ylides because of steric 
hindrance in the transition states (Scheme 23 and 24). How products result 
from the decomposition of oxaphosphetanes is not obvious. There was an idea 
of this happening through a pseudorotation movement from P-C bond to P-O 
bond to explain the collapse, as shown in Scheme 25. It was thought this 
collapse happens asynchronously where the breakage of the P-C bond is faster 
than formation of P=O bond.(42) Therefore, there is no decomposition if the 
process of pseudorotation is hindered or blocked.(42) Moreover, the study by 
Vedejs also found the rate of decomposition process is 108 times slower than 
the pseudorotation itself.(43) 
 
Scheme 25: Prospective pseudorotation in oxaphosphetanes 
On the other hand, the use of stabilised ylides is mechanistically less well 
understood, where mechanistic studies have not given any proof of betaine or 
oxaphosphetane formation. The destabilisation of the oxaphosphetane leads 
to the collapse that could be due to the electron withdrawing groups on 
intermediate. Therefore, oxaphosphetane (trans) that resulted from the 
reaction of stabilised ylides produces a stable product under thermodynamic 
conditions. 
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3.4 The reactivity of Wittig reaction 
Both the ylide and carbonyl compound are important in Wittig reactivity. In 
general, aldehydes are more reactive than ketones and the type of reactivity 
can be compared with various ylide structures, as shown in the Table 1.  
Table 1: Ylide reactivity (Y-reactive, N-non-reactive) 
Class Example Aldehydes Ketones 
Unstabilised Ph3P=CHMe YYY YYY 
Semi-stabilised Ph3P=CHPh YY Y 
Stabilised Ph3P=CHCN Y N 
Delocalised 
 
N N 
 
Generally, the stereoselectivity of Wittig reaction depends on the structure of 
ylide that is easily predicted, which might be related to the mechanism. It is 
worthy to note that unstabilised ylides give (Z)-alkenes and stabilised ylides 
invariably produce (E)-alkenes as the principal isomers. Whereas, semi-
stabilised ylides are mostly afforded unselective intermediates, resulting to 
mixtures of both (E) and (Z)-alkenes (Figure 1).  
 
Figure 1: Classification of phosphoranes 
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3.5 Tandem reactions involving Wittig reaction 
TOPs are a significant tool in organic chemistry and Wittig reactions are widely 
used as a part of them to synthesise a wide range of products. For example, 
Taylor and co-workers have developed one-pot synthesis of 1,1-
dibromoalkenes 90 from oxidation of a variety of activated alcohols such as 
benzylic, heterocyclic and propargylic alcohols in the presence of MnO2, 
phosphonium salts and MTBD (1-methyl-1,5,7-triazabicyclo[4,4,0]dec-5-ene) 
89, as well as the conversion of those resulting alkenes into their terminal 
alkynes in good to excellent yields, Scheme 26.(44) 
 
Scheme 26: Sequential one-pot MnO2 oxidation/alkynylation synthesis 
New developments are always being reported in Wittig Chemistry. For 
example, Xu and co-workers have recently prepared 1,4-dienes through the 
allylic alkylation of phosphorous ylides with allylic carbonates via a one-pot 
SN2/ alkylation-Wittig strategy obtaining high to excellent yields, as shown in 
Scheme 27.(45)  
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Scheme 27: One-pot SN2/ alkylation-Wittig reaction 
Recently, Sultan and co-workers (2017) raise several concerns about the 
handling of aldehydes and considered them to be unsuitable substrates. The 
authors investigated an efficient methodology to synthesise new one-pot 
chlorination/oxidation/Wittig olefination reaction for preparation of α-chloro-
α,β-unsaturated esters from different alcohols. This method undergoes TOP 
reaction using N-chlorosuccinimide (NCS) as a chlorine source and manganese 
dioxide as the selective oxidant, affording moderate to good yields (Scheme 
28).(46) 
 
Scheme 28: TOP reaction of α-chloro-α,β-unsaturated esters using NCS and 
MnO2 
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In recent years, there has been an increasing amount of literature on tandem 
Wittig reaction. In 2011, a one-pot Wittig/aldol reaction has been investigated 
by Toy and Lu, where this sequence is based on the synthesis of complex 
compounds. Scheme 29 illustrates the reaction of 2-bromoacetophenone 97 
and benzaldehyde 98 (used twice) which are converted into the product 100 in 
67% yield. Interestingly, it can be used with two different aldehydes in this 
reaction to afford new isomers. It was noticed that the anti-isomer is slightly 
preferable than the syn isomer in this reaction.(47) 
 
Scheme 29: Tandem one-pot Wittig/reductive aldol reactions 
Additionally, the synthesis of substituted coumarins has been suggested by 
Schmidt and Riemer using a tandem sequence of olefination, Claisen 
rearrangement and cyclisation, under microwave conditions. Their analysis 
disclosed that the ability of synthesis of cumarin derivatives from various 
starting materials also affords reproducible yields using microwave irradiation 
at 250  ͦC in the presence of N,N-diethylaniline, as compared with the two steps 
separately. Gratifyingly, no isomers or variable compounds resulting from this 
sequence have been observed, as shown in Scheme 30. However, they noted 
that some other starting materials such as propargyl ether reacts under the 
same previous conditions but produce two different compounds, benzofuran 
and benzopyran.(48) 
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Scheme 30: Tandem olefination/Claisen rearrangement/ isomerisation/ 
cyclisation sequence 
3.6 Wittig reaction to synthesis trienes 
The synthesis of functionalised 1,3-dienes and polyenes by Wittig chemistry is 
somewhat rare. McNulty and co-workers have investigated the aqueous Wittig 
reaction of ylides derived from trialkylallyl phosphonium salts under basic 
conditions and those resulting semi-stabilised ylides were shown to react with 
aromatic, unsaturated, as well as enolisable aliphatic aldehydes to yield a 
diverse range of 1,3-dienes 105 and 1,3,5-trienes 107. The isolated yields of 
the 1,3-dienes 105 compared to 1,3,5-trienes 107 were high in all cases 
investigated. The major advantage of this process is the easy separation of the 
water-soluble triethylphosphine oxide from the organic product which 
generally precipitated from the aqueous solution. The E/Z-selectivity is, 
however, modest because the ylides formed in the reaction are semi-
stabilised, and therefore have intermediate selectivity (Scheme 31).(49) 
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Scheme 31: Synthesis 1,3-diene and polyene by the aqueous Wittig reaction 
4 Pericyclic Reactions  
A pericyclic reaction is one that proceeds through a cyclic transition state. 
Pericyclic reactions are generally completely stereo-specific under thermal or 
photochemical conditions; that is; a single stereoisomer of the reactant forms 
a single stereoisomer of the product. Scheme 32 describes the types of 
pericyclic reactions which are distinguished by the number of σ bonds made or 
broken.(50) 
 
Scheme 32: Types of pericyclic reactions 
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4.1 Electrocyclisation reactions 
In an electrocyclisation closure, a conjugated polyene system is converted into 
a cyclic product in one step. The stereochemistry changes depending on 
whether irradiation (for example UV-light) or heat is used to promote the 
reaction. There are two possible modes for ring-closing and ring-opening of 
electrocyclisation reactions. The first mode is disrotatory where the σ bond is 
broken by twisting the termini in opposite directions. On the other hand, the 
other termini can be twisted in the same direction resulting in a conrotatory 
mode. The mode of the electrocyclisation reaction determines the 
stereochemistry of the product (Scheme 33). 
 
Scheme 33: Two fashions of rotations 
A set of rules based on orbitals and symmetry of pericyclic reactions was 
proposed by Woodward and Hoffmann in 1965,(51) based on Frontier Molecular 
Orbital (FMO) analysis involving the HOMO (Highest Occupied Molecular 
Orbital) and LUMO (Lowest Occupied Molecular Orbital). Electrocyclisation 
reactions can be done under thermal and photochemical conditions and the 
obtained products have different stereochemistries according to the method 
of promotion. Under thermal control, the electrocyclic ring closure of (E,E)-2,4-
hexadiene, cyclisation happens in a conrotatory mode due to the HOMO of a 
conjugated diene having phases of the outermost lobes on opposite sides of 
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the molecule. As can be seen, one methyl group is pushed down and another 
one is pushed up, placing them in the trans relationship in the product. 
Conversely the thermal ring closure of (2E,4Z,6E)-2,4,6-octatriene occurs in a 
disrotatory mode that the HOMO of a conjugated triene has the same face of 
the molecule compared with the outermost orbital lopes, making a cis 
relationship in the product, as shown in Scheme 34.  
 
Scheme 34: Thermal cyclisation of polyene 
This is a specific example of the general process observed for conjugated 
polyenes with an even number of π bonds, which is shown in Figure 2. Both 
electrocyclisation ring opening and closing reactions follow the same rules. 
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Figure 2: FMO for the π system of (2E,4E)-2,4-hexadiene 
In terms of the photochemical cyclisation, the reactions follow similar rules as 
for the thermal electrcyclisations, but there is one an important difference. As 
a result, the method of ring closure of a photochemical electrocyclisation 
reaction is reverse to that of a thermal one for the same number of π bonds. 
So photochemical electrocyclisation reactions occur in a disrotatory fashion for 
a diene with an even number of π bonds that means making a cis product. 
However, the same reactions for the conjugated triene occur in a disrotatory 
fashion by making a trans-product, as shown in Scheme 35.    
 
Scheme 35: Photochemical cyclisation of conjugated systems 
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The photochemical irradiation of cis-3,4-dimethylcyclobut-1-ene is sufficient 
to promote an electron from the HOMO (Ψ2) to (Ψ3). This results in a singly 
occupied molecular orbital and generates a new exited state orbital HOMO*, 
as shown in Figure 3. Table 2 illustrates the summary of the Woodward-
Hoffmann rules for electrocyclisation reaction of ring-closure and ring-
opening. 
 
Figure 3: FMOs of (E,E)-2,4-hexadiene 
Table 2: The summary of WHR for electrocyclisation reactions 
Number of π electrons Thermal Photochemical 
4n conrotatory disrotatory 
4n+2 disrotatory conrotatory 
 
4.2  Cycloaddition reactions  
Two π systems are joined with the formation of two new σ bonds resulting in a 
cyclic product. The popular Diels–Alder reaction involves the addition of an 
alkene (dienophile) to a diene in one step where the stereochemistry of the 
product determined by the cycloaddition reaction based on thermal or 
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photochemical reaction conditions. Again the mode of cycloaddition is always 
opposite in thermal and photochemical reactions (Scheme 36). 
 
Scheme 36: Cycloaddition reaction 
[4+2] Cycloaddition reactions involve the movement of electron density from 
one reactant to another where the interactions occur from the HOMO of one 
component (the diene) to the LUMO of the second one (the dienophile). As a 
result, the (2E,4E)-2,4-hexadiene forms a cyclohexene with cis substituents 
whereas the (2E,4Z)-2,4-hexadiene affords a cyclohexene with trans 
substituents respectively, which shown in Scheme 37. 
 
Scheme 37: The stereochemistry of Diels-Alder products 
These observations of [4+2] cycloaddition reactions can be summarised in 
Table 3. In the suprafacial-suprafacial case, the cycloadditions are symmetry 
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and geometrically allowed but in suprafacial-antarafacial cases, the 
cycloadditions are symmetry allowed and geometrically forbidden. 
Table 3: The summery of WHR for cycloaddition reactions 
 
5 Nazarov Cyclisations 
Nazarov cyclisation has been studied since the 1940s by Nazarov and 
Zaretskaya(52a) and is a useful reaction for the synthesis of cyclopentenone 
compounds in the presence of Lewis acids such as FeBr3, benzoic acid, ZrCl4 
and AlCl3.  A considerable amount of literature has been published on Nazarov 
cyclisation. These studies reported that the Nazarov reaction is a cationic 
electrocyclisation, initially shown to be promoted by strong Lewis acid, but it 
was noticed later this reaction can be promoted even by mild Lewis acids.(52b)  
This reaction is carried out through a conrotatory 4π-electrocyclic ring closure, 
as shown in Scheme 38, where Nazarov and co-workers found that the allyl 
vinyl ketones have been synthesised using the hydration of dienynes.(52a) 
 
Scheme 38: Initial Nazarov cyclisation 
Number of 
π electrons 
Thermal 
cycloaddition 
Photochemical 
cycloaddition 
4n suprafacial-suprafacial suprafacial-antarafacial 
4n+2          suprafacial-antarafacial          suprafacial-suprafacial 
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The reaction of allyl vinyl ketone was formulated by Nazarov. Hence, Braude 
and Cloes(53a) report another reactant for the synthesis of 2-cyclopentenone 
from α,α/-divinyl ketones (Scheme 39). 
 
Scheme 39: Braude and Cloes’ cyclisation 
Mechanistic studies have demonstrated cationic intermediates in Nazarov 
cyclisation such as pentadienyl cation and an oxyallyl cation.(53b) The key 
process is therefore a 4π-electrocyclisation to create a new carbon-carbon 
bond with two stereocentres. To illustrate FMO analysis of the Nazarov 
cyclisation, anti-product 114 is formed under the thermal conditions via the 
conrotatory ring closure of the ground state of HOMO cyclopentadienyl cation 
113, as shown in Scheme 40. Therefore, recent developments in the field of 
Nazarov cyclisation have led to a renewed interest in the activation of reaction 
by using Lewis acids. Scheme 40 illustrates the mechanism of Nazarov reaction 
where the substrate is activated by a Lewis acid generating a pentadienyl 
cation 116 that undergoes intramolecular 4π-electrocyclisation to form oxyallyl 
cation 117 as mentioned before. The re-protonation of enolate 118 gave 
cyclopentenone 119 as the final product. The above finding is consistent with 
the study by West.(53c) West examined the  impact of Lewis and Brønsted acids 
in Nazarov cyclisation.  
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Scheme 40: The FMO analysis and mechanism of Nazarov cyclisation 
Another effect could influence on the activation of the Nazarov cyclisation, 
Frontier and co-workers(54) postulated that the presence of electron-
withdrawing and electron-donating groups can polarise a pentadienyl cation as 
shown in Scheme 41. As can be seen, the electrocyclisation depends on the 
location of the stabilising substituent for example electron donating groups 
should accelerate the rate of reaction when in the α position (C-4) and 
decelerate in the β position (C-5).  
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Scheme 41: The effect of polarisation on Nazarov Reaction 
The present study explores the influence of the electron withdrawing group 
(EWG) and R2 on the dienone. Substrates with a carbomethoxy group, as an 
electron withdrawing group (EWG), at the α position (C-4) and (R2 = 2,4,6-
trimethyoxyphenyl [TMP] and cyclohexyl [Chx]), can increase the reaction rates 
and be cyclised efficiently leading to improved regioselectively of the double 
bond and to give excellent yields. On the other hand, it was noted that the 
cyclisation of substituent (EWG = H) was low-yielding (30-42%).(54)  
6 Diels-Alder reaction 
The Diels-Alder reaction is the cycloaddition reaction of a conjugated diene to 
a dienophile to produce a cyclohexene. The reaction was discovered by 
German chemists Otto Diels and Kurt Alder, who received the Nobel prize for 
this achievement in 1950. The normal Diels-Alder reaction is favoured by 
electron withdrawing groups on the dienophile and by electron donating 
groups on the diene. In particular, the reaction is a stereospecific syn 
(suprafacial) addition with respect to both the alkene and the diene. There are 
two possible stereochemical orientations with respect to the diene. In the 
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endo mode the reference substituent on the dienophile is oriented toward the 
π orbitals of the diene. Whereas in the exo mode the substituent is oriented 
away from the π system, as illustrated in Figure 4.(55) 
 
Figure 4: Two stereochemical orientations 
The following scheme shows various substrates which are good and poor 
Diels−Alder components (Figure 5). 
 
Figure 5: Diels−Alder components 
Tandem cycloadditions utilise olefins to obtain new alkenes that can be 
reacted further. Cycloadditions are therefore well suited for use in tandem 
reactions,(56) and can even be used as all steps in a tandem process for 
example, Winkler has showed an alternative tandem Diels-Alder cycloaddition 
approach to the synthesis of fluorenone by the reaction of nona-1,3,6,8-
tetraene and divinyl or alkynyl vinyl ketones which is based on Scheme 42.(56) 
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Scheme 42: Tandem /cycloaddition reaction 
Cycloadditions can be also used in addition to other reaction types in a domino 
reaction. Marko has reported the synthesis of novel of tricyclic systems based 
on the reaction of 2-pyrone with α,ω-dienes. As can be seen, the final adducts 
without CO2 were obtained as the sole product, as shown in Scheme 43.(57) 
Marko and co-workers examined various α,ω-dienes with the same starting 
material, which was 2-pyrone. Marko and co-workers have separated their 
bicyclic lactones, which can be considered as interesting intermediates in the 
synthetic chemistry via this methodology, which can be employed for the 
stereo-controlled preparation of highly oxygenated cyclohexane ring 
systems.(58) 
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Scheme 43: Tandem process 
The biological effectiveness of natural and synthetic substituted pyridine 
motifs is well known and it is therefore easy to understand the use of tandem 
reactions to make them.(59) There are two reports which have demonstrated 
the conversion of a range of substituted 1,2,4-triazines into highly substituted 
pyridines. Taylor and co-workers have developed a procedure called Tethered-
Imine-Enamine (TIE) methodology. In the first report, they prepared the 
corresponding pyridines from the reaction of 1,2,4-triazines with 
cyclopentenone using chloroform, 4Å molecular sieves, and amines in order to 
afford substituted pyridines which are shown in Scheme 44 via Diels-Alder 
reaction.(59) Whilst in the second one, they extended their synthesis of 
pyridines by using some cycloketones and also reported a tandem oxidation 
process reaction as a direct methodology for the synthesise of substituted 
pyridines in good yields.(60) 
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Scheme 44: TIE methodology 
7 Indole alkaloids 
One of the most significant nitrogen-containing secondary metabolites are 
indole alkaloids which include one or more indole/ indoline rings in their 
structures.(61) It has been noticed that these structures have obvious 
pharmacological activities and clinical uses.(62) Most sources of indole alkaloids 
originate from plants, animals, prokaryotic microorganisms and eukaryotic 
organisms such as bacteria and fungi (Ascomycota).(63) The great interest by 
many academic scientists results from the high biological activity of these 
compounds. Macroline 137 and Sarpagine 138 indole alkaloids which are 
extracted from the plants to produce a drug popular in medicine.(64-66) In 
addition, different indole alkaloids were extracted from Alstonia trees to give 
high biological activity against protozoal diseases.(67, 68) Also Emetine 139, one 
of the indole alkaloids, was compared with indolic natural products such as 
Tubulosine 140 to kill parasite species (Figure 6).  
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Figure 6: The Macroline, Sarpagine, Emetine, and Tubulosine indole alkaloids 
7.1 Carbolines 
Carboline derivatives (pyrido[2,3-b] indoles) are one of the biologically active 
compounds that are often used as antivirals and antitumor agents. As a result, 
the interest in the preparation of such compounds has been recently 
increased. These compounds form intercalation complexes with DNA 
molecules to inhibit the key DNA replication enzyme topoisomerase II.(69) Some 
publications have mentioned that carboline compounds were employed to 
reduce the anxiety, inflammation and stimulate the central nervous system.(70) 
Three types of carbolines can be classified depending on the location of 
nitrogen, hence, they are considered as the core structure of some natural 
products, as described in Figure 7.(71) 
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Figure 7: The simple structures of α- (141), β- (142), and γ-carbolines (143) 
One of the most significant reactions that is employed for the synthesis of β-
carbolines is Pictet-Spengler reaction. This system of synthesis can vary 
depending on the number of steps of reaction. An example of this is the study 
carried out by Konakahara and co-workers (2012)(72) in which they synthesised 
β-carboline derivatives through three steps by the Pictet-Spengler reaction of 
L-tryptophan(73) or of indolylethylamines(74) (Scheme 45). 
 
Scheme 45: A conventional route to synthesise of β-carbolines derivatives 
7.2 Synthesis of tetrahydro-β-Carbolines 
Tetrahydro-β-carbolines (THβC) are one of the most widely used groups of 
indole alkaloids and have been extensively used for biological purposes. The 
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common structure of tetrahydro-β-carboline products consist of three linked-
rings, with a partially hydrogenated pyridine ring. Tetrahydro-β-carboline 
derivatives play a vital role in the metabolism of animal and plant biological 
processes where the impact of these compounds on monoamine oxidases is 
shown by linking to benzodiazepine receptors.  
There are excellent methodologies that are employed to synthesise THβCs 
such as the Pictet-Spengler reaction(75) and Bischler-Napieralski cyclisation,(76) 
however, other authors have formed THβCs in a variety of ways.(77-80) For 
example, various THβC compounds have been synthesised by Pictet-Spengler 
reaction and identified as inhibitors of the Breast Cancer Resistance Protein by 
Spindler and co-workers (2016).(75d) According to a first definition suggested by 
Ross and co-workers (1998) who used ABCG2' term to refer to the gene which 
is the responsible for the breast cancer resistant protein (Scheme 46).(75f) 
 
Scheme 46: Pictet-Spengler and Bischler-Napieralski cyclisations of tryptophan 
to afford tetrahydro-β-carbolines 
Recent developments in the field of the synthesis of THβCs have led to 
increasingly rapid advances in the field of employing new techniques in organic 
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synthesis. Microwave irradiation can play an important role in reducing 
reaction times and improving yields. Many studies have described the use of 
microwave in the Pictet–Spengler reaction for the preparation of THβC 
scaffolds; however, most of this research used protic solvents with acid 
catalysed reactions.(78a,81)  Scheme 47 illustrates the Pictet-Spengler cyclisation 
of  tryptamine hydrochlorides and a number of substituted aldehydes under 
solventless microwave irradiation for 2.5-9 min at 200 W affording compound 
such as 156 in good yields. 
 
Scheme 47: The Pictet-Spengler cyclisation for the synthesis of tetrahydro-β-
carboline hydrochloride 
Furthermore, metal catalysed methodologies have been described for the 
construction of the THβC scaffold. In 2012, Driver and co-workers used 
amination of 4-(2-azidophenyl) pyridinium derivatives using a rhodium catalyst 
to easily produce β-carbolinium ions from ortho-substituted aryl azides, 
followed by reducing the ions using NaBH4 to give good recovery of 
tryptolines.(77b) In addition Iodine as a catalyst for tandem electrophilic 
cyclisation of 2-[3-(allylamino)prop-1-ynyl]anilines) derivatives was recently 
employed to prepare substituted 4-iodomethyl-tetrahydro-β-carbolines 
affording good to excellent yields (Scheme 48).(82) 
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Scheme 48: The construction of the THβC scaffold via metal-catalysed systems 
7.3 Pharmaceutical importance of tetrahydro-β-carbolines(THβCs) 
1, 2, 3, 4-Tetrahydro-β-carbolines are one of the most widely used groups of 
indole alkaloids and have been extensively used for their pharmacological 
importance that has been reported in 2005;(83) whereas, their biochemical 
functions have been studied in 2007.(84) In reviewing the literature, many 
reports can be found on their pharmacological properties and the relationship 
between THβC compounds and its C1 stereocenters. All these reviews 
emphasized the role of their biological activities. Due to the high biological 
activity of C1-substituted THβC substrates, many published papers significantly 
employed these compounds in pharmacological applications to be used as 
antiviral,(85-87) PDE5-inhibitory,(88) antitumor(89-92) and antimalarial(93-98) drugs.  
7.4 Antiprotozoal activity 
There is evidence that THβC compounds play a crucial role in exhibiting 
significant antiprotozoal activity, notably antimalarial, as shown in Figure 8. 
Globally, one of the major parasitic, infectious and life-threatening diseases in 
many regions of the world is malaria. The World Health Organisation (WHO) 
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found that more than one million people die and between 300 and 500 million 
are infected annually.(99) There would therefore seem to be a definite need for 
providing new antimalarial drugs via the isolation of antiprotozoal components 
from terrestrial plants and marine creatures. The relationship between the 
types of THβC compounds and the treatment of malaria has been widely 
investigated by a number of studies.(93-98 
An example of this is the study carried out by Quinn et al (2010) in which the 
isolation of a natural product 162 from a Sponge, is called Ancorina sp, with 
the full elucidation of its structure and its antimalarial activity. It was noticed 
that the resulting compound show significant IC50 values compared with each 
of chloroquine-sensitive (3D7) and chloroquine resistant (Dd2) strains of 
Plasmodium falciparum, namely 3.5 μM and 5.4 μM respectively.(93) The above 
similar finding is consistent with the study by Quinn. Chan et al revealed the 
same result of moderate antimalarial activity of similar compounds.(94)  
In 2012, the synthesis of a general structure of 1-substituted THβC derivatives 
163 was done according to the procedure of Gellis and co-workers with various 
substituents on the phenyl ring. They reported 20 substrates against the W2 
culture of Plasmodium falciparum strains, which they have compared with 
pyrimethamine, chloroquine, proguanil and other compounds showing 
antiplasmodial activity. The results, as shown in this study, indicated that para-
methoxy-substituted on phenyl ring at C1 stereocentre of THβC compound 
possess the most active substrate where it gave IC50 of 0.7 μM (W2 IC50 of 
chloroquine 0.7 μM).(95) Despite the synthesis and creation of new generation 
of treatments to destroy malaria, there are still new colonies of malaria 
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displaying potent resistance against those drugs. The synthesised 
spiroindolone compounds have paid attention in the last years through 
assaying of its mechanism against Plasmodium falciparum and comparing them 
with that of the existing antimalarial drugs. From the data in this work, it is 
apparent that the effective compound NITD609 164 provides the highest IC50 
value of 0.2 nM.(98) Two years later, this antimalarial drug has been adopted 
into phase II clinical trials due to its high activity.(100) 
 
Figure 8: THβCs with antiprotozoal properties 
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Chapter 2 Results and Discussion I: Electrocyclisation 
2 Introduction:  
6π-Electrocyclisation reactions are a relatively underused technique for the 
synthesis of complex motifs in organic chemistry which is surprising given the 
powerful nature of the reaction. These reactions are reversible therefore a 
conjugated polyene converts to a cycloalkene by ring closure, likewise, a 
cycloalkene can open to a conjugated polyene by ring opening. In this case, it 
was observed that the resulting stereochemistry of the final products in this 
reaction is depended on if it is carried out under photochemical or thermal 
conditions, as shown in Scheme 49.(101) 
 
Scheme 49: Ring closure of a conjugated polyene thermally and 
photochemically 
 
The conjugated π-system is often generated in situ, using various methods. In 
2014, the use of vinyl ketene-iminium salts in 6π/10π-electrocyclisations was 
reported to form substituted naphthylamines by Mesmaeker via the reaction 
of N,N-dimethyl-2-(2-vinylphenyl) acetamide 165 with triflic anhydride in the 
presence of Sym-collidine (2,4,6-trimethylpyridine), which is shown in Scheme 
50.(102) This reaction permitted a wide scope of functional groups from acyclic 
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to cyclic, electron rich and electron poor substituents and allowed access to 
more complex tricyclic compounds.  
 
Scheme 50: Electrocyclisation of ketene-iminium salt to naphthylamine 
Electrocyclisation can also be achieved using transition metals as a catalyst to 
form the necessary triene to obtain the desired polycycles. For instance, Saa 
et al describe a new synthetic process including ruthenium catalysed addition 
of alkene to 1,6-diyne compounds followed by electrocyclisation to afford 
bicyclic cyclohexadienes, as which shown in Scheme 51.(103) 
 
Scheme 51: The consecutive transformations of alkenes 
Furthermore, Liu has developed a novel tungsten mediated-electrocyclisation 
of o-[ethynyl] styrenes via tungsten vinylidene complexes to afford unusual 
1,2-iodo and aryl shifts. In light of this, one of the best metal complexes for 
the electrocyclisation of aromatic enynes, is W(CO)5(THF), which effected the 
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aromatisation of o-(iodoethynyl) styrene to give iodo-substituted 
naphthalene, which is based on Scheme 52.(104) A similar system has been 
reported by Akiyama.(105) 
 
Scheme 52: Aromatisation of substituted styrenes 
As shown by Ellman and co-workers, a range of α,β-unsaturated imine 
substrates can be coupled with alkynes in the presence of a ruthenium catalyst 
to afford dihydropyridines through a 6π-electrocyclisation reaction. These 
reactions also work well for strained bicyclic enamines with bridgehead 
unsaturation, as shown in Scheme 53.(106) 
 
Scheme 53: Synthesis of dihydropyridines 175 
2.1 Carbocyclic electrocyclisation:  
Several methods have been developed for the construction of new rings via 
electrocyclisation reactions. Langer has reported the formation of 1,2-dihydro-
carbazoles by a domino twofold Heck-6π-electrocyclisation from 2,3-dibromo-
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N-methyl indole 176 and various acrylates catalysed by Pd(OAc)2, which is 
presented in Scheme 54.(8) Formation of the initial product breaks the 
aromaticity of the indole and therefore a rapid isomerisation takes place to 
generate the indole product and to restore it. 
 
Scheme 54: Synthesis of 1,2-dihydrocarbzoles by 6π-electrocyclisation 
The successful synthesis of the carbazoles by electrocyclisation reaction 
methodology opened new possibilities for the preparation of many analogues 
of substituted carbazoles by utilising different conditions. Pindur has described 
the 6π-thermal electrocyclisation of 2,3-divinyl-1H-indoles to annulated 
carbazole derivatives in yields of (7-84%). The reaction of 180 in boiling 
bromobenzene and in the presence of Pd/C as a dehydrogenation catalyst 
afforded 182 as novel compounds, as shown in Scheme 55.(33b) 
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Scheme 55: 6π-Thermal electrocyclisation by Pd/C 
The three trienes, shown in Scheme 56, have been prepared and cyclised by 
Marvell and co-workers in the presence of inert solvents at 120-150   ͦC. This 
work also demonstrated the influence of the triene terminal substituents on 
the electrocyclisation process. The results indicated that the substituent 
interaction would play a dominant role in pericyclic reactions, and this effect 
is called a "push-pull" substitution. It has shown that the substituents in the 
trans positions have little steric interactions but such steric effects dominate 
in the cis position. Consequently, the push-pull substitution have little effect 
on rates of triene electrocyclisations.(107) 
 
Scheme 56: Electrocyclisation for substituted trienes 
6π-Electrocyclisations can also proceed by photochemical promotion. For 
example, the electrocyclisation of 1,2-bis(1-phenylvinyl) benzene 186 to o-
xylylene 188 demonstrated by Miyashi, is unique for the generation of o-
xylylene derivatives; although the explanation of its mechanism has yet to be 
investigated (Scheme 57).(108) 
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Scheme 57: Electrocyclisation of 1,2-bis(1-phenylvinyl) benzene 186 
In view of the synthesis of the corresponding substituted cyclohexa-1,3-
dienes by the above reaction, another method was devised, by de Meijere via 
heating in n-Bu2O as a solvent. Scheme 58 shows the 6π-electrocyclisation of 
the 1,3,5-(E,Z,E)- hexatrienes 189 to obtain compound 190. Whereas, under 
the irradiation of 189 in diethyl ether at  ̶ 5  ͦC, no electrocyclisation reaction 
took place, instead the irradiation produced (E to Z) isomerisation (Compound 
191).(109) 
 
Scheme 58: Thermal & photochemical reactions of 1,3,5-(E,Z,E)-hexatrienes 
189 
A new strategy for the aromatic annulation of cyclic ketones is the propargyl 
alcohol coupling reaction shown in Scheme 59. In the presence of a palladium 
[0] complex as a catalyst, vinyl triflate 192 afford vinyl alcohol 193 that reacts 
with the vinyl Grignard reagent followed by 6π-electrocyclisation via heating 
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the mixture to effect closure. Treatment with MnO2 oxidised the diene 
formed into the arene product 197.(110) 
 
Scheme 59: Electrocyclic ring closure oxidation strategy 
Tilve and co-workers have developed an efficient synthesis of indolecarbazole 
alkaloids via the thermal electrocyclisation route of a 2,3-divinylindole 198 
and subsequent oxidation to afford 2-nitrophenyl carbazole 199. They 
examined several reaction conditions involving various solvents such as 
dichloromethane, DMSO and nitromethane (Scheme 60).(111) Iodine was used 
in this case to oxidise the initial product to the carbazole. 
 
Scheme 60: Electrocyclisation and aromatisation step of 2,3-divinylindole 
Tang has developed a novel synthesis of substituted cyclopentanones 201 via 
the transition metal catalysed reaction of diazo compounds with ketenes, as 
shown in Scheme 61.(112) The initial alkene undergoes acid catalysed Nazarov 
4π-electrocyclisation ring closure to give the final product. 
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Scheme 61: One-Pot synthesis of some substituted cyclopentanones 
2.2 Project Introduction 
The objective of this project was to extend the concept of TOP chemistry to 
enable the elaboration of simple to complex molecules (trienes) through the 
reaction of dieneols with phosphorane ylides in the presence of oxidants. A 
proposed four step oxidation-Wittig, 6π-electrocyclisation, and oxidation 
sequence would construct the C-C bond and examine 6π-thermal ring 
closure/oxidation to make rings (Scheme 62).  
 
Scheme 62: The proposed sequence of this project 
The study and development of this process would unlock a general method for 
the construction of C-C bonds from diols under mild reaction conditions via 
TOP reactions, followed by examination of tandem 6π-thermal 
electrocyclisation/Diels-Alder reactions of synthesised trienes. Scheme 63 
illustrates an attempted route to synthesis complex compounds.  
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Scheme 63: An attempted application of trienes via tandem 6π-thermal 
electrocyclisation/Diels-Alder reactions 
2.3 Preparation of substrates: 
To test this methodology the synthesis of following dieneols was undertaken 
individually, as shown in Figure 9:  
 
Figure 9: The starting materials (synthesised diols) 
The initial substrate chosen was benzene-1,2-dimethanol 202. Although part of 
the conjugated 6π-system is embedded into the aromatic benzene ring, the 
ease of preparing this substrate made it good starting point. The reduction of 
phthaldialdehyde 208 to afford benzene-1,2-dimethanol 202 by using sodium 
borohydride in methanol, was accomplished in 33% yield, as shown in Scheme 
64. The low yield reflects the difficulty in isolating the polar product.                                                                            
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Scheme 64: Reduction of aldehyde 205 to alcohol 202 
It was shown from the analysis of 1H-NMR that the protons of aldehyde group 
disappeared and were replaced by the hydroxyl group (a, 3.07 ppm), and the 
methylene group (b) was appeared at 4.76 ppm. Further analysis noted that no 
13C-NMR peak of aldehyde was observed; while at peak 64.05 ppm was 
attributed to (-CH2-) groups.(113) 
Additionally, The transformation of pyromellitic acid 209 to 
tetraethylpyromellitate 210 was accomplished in 30% yield according to the 
Bailey and co-workers procedure.(114) Despite the use of azeotropic 
esterification, the reaction does not work well0, as shown in Scheme 65. 
 
Scheme 65: Fischer esterification of pyromellitic acid 209  
Tetraethyl pyromellitate 210 reduces to 1,2,4,5-tetrakis(hydroxymethyl) 
benzene 203 via reduction reaction using Lithium aluminum hydride in 
anhydrous THF (Scheme 66). The main disadvantage of this experimental 
method is that no 203 was obtained after its workup. Therefore, this 
compound was prepared by adapting the procedure used by Lenz (1989)(115) in 
which the crude product of the previous reduction reaction was acidified by 
H2SO4 and then refluxed in pyridine for an hour affording a white solid as a 
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product. This experiment yielded 50% of 203. NMR analysis confirmed the 
formation of the desired product; 1H-NMR peaks were found at 4.50 ppm (s, 
8H) and 7.40 ppm (s, 2H) belonging to (-CH2-OH) and the protons of the 
benzene ring respectively.   
 
Scheme 66: The reduction reaction of tetraethyl pyromellitate 207 by LiAlH4 
Methyl-N-methyl-2-indole-carboxylate 212 was successfully prepared by 
esterification of 1H-indole-2-carboxylic acid 211 in the presence of methyl 
iodide in DMF under different basic conditions. Its 1H-NMR spectra further 
confirmed these structures. Thus, the peak at 4.12 ppm (s) was assigned to the 
(N-CH3) of 212, while ester groups (O-CH3) appeared at 3.95 ppm (s).(116) The 
second of the process, based upon Bennasar’s methodology, was the Vilsmeier 
formylation reaction (Scheme 67).(117) The reaction was performed at 50  ͦC, the 
crude was neutralised with a solution of 2M sodium hydroxide (NaOH) as a 
base to afford the final product methyl 3-formyl-1-methyl-2-indole carboxylate 
213 in 50% yield. NMR analysis showed a singlet peaks at 10.62 ppm (CHO) and 
the proton at the position 3 on the pyrrole ring (7.33 ppm) disappeared and 
was replaced by the aldehyde proton, indicating this reaction proceeded as 
planned.(118)  
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Scheme 67: The synthesis of aldehyde 213: (i) CH3I, K2CO3, DMF, 80   ͦC, 3-4 
days; ii) POCl3, DMF, rt (30 min), then heating at 60   ͦC, 3 h. 
Compound 212 was converted into the corresponding 2-hydroxymethyl-1-
methyl indole 214 via a reduction reaction by using lithium aluminum 
hydride(119a) and then reacted via two paths. The first reaction was done by the 
Vilsmeier formylation reaction using POCl3 and DMF. One unanticipated finding 
was that the sole formation of N-methyl-3-formyl-2-chloromethyl indole 215 
was observed. While, the second reaction involved the formylation reaction of 
214. Two methodologies were employed to afford 2-(N-
methyl)indolylmethylacetate 216, where no significant difference was found 
when lithium chloride catalysed the  acetylation of 214 in the presence of 
acetic anhydride. While a good result was obtained, compound 214 was 
treated with triethylamine, acetic anhydride and 4-(dimethylamino)pyridine 
(DMAP)-promoted acetylation.(119b) 1H and 13C NMR on this material (216) 
confirmed the disappearance of the alcohol signal and presence of signals due 
to acetyl group, with peaks at 1.99 ppm (3H, s, COCH3) and 171.54 ppm 
(COCH3) observed (Scheme 68). Following the success of these reactions, N-
methyl-3-formyl-2-indolylmethylacetate 217 was synthesised from the 
reaction of 216 with POCl3 with a 55% yield.  
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Scheme 68: The synthesis of aldehydes 215 and 217 via Vilsmeier formylation: 
(i) LiAlH4, dry THF,  ̶10 °C to rt, 5-10 min; (ii) POCl3, DMF, rt (30 min), then 60  
 Cͦ, 24 h; (iii) acetic anhydride, Et3N, DMAP, ether, rt, 24 h; (iv) LiCl, acetic 
anhydride, rt, 24 h, no reaction; (v) POCl3, DMF, rt (30 min), then heating at 60 
 Cͦ, 3 h. 
Various indole derivatives have been used as starting materials in reduction 
reactions using LiAlH4 as a powerful reductant. In the literature, different 
authors have reported the synthesis of desired diols at a variety of 
temperatures (0  ͦC conditions to 70  Cͦ conditions). In this work, the successful 
methodology employed to synthesised diols chemoselectively used LiAlH4 at   ̶
10  ͦC conditions with a suitable workup. The results in Scheme 69 shows two 
substrates namely, methyl-N-methyl-2-indole carboxylate 212 and methyl-3-
formyl-1-methyl-2-indole carboxylate 213, which were reacted with LiAlH4 
under  ̶ 10  ͦC in dry THF,(120a) and N-methyl-3-formyl-2-indolylmethylacetate 
217 was reacted with NaBH4 at 0-5  ͦC. However, this reaction proved to be 
unsuccessful as no reaction occurred. In terms of 214, the successful reduction 
reaction was obtained in 90% yield where NMR analysis confirmed the 
conversion of 212 into 214 It was noted that 13C-NMR analysis showed the 
singlet peak at δ = 4.74 ppm (57.55) is related to methylene group (a) in 214, as 
shown in Scheme 69.(120a) Many attempts were tried to reduce N-methyl-3-
methanol-2-indolylmethylacetate 217 to N-methyl-3-methanol-2-
Chapter 2                                                                            Results and discussion I 
63 | P a g e  
 
indolylmethyl-acetate 219 by reaction with NaBH4 in methanol at 0-5  Cͦ, but 
unfortunately no product  was observed from this stating material.  Analysis of 
this crude mixture by NMR revealed that starting material 217 was 
decomposed before the reaction workup.  
 
Scheme 69: The reduction reaction of 212, 213 and 217 
The attempted synthesis of diol 205 has been shown to be critical due to its 
decomposition through chromatographic purification. Therefore, it was found 
that a disappointing yield was obtained from this reaction despite the 
formation of the desired product 205.  It was formed in 40% yield with the 
appearance of diol peaks at 1.98 (s, 1H, d), 2.6 (s, 1H, b), 4.82 (s, 2H, c) and 
4.87 (s, 2H, a) ppm, as depicted above in Scheme 69. Therefore, reduction of 
213 to 205 proved to be more difficult than initially anticipated. A possible 
explanation for this result may be the synthesis of the undesired 3-methyl 
indole derivative 220. This was proposed to occur from the over-reaction of 
the initial product, as shown in Scheme 70.(120a)    
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Scheme 70: The predicted mechanism of diol over-reaction 
Indeed, this investigation is consistent with the findings of Skibo and Xing 
(2001) who showed that the selective reduction of 2,3-dicarbonyl indoles 221 
is possible (Scheme 71), but that yields are often low.(120b)  
 
Scheme 71: The Synthesis of 2,3-dihydroxy methyl indole derivatives 
At first glance, a synthetic route for preparing the compound 223 uses methyl 
iodide as a methylating agent with indole-2-carboxylic acid 212 yielding in 92% 
yield. Next, substrate 224 was synthesised with an electron withdrawing 
protecting group (Boc) from methyl-2-indole-carboxylate 223. In terms of 224, 
treatment of 223 with di-tert-butyl dicarbonate (Boc2O) in acetonitrile yielded 
the corresponding ester 224 where, consistent with findings by Freed et al,(121) 
the signals at 1.55 ppm (s) and 3.84 ppm (s) could be assigned to three methyl 
groups [-(CH3)3] and ester group (-OCH3). However, regarding the formylation 
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reaction of 224 into 225, there was an unexpected result, no reaction was 
observed (Scheme 72). 
 
Scheme 72: The synthesis of methyl-3-formyl-N-(tert-butyloxycarbonyl)-2-
indole carboxylate 225 
As the use of Boc as a protective group had not proved to be a useful 
improvement in this project, the next step was to find of alternative protecting 
groups. The compound 226 was prepared by adapting the procedure used by 
Kerr and Karadeolian (2010).(122) In particular, the synthesis of 226 was 
problematic in terms of its yield. At first glance, many attempts were employed 
through the use of different equivalents of each component in this reaction 
(Table 4). 
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Table 4: Attempts of tosylation reaction by TsCl using different bases 
 
Run[a] 223 (eq.) TsCl (eq.) Base (eq.) Solvent 226% 
A 1 1.3 NaH (1.3) DMF 33 
B 1 2.2 NaH (1.3) DMF 0 
C 1 1.8 K2CO3 (2.9)[b] pentanone 0 
D 1 2.0 NaH (1.3) DMF 21 
E 1 1.1 Tbhs (0.07)[c] CH2Cl2 0 
[a] A, B, and D reactions were carried out in DMF, stirring for 24 hours at 
room temperature (rt) [b] C reaction was done at reflux for (4-24 h) [c] E 
reaction was carried out at rt with stirring for 24 h using tetrabutylammonium 
hydrogensulfate (Tbhs) in CH2Cl2.  
It can be seen from the data in Table 4 that, the method A worked better than 
the other different conditions. No reaction was detected when methods B, C 
and E used. This outcome is contrary to that of Lindsey et al (2007) who 
reported a wonderfully efficient methodology.(123)   
As mentioned before, the Vilsmeier formylation reaction is a typical approach 
to gain the desired aldehydes. Two strategies were employed to synthesise 
227 from 226. First, the synthesis commenced with the key formylation 
reaction(117) according Bennasar’s methodology, where the transformation of 
methyl N-tosyl-2-indole carboxylate 226 into methyl-3-formyl-N-tosyl-2-indole 
carboxylate 227 was disappointing, proceeding in just 20% yield. This result 
corroborated the ideas of Kehler et al (2010), who suggested that it was 
difficult to formylate tosylated indole products, so it was necessary to 
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detosylate these substrates prior to the Vilsmeier formylation reaction.(124a) 
Meanwhile, an alternative method was applied by using a AgOTf-promoted 
formylation reaction,(124b) using dichloromethyl methyl ether (Cl2CHOCH3) as 
the formylating reagent.(125) For the synthesis of 227, dichloromethyl methyl 
ether was adding to a cooled solution of 226 in dichloromethane, followed by 
added silver triflate to afford exclusively methyl-3-formyl-N-tosyl-2-indole 
carboxylate 227 in 92% yield (Scheme 73). However, this method is still not 
ideal given the high cost of the starting materials.  
 
Scheme 73: The synthesis of methyl-3-formyl-N-tosyl-2-indole carboxylate 227 
The proposed formylation mechanism would proceed via the reaction pathway 
with AgOTf shown in Scheme 74. Initially, activation of dichloromethyl methyl 
ether (Cl2CHOCH3) by AgOTf may occur, leading to a highly active intermediate 
228. Nucleophilic addition of indole to 228 preferentially at the position 3, 
followed by hydrolysis would provide the corresponding aldehyde 227. 
Although highly acidic trifluoromethanesulfonic acid is generated under the 
reaction conditions, the formalyation of indoles is tolerated under the low 
reaction temperature (  ̶78  Cͦ).(124b) 
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Scheme 74: The feasible mechanism of the AgOTf-promoted formylation 
reaction 
1H-NMR analysis of the product 227 revealed that it had a signal at 10.13 ppm 
(1H, s) is attributed to aldehyde proton, while peaks at 2.38 ppm (3H, s) and 
4.11 ppm (3H, s) belonging to the (Ar-CH3) and (O-CH3) groups respectively.  
Another approach to the synthesis of 225 and 227 from 229 has been 
investigated as shown in Scheme 75. It was decided to alter the sequence of 
the reactions and carry out the formylation of 223 followed by protection. The 
Boc protecting reaction with 229 appeared extremely successful, 83% 
conversion into the product 225 being observed when it is performed in the 
presence of DMAP with di-tert-butyl dicarbonate (Boc2O) in dichloromethane. 
1H-NMR on 225 confirmed the appearance of the signal due to the carbonyl 
group of aldehyde at 10.21 ppm (1H, s) and the likely introduction of a new 
substituent (Boc group) at 1.67 ppm (9H, s). However, the unsuccessful 
tosylation transformation of 229 into 227 was observed. This reaction was also 
disappointing however; after 24 hours, and many attempts, only 30% total 
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conversion was obtained where a mixture of both tosyl chloride and stating 
material 229 was present as well.   
 
Scheme 75: The protection of the formylated 229 
After the disappointing synthesis of diols 219 and 205, examination of the 
synthesis of alternative diols which have N-protective groups instead of the 
methyl group was the next objective. It was anticipated that the electron 
withdrawing protecting group would prevent overreduction.  Thus, with 
methyl 3-formyl-1-(tert-butyloxycarbonyl)-1H-indole-2-carboxylate 225, and 3-
formyl-methyl N-tosylindole-2-carboxylate 227, the performance of these 
compounds in reduction reaction was examined (Scheme 76, Table 5).  
 
Scheme 76: The reduction reaction of 225 and 227 by LiAlH4 
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Table 5: Using different reducing agents for the synthesis of diols 
 
 
 
 
The initial reaction with compound 225 and LiAlH4 was low yielding with 5.5% 
conversion into the product N-(tert-butyloxycarbonyl)-2,3-bis(hydroxyl-
methyl)indole 206 being observed at  ̶ 10  ͦC. However, upon heating at 70   Cͦ, 
this was slightly improved to 11%. The most striking result to emerge from the 
data is that the formation of an unexpected product from this reaction 
(Scheme 77); this is consistent with the ester substituent not being reduced by 
LiAlH4,(120a) with 18% of this side-product (1-(tert-butyl)-2-methyl-3-
(hydroxymethyl)-1H-indole-1,2-dicarboxylate 230) isolated by 
chromatography. Furthermore, the use of diisobutylaluminum hydride solution 
(DIBAL) afforded a disappointing result as a reducing agent with 225.   
 
Scheme 77: The synthesis of side-product 230 from the nonselective reduction 
LiBH4 was next tested as an alternative reducing agent. The reaction of lithium 
borohydride with methyl 3-formyl-1-(tert-butyloxycarbonyl)-1H-indole-2-
carboxylate 225 led to a significant improvement; N-(tert-butyloxycarbonyl)-
Entry SM Reduction agents Products 
  LiAlH4  LiBH4 DIBAL  
Yield% Yield% Yield% 
1 225 
225 
5.5 ( ̶  10   ͦC) 
11 (70   ͦC) 
46 
0 
0 
0 
206 
206 
2 227 0 71 0 207 
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2,3-bis(hydroxylmethyl)indole 206 was isolated in 46% yield, as shown in 
Scheme 78. The NMR spectra showed that the hydroxyl groups were present 
as well as the methylene groups being shielded and observed at δ = 2.10 ppm 
(br.s, 1H, b), 3.99 ppm (s, 1H, d), 4.85 ppm (s, 2H, a), and 4.90 ppm (s, 2H,  b) 
respectively. In addition, three methyl group that are related to (Boc) group 
were observed at δ = 1.75 ppm. This successful methodology was then 
extended to the synthesis of N-(toluene-4-sulfonyl)-2,3-
bis(hydroxylmethyl)indole 207 from 3-formyl-methyl N-tosylindole-2-
carboxylate 227 where the hydroxyl and methylene groups were observed at δ 
= 1.61 ppm (s, 2H, d, b), 4.84 ppm (s, 2H, a), 4.98 ppm (s, 2H, c) in 71% yield 
respectively (Scheme 78).  
 
Scheme 78: The reduction reaction of 225 and 227 by LiBH4 
2.4 Preparation of phosphorane ylides  
To test the proposed 6π-electrocyclisation/Diels-Alder methodology it was 
necessary to prepare phosphorane ylides with an appended alkene group.  
All halides required for the synthesis of phosphonium salts in this chapter were 
prepared via a range of approaches. Four types of 2-haloacetyl-allyl esters 
(Scheme 79, Table 6) were prepared via amidation under basic conditions(126) 
as well as acidic Fischer esterification(114)  by acid. The 45-50% yields of entries 
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(1-3) were slightly low due to the extraction solvent, utilising acids such as 
(H2SO4, CH3COOH, CF3COOH) and a dehydration step that occurs in the 
reaction.  
Entries 3-6, three methods under different conditions were employed to 
synthesise allyl esters 238 and 240 from allyl alcohol 231 and 3-butenyl alcohol 
239 respectively. It was found that the Fischer esterification by using acetic 
acid as well as using DCC and DMAP in acetonitrile gave reasonable yields of 
entries 3 and 4. However, a substantially better catalyst for the synthesis of 
238 and 240 proved to be pyridine (Table 6, entries 5 and 6), which gave in 
100% and 88% yield in dichloromethane respectively.(127) The synthesis of each 
of these esters was evident from the characteristic alkene peaks in the 1H-
NMR. It was immediately clear that the methyne (CH) proton displays a 
characteristic ddt signal between 5.80-6.00 ppm e.g. entry (1), 5.93 ppm for 
entry (2), 5.88 ppm for entries (3-5) and multiple peaks at 5.74-5.84 ppm for 
entry (6). 
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Scheme 79:  Preparation of allyl esters derived from allyl alcohol 231 and 3-
butenyl alcohol 239 
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Table 6: Preparation of allyl esters derived from allyl alcohol 231 and 3-butenyl 
alcohol 239 
Entry  Halo 
compounds 
Product Yield% Catalyst 
 
1 
 
 
 
231 
 
 
232 
 
 
236 
 
50 
 
Base a 
pyridine 
 
2 
 
 
231 
 
233 
 
 
237 
 
45 
 
Acid b  
CH3COOH 
 
3 
 
 
 
231 
 
 
234 
 
238 
 
45 
 
Acid b  
CF3COOH 
 
4 
 
 
231 
 
 
234 
 
 
238 
 
40 
DCC, 
DMAP in 
MeCN c 
 
5 
 
 
231 
 
 
234 
 
 
238 
 
100 
 
Base d 
pyridine 
 
6 
 
 
239 
 
235 
 
 
240 
 
 
88 
 
Base d 
pyridine 
a) Prepared according to Evans et al(126), b) Prepared according to Bailey and 
co-workers (114); c) Reaction was carried out on N,N′-
dicyclohexylcarbodiimide (DCC) (1.1 equiv.) and DMAP (0.2 equiv.) in 
acetonitrile (127); d) Prepared according to Anderson et al.(128) 
Furthermore, the preparations of N-allyl chloroacetamide 245, N,N-diallyl 
chloroacetamide 246, and N-allyl-N-benzyl chloroacetamide 247 were 
achieved by adapting literature method for the general preparation of amides 
by using Evans’s protocol (Scheme 80).(126)  
Chapter 2                                                                            Results and discussion I 
75 | P a g e  
 
 
Scheme 80: The synthesis of allyl amides derived from chloroacetyl chloride 
and allyl amines 
NMR analysis of 246 clearly showed standard peaks for allyl and methyl groups 
and no evidence to suggest the presence of rotamers. However, the diagnostic 
proton NMRs compounds (245 and 247) were more complicated due to the 
presence of amide rotamers. Rotamers are conformational isomers and are 
not resolved on the NMR timescale due to restricted rotation about the C-N 
bond as a result of delocalisation of the N lone pair into the carbonyl (Scheme 
81).  
 
Scheme 81: Representation of the amide rotamers 
It can be seen from the data in Figure 10 that the 1H-NMR spectrum of 
compound 245 presented duplicated signals for each NH, COCH2-. In terms of 
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allyl amide 245, the multiplet signal of -NHCH2- was present to a lesser extent 
at 3.75-3.80 ppm for both minor and major rotamers. Meanwhile, the -NH 
showed two signals at 5.19 ppm (s, major) and 5.20 ppm (s, minor). In contrast, 
the doublet signals for the allyl -NCH2- of 247 refers to 3.89 ppm and 4.01 ppm 
for the major and minor rotamers. Additionally, the multiplet peak of 4.57-4.60 
ppm assign the signal of -CH2 on position 6. These results confirmed the 
presence of rotamers. 
 
Figure 10: 1H-NMR signal duplications and other NMR details of 245 and 247 
The next step was the preparation of phosphonium salts from these 
compounds. The required phosphonium salts were prepared by reaction of 
triphenylphosphine and the required halo ester or amide compounds using the 
‘salt-method’ via SN2 substitutions. This is in fact a two-step process which 
involves initial synthesis of the phosphonium salt from phosphine and the 
requisite halo esters amide compounds, then a subsequent deprotonation step 
to form the resulted ylide. The key to this strategy is the strength of base used 
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and this obviously depends on the CH acidity of the phosphonium salt 
conjugate acid.  As firstly noted by Michaelis and Gimborn (1984)(129)  the use 
of stabilised ylides (salt pKa ~ 9) can be reacted successfully with bases such as 
hydroxide or alkoxide compared with unstabilised ylides (salt pKa ~ 22), which 
require stronger bases such as alkyllithiums.(130) Scheme 82 shows two-step 
overall process for the synthesis of methyl 
(triphenylphosphoranylidene)acetate 52 affording a 76% yield of the 
product.(34a) 
 
Scheme 82: The ‘salt method’ for the preparation of ylides 
In most cases the ‘phosphonium salts’ were not solids as expected, but proved 
to be a hygroscopic syrup, hence, they could not be crystallised or purified, but 
it was found that this material could be carried through to the next stage 
without further purification to synthesise the desired ylides. The resulting 
phosphonium salts from the reaction of allyl ester and allyl amide failed based 
on the 1H-NMR analysis of the corresponding salts, which did not show any 
peak related to the allyl group. Running the 31P{1H}-NMR for the entry (1 and 2, 
Table 7) there were two peaks at -5.95 ppm and 20.83 ppm that related to 
Ph3P and a phosphonium salt, but not the one that was desired. The product 
could not be identified spectroscopically hence, no attempt was made to 
identify this undesired phosphonium salt. To the best of our knowledge, there 
is no literature evidence regarding the decomposition of allyl ester ylides (or 
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their phosphonium salts) but it is possible that triphenylphosphine attacks the 
allyl ester group rather than the bromoalkane respectively. As can be seen 
from the Scheme 83 and Table 7, neither different solvents nor leaving groups 
worked. These reactions were all repeated several times to confirm that it was 
the procedure rather than experimental error that was the problem. These 
results suggest that trying different starting materials and conditions could be 
useful to synthesise the desired phosphorane ylides by using the salt 
method.(34a)  
 
Scheme 83: The unsuccessful synthesis of phosphorane ylide 248 
Table 7:The unsuccessful synthesis of phosphorane ylide 248 
Entry Halo 
compounds 
PPh3  
(equiv.) 
Conditions/ 
24 h 
 
1  
 
236 
1.2 
 
Toluene, rt 
MeCN, 50   ͦC 
 
2 
 
238 
1.1 
 
Toluene, rt 
Toluene, 130   ͦC 
 
3  
237 
1.1 TFA, 55   ͦC 
 
4 
 
238 
1.02 
 
MeCN, 90   ͦC 
MeCN, 130   Cͦ 
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The experiments above showed that the preparation of allyl ester ylides was 
unsuccessful, so other starting materials with allyl amides was attempted 
instead, as illustrated in Table 8. The resulting phosphonium salt and the 
compounds where checked for success by 31P{1H}-NMR.  The key signals of 
entries 3-5 in the 31P{1H}-NMR data were between 17.7 (s) ppm to 24.9 (s) 
ppm. The proton NMRs of these compounds proved to be complicated due to 
the presence of rotamer forms that are not resolved on the NMR timescale 
due to restricted rotation about the C-N and C-O bonds, as shown above in 
Scheme 81.  
The successful results obtained from the preliminary synthesis of phosphorane 
ylides, are summarised in Scheme 84 and Table 8. 
 
Scheme 84: The synthesis of phosphorane ylides 
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Table 8: The synthesis of phosphorane ylides 
Entry Halo 
compounds 
PPh3 (equiv.)/ 
conditions/24 h 
Ylides/% 
 
1a  
236 
1.0/Toluene 
75   Cͦ 
 
 
248. 70 
 
2b  
245 
1.02/MeCN 
90   Cͦ 
 
 
251, 0 
 
3b 
 
246 
1.02/MeCN 
90   Cͦ 
  
252, 65 
 
4c 
 
247 
1.1/MeCN 
90   Cͦ 
 
253, 34 
 
5a 
 
 
240 
1.0/Toluene 
75   Cͦ  
 
254, 70 
(a) Prepared according to Shan and co-workers procedure;(131) (b) 
Prepared according to Lang and co-workers using the salt 
method;(132) (c) Prepared according to Jones and co-workers.(133) 
The identity of ylides and their successful formations could be determined by 
the signal form the key methyne proton. In each case, a 1H doublet with a 2JPH 
coupling of ~ 22 Hz was observed. 
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2.5 TOP experiments towards trienes 
Tandem oxidation process (TOP) is important for a wide range of scientific and 
industrial processes where it constitutes a novel methodology to synthetic 
organic chemistry.  
The first TOP reactions were undertaken with diol 202 methyl ester ylide 52, 
252 and 253 (Table 9, Scheme 85). Initially, the reaction was investigated using 
a standard MnO2 mediated TOP reaction with three phosphoranes (methyl 
(triphenylphosphoranylidene) acetate 52, N,N-
diallyl(triphenylphosphoranylidene) acetamide 252 and N-allyl-N-benzyl 
(triphenylphosphoranylidene) acetamide 253. Heating benzene-1,2-
dimethanol 202 with (10 equiv.) of MnO2 and (2.5 equiv.) of phosphoranes led 
to the synthesis of the desired trienes; this constituted a general procedure for 
all TOP reactions attempted in this chapter. In the 1H-NMR analysis, it was 
satisfying to observe that these reactions were successful; 50% of (2E,2’E)-
dimethyl-3,3’-(1,2-phenylen)diacrylate 251 was obtained. However, it was 
noted that (E)-3-{o-[(E)-3-(diallylamino)-3-oxo-1-propenyl]-phenyl}-1-
(diallylamino)-2-propen-1-one 252 and (E)-3-(o-{(E)-3-[(benzyl)-N-allylamino]-
3-oxo-1-propenyl}phenyl)-1-[(benzyl)-N-allyl-amino]-2-propen-1-one  253  
existed as a 5.5:1 and 1.2:1  mixture of isomers in solution respectively.  
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Scheme 85: Initial TOP reaction of benzene-1,2-dimethanol 202 
Table 9: Initial TOP reaction of benzene-1,2-dimethanol 202 
Entry Phosphorane/ R [255]/ 
Yields% 
 
1 
 
CO2CH3     
 52  
256, 50% 
 
2 
 
CON(CH2CH=CH2)2     
252  
257, 40% 
 
3 
 
CON(CH2CH=CH2)CH2C6H5   
253  
258, 35% 
 
The identity of the product was shown by the presence of the key alkene 
signals in the 1H-NMR data. Doublets (J = 15.4 Hz) were observed at 7.99 ppm 
for the major rotamer and 8.43 ppm for the minor rotamer for 257 and 8.48 (J 
= 15.2 Hz) for both minor and major rotamers for 258.  
Mechanistically, the general reaction initiates with the oxidation step of 
alcohol I into the aldehyde II using manganese dioxide (MnO2) in THF, and then 
this aldehyde converted to the desired alkene III via Wittig reaction (Scheme 
86). 
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Scheme 86: General mechanism of TOP reaction 
These yields are slightly misleading, some of the diols, for example 257, 
underwent incomplete oxidation and Wittig reaction to prepare aldehyde 259 
(Scheme 87). The single most striking observation to emerge from the data 
comparison was only low yield of the triene 257. Instead, these reactions 
produced high yields of the starting material (aldehyde 202) and used ylide 
252, where, the oxidation step precedes the mono-oxidised product 259 as an 
unexpected product, presumably the increased steric bulk the second 
olefination step. This observation confirmed the lower yield of triene 257. 
NMR analysis of 259 gave obvious peaks at 6.67 ppm (J = 15.8 Hz) and 8.42 
ppm (J = 16.1 Hz) that related to alkene group resulting from the TOP reaction. 
While the key signal of aldehyde peak was present at 10.37 ppm that proved 
this structure 259.   
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Scheme 87: Unexpected side product 259 from TOP reaction 
In addition to benzene-1,2-dimethanol 202, unsaturated diols such as (Z)-2-
butene-1,4-diol and 2-butyne-1,4-diol were also used. The reaction with the 
methyl ester ylide 52 shows an excellent yield in terms of 261 in a 90% yield 
and a 3:1 ratio of (E,E,E:E,Z,E) isomers. Although the TOP reaction still occurs, it 
is less significant than that observed with 202; a 13% yield of 263 was obtained 
following chromatography, as shown in Scheme 88.   
 
Scheme 88: TOP reaction of unsaturated diols by MnO2 
The analysis of trienes was particularly problematic due a mixture of isomers 
being obtained. Reasonable yields were obtained via TOP reaction of diols, 
regardless of terminal substituent (R) in indole system (Scheme 89). The results 
obtained from the preliminary analysis of ‘triene’ indoles can be compared in 
Scheme 89 and Table 10. Initial attempts to perform the TOP reaction of 
entries 4 and 6 were unsuccessful, with a complex mixture of compounds 
obtained.  
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The 1H-NMR analysis of these crudes products proved the presence of complex 
mixture of starting material with ‘triene’ indoles (product). It is somewhat 
surprising that no 270 and 272 compounds were synthesised from this 
reaction, as illustrated in Table 10, where it was noted the decomposition of 
those products. This was observed many times via the purification step using 
column chromatography. To circumvent this problem, preparative TLC was 
instead used. This initiative proved again unsuccessful and gave decomposed 
material (pink solid). On the other hand, entries 1-3 and 5 gave modest yields 
after purification. NMR analysis confirmed the appearance of alkene protons of 
‘triene’. For example, 1H-NMR spectroscopy of 267 showed 6.25 ppm (d, J = 16 
Hz, c), 6.50 ppm (d, J = 16 Hz, a), 7.82 ppm (d, J = 16 Hz, b) and 7.93 ppm (d, J = 
16 Hz, d) ppm. In terms of 268 and 269, four doublet protons that related to 
the alkene appeared in the range 6.08-8.25 ppm. Meanwhile the structure of 
271 was confirmed by the appearance of doublet protons at 6.06 (J = 15.8 Hz, 
a), 6.57 (J = 16.2 Hz, c), 7.60-7.62 (m, d), 8.31-8.35 (m, b) ppm, as illustrated in 
Scheme 89.  
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Scheme 89: Preparation of alternate ‘triene’ indoles 
 
Table 10: Preparation of alternate ‘triene’ indoles 
 
 
 
 
 
 
*
Decomposed on silica 
In summary, these results show that the possible of employment TOP reactions 
for the synthesis of triene despite the difficulties that have faced in this work 
and the ability of purification of these products using different eluents. The 
next step will be the 6π-electrocyclisations of these trienes using microwave 
irradiation.   
Entry R R1 Products/ 
[266] 
Yield% 
1 CH3 CO2CH3 52 267 19 
2 Boc COCH3 52 268 18 
3 Boc CON(CH2CH=CH2)2 252 269 29 
4 Boc CON(CH2CH=CH2)CH2C6H5 253 270* 0 
5 Ts CO2CH3 52 271 51 
6 Ts CN 265 272* 0 
Chapter 2                                                                            Results and discussion I 
87 | P a g e  
 
2.6 Photochemical and thermal electrocyclisations 
As mentioned in the first chapter, the formation of cyclohexa-1,3-dienes 
system has been proposed in the biosynthesis of natural products via a 
disrotatory electrocyclisation of 1,3,5-hexatrienes which is considered an 
important process, particularly in this project. Generally, this cyclisation is 
classified into two categories; thermal and photochemical electrocyclisations. 
Thermal cyclisation typically requires high temperatures between 150 to 200  
 ͦC which are necessary to close the triene ring, while photochemical cyclisation 
undergoes a conrotatory cyclisation mode according to the Woodward-
Hoffmann rules.  
Although part of the conjugated 6π-system is embedded into the aromatic 
benzene ring the ease of preparing the substrates 256 made it a good starting 
point. Two approaches were attempted with the ‘triene’ (Table 11, Scheme 
90). It was anticipated that the presence of O2 in the atmosphere / solvent 
would be sufficient to oxidise the diene if it did form. 
 
Scheme 90: 6π-electrocyclisation reaction of 256 
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Table 11:Conditions of electrocyclisation reaction 
Conditions MnO2 Result 
Thermal, Ph2O, 250   ͦC -------- No reaction 
Thermal, Ph2O, 250   ͦC 50 equiv. No reaction 
Microwave, toluene, 175   ͦC -------- No reaction 
Microwave, toluene, 175   ͦC 50 equiv. No reaction 
 
Thermolysis of triene 256 in diphenyl ether (boiling point 258   ͦC) led to no 
reaction and the starting material was recovered along with small amounts of 
decomposition. Similarly, microwave irradiation at 175   ͦC in toluene had no 
effect on the substrate, no reaction being achieved. Both reactions were 
repeated with 50 equiv. of MnO2 added to act as the oxidant, shown in Table 
11 above. Wangelin and co-workers have previously shown that MnO2 can 
aromatise cyclohexadienes.(134) Unfortunately the addition of MnO2 to 
promote the oxidation had no effect.  Given the high energy barrier to reaction 
that would be involved in the aromaticity, the failure of this reaction was 
unsurprising. Though the triene 256 had previously been cyclised under 
photochemical promotion, no thermal reactions have been shown at this 
stage, and no photochemical reactions were attempted. Meanwhile, with the 
substrates 257 and 258, the 6π-electrocyclisations were attempted. 
Thermolysis of 257 and 258 through microwave irradiation at 175   ͦC in 
toluene, with and without MnO2, led to no reaction observed in any 
experiment. To conclude, it is clear that the aromaticity is too high to break in 
annulation reactions. To develop the methodology further, an investigation 
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into the use of dimethyl-2,4,6-octatrienedioate 267 and dimethyl (2E,6E)-2,6-
octadien-4-ynedioate 269 (Scheme 88) as triene substrates to irradiate using 
microwave under the same conditions that mentioned above with or without 
MnO2 to accelerate the oxidation.  
All attempts to accomplish the desired products by 6π-electrocyclisation were 
unsuccessful. These attempts were useless for triene compounds containing 
six-membered ring such as benzene. To apply more reactive ‘triene’ 
compounds it is therefore necessary to use substrates with five-membered 
ring such as indoles (Table 12, Scheme 91). 
 
Scheme 91: 6π-Electrocyclisation reaction of synthesised ‘trienes’ indoles 
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Table 12: 6π-Electrocyclisation reaction of synthesised ‘trienes’ indoles 
Entry Triene Procedures Cyclised products Yield% 
1  
 
267 
A  
-- 
0 
2  
 
268 
A  
 
275 
0 
B 69 
3  
 
269 
A  
 
-- 
0 
4  
 
271 
A  
 
276 
0 
C 0 
D 71 
A) Photochemical electrocyclisation in a Microwave: 15-30 min, toluene, 200  Cͦ; B) 
Thermal electrocyclisation: 10% Pd/C (1.4 equiv.), bromobenzene, reflux, 15 h; 
C) Thermal electrocyclisation: 10% Pd/C (1.88 equiv.), dry xylene, reflux, 
overnight; D) DDQ (2 equiv.), bromobenzene, reflux, 3 h. 
 
As can be seen from the data in Table 12 above and Scheme 91 that the 
microwave protocol tolerated 267, 268, 269 and 271 bearing the N-Me, N-Boc 
and N-Ts groups respectively, producing negative results using photochemical 
promotion at 175   ͦC in toluene. However, at thermal promotion it was 
revealed that the presence of protective groups of indole would be not 
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problematic. For successful completion of the synthesis of 275 bearing a Boc 
group at indole-1-N derived from 268 by catalytic reaction was subjected to 
6π-electrocyclisation with 10% palladium on carbon in bromobenzene under 
reflux to give 275 in 69% yield. Interestingly, it was noticed that deprotection 
of the Boc group in 268 occurred. In addition to the synthesis of 276, it was 
successfully prepared thermally only using DDQ in bromobenzene in a yield 
71%, whereas no reaction was obtained by using 10% palladium on carbon. 
The NMR analysis confirmed the structure of 275 and 276. Spectroscopic 
analysis by 1H-NMR showed the disappearance of doublet protons of -CH=CH- 
(a, c positions) as shown in Scheme 91.(135) However, given the failure of the 
indole triene to cyclise under TOP conditions, or in the presence of a 
compliable oxidant such as MnO2, it was realised that there was no benefit to 
further studies. The difficulty in preparing indole trienes with appended allyl 
esters or amides also meant that the 6π-electrocyclisation/Diels-Alder reaction 
could not be studied. 
2.7 Conclusion: 
• A one pot oxidation-Wittig sequence of 1,2-diols have been 
investigated as a route to α,β-saturated esters, where these diols were 
oxidised with MnO2 and reacted with stabilised Wittig ylides. After 
several attempts for the synthesis of trienes was achieved to give 19-
51% yield of products 267-269, and 271. 
• Microwave‐assisted one‐pot synthesis of ‘triene’ substrate (256) failed 
to yield the corresponding product. This result is likely due to the high 
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energy barrier of breaking aromaticity of the benzene ring being 
unsurmountable. 
• Thermal 6π-electrocyclisation of ‘trienes’ 268 and 271 with 10% Pd/C 
led to the preparation the requisite products in good to moderate 
yields.  
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Chapter 3 Results and discussion II: Nazarov Cyclisation 
3 Introduction: 
There is a growing body of literature highlighting the importance of the 
development of efficient techniques for the construction of five-membered 
rings, particularly because they are abundant in natural product skeletons. The 
Nazarov reaction has been an object of research since the 1940s,(48a) and is an 
important reaction for the preparation of cyclopentenones. It is based on the 
use of conjugated dienones which can be promoted with Lewis or Brønsted 
acids, via 4π-electrocyclisation, to construct cyclopentenones. 
3.1 Classical Nazarov cyclisation 
The classical Nazarov reaction can be described as proceeding via the 
sequence of steps summarised in Scheme 92. Typically, a divinyl ketone 277 is 
treated with a strong Lewis or protic acid to form an intermediate (pentadienyl 
cation), followed by thermally 4π-conrotatory cyclisation to generate an allylic 
carbocation. Loss of a proton leads to either cyclopentenone 281 or 282. 
Generally, this reaction requires either a protic acid (CH3SO3H and CF3SO3H) or 
strong Lewis acid such as boron trifluoride ethyl etherate (BF3·OEt2), tin(IV) 
chloride (SnCl4), titanium(IV) chloride (TiCl4), or aluminum chloride (AlCl3). 
More recently, more contemporary Lewis acids have been employed to 
promote Nazarov reaction, such as TMSOTf,(136) Cu(OTf)2,(137) and 
PdCl2(MeCN).(138, 139)  
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Scheme 92: The Classical Nazarov cyclisation of divinyl ketones 277 
3.2 Catalysis of Nazarov cyclisation 
The catalysts for the Nazarov cyclisation can be grouped into the following 
types: Brønsted acids, organo-catalysts, heterogeneous catalysts, and Lewis 
acids including transition-metal catalysts. 
 It is common knowledge that Brønsted acids are among the most effectively 
used types of catalysts. Several types of Brønsted acids have been 
demonstrated in this chapter as examples namely; triflic acid,(140) p-
toluenesulfonic acid,(141) and triflamide.(142) Herein, many reports have focused 
on the use of triflic acid in the Nazarov reaction where firstly Klumpp et al (140a)  
investigated electrocyclisation of N-acyliminium salts 283 via aza-Nazarov 
cyclisation to form the product 284. The main aim of this study is to examine 
the differences between superacids and weaker acids. It was found that 
transformations using the weaker acid catalyst (trifluoroacetic acid) were 
ineffective giving a disappointing yield (17%). whereas, the use of superacid 
triflic acid instead afforded an excellent 92% yield for the transformation 
product (Scheme 93). 
Chapter 3                                                                         Results and Discussion II 
95 | P a g e  
 
 
Scheme 93: Aza-Nazarov cyclisation of N-acyliminium salts 283 by triflic acid 
In 2009, Panda et al reported a new and convenient synthetic procedure with 
an expansion of the Nazarov cyclisation to obtain fused aromatic or 
heteroaromatic tricycles 286 by reacting with different triflic catalysts to yield 
(91-92%) diastereoselectivity (>99:1 d.r.), as shown in Scheme 94.(140b)    
 
Scheme 94: The construction of tricycles 286 using Nazarov cyclisation 
P-Toluenesulfonic acid (P-TsOH.H2O) is one of the most important catalysts for 
the Nazarov reaction and has been extensively used under mild conditions for 
cyclisation of many Nazarov substrates.(141a) Under TsOH-catalysed Nazarov 
conditions, the formation of product 288 from dolabelladienone 287 has been 
investigated by Williams and co-workers.(141b) Furthermore, another significant 
catalyst used as a Brønsted acid catalyst, is triflimide where the dienone 289 
can be cyclised via a microwave-assisted triflimide-Nazarov reaction affording 
81% for the final product 290 (Scheme 95).(142) 
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Scheme 95: catalytic Brønsted acids via Nazarov cyclisation 
A variety of Lewis acids were employed in Nazarov cyclisation to cyclise 
substituted dienones that afforded good yield and stereoselectivity of the final 
products such as copper (II) salts,(143) iridium, (144) gold,(145) and active 
vanadium(146)  complexes.  
The aluminium chloride AlCl3 catalyst reported by Sarpong and Marcus in 2010 
has proved extremely active for the Nazarov cyclisation of aryl vinyl 
intermediate 281 for the construction of tetrapetalone A 293 (Scheme 96). 
They found no cyclisation occurred when R = H because there were no 1,3-
allylic interactions with the methyl group at the γ-position of the C=O 
group.(147)    
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Scheme 96: Cyclisation of aryl vinyl intermediate 291 using an aluminium 
chloride catalyst 
In the late 2000s, Itoh et al invested considerable effort into the use of iron 
salts as Nazarov catalysts, such as ferric chloride (FeCl3), which work under 
mild conditions for the Nazarov cyclisation of polarised substituted thiophene 
enones.(148) However, other catalysts such as lithium perchlorate (LiClO4) and  
scandium triflate Sc(OTf)3(149)  gave no reaction with 2-substituted thiophene 
enones.  
In other recent studies of transition metal-catalysed Nazarov cyclisation of 
indole enones, Qi-Lin and co-workers developed a method for cooperative 
catalysis by zinc dichloride (ZnCl2) and chiral phosphoric acids (SPAs) to 
synthesise asymmetric products with excellent enantioselectivity. They noticed 
that the reaction of substrate with ZnCl2 without SPA (co-catalyst) was slower 
than if used together; where the presence of SPA accelerated the reaction rate 
to afford the product in excellent yields at a range of temperatures.(150)    
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3.3 Project introduction: 
The purpose of this work was to prepare dienes in situ from dihydroxyacetone 
294 obtained via a TOP reaction. This work will pay attention to the possibility of 
preparation of trienes that can undergo vinylogous Nazarov reaction and will 
highlight the use of Lewis acid to promote the reaction. Dihydroxyacetone 294 
will be used as a first example in this work to synthesise the desired compounds 
with illustrating the difficulties of this project (Scheme 97).   
 
Scheme 97: The hypothesised route for the construction of dienes and trienes 
 
Additionally, Lewis acids-mediated TOP-Nazarov cyclisation reaction of 
dihydroxyacetone 294 has been applied for the synthesis of substituted 
cyclopentenones 298 or 299 through C–C bond formation in a one-pot 
procedure (Scheme 98).  
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Scheme 98: Mechanism of the Nazarov cyclisation of 296 
These above aims raise the following core project objectives:  
• To avoid handling reactive/sensitive intermediates that could potentially 
support to a reduction in the production of by-product waste, the amount of 
solvent waste and the production costs. 
• To examine conditions necessary to make dienes and trienes and investigate if 
we can control this reaction. 
• To examine conditions to make Nazarov cyclisation as a final step. 
3.4 Studies towards the construction of the divinyl ketone core from 4-
oxopimelate  
An insignificant amount of literature has been published on the formation of 
divinyl ketone of 4-oxopimelate(151) and also cross-conjugated trienes.(152) Most 
researchers have used a single approach based on the Lemaire-Audoire and 
Chapter 3                                                                         Results and Discussion II 
100 | P a g e  
 
Vogel method.(153) Vogel (1999) reports the formation of the diethyl (E,E)-4-
oxohepta-2,5-diene-1,7-dioate 302 via two steps. Firstly, a selective 
dibromination of 4-oxopimelate 300 through the enol was done using bromine 
(Br2) in dichloromethane at 0 °C to afford the desired diethyl-3,5-dibromo-4-
oxoheptadioate 301 in 80% yield, as shown in Scheme 99. NMR analysis of 301 
shows the appearance of triplet peak at 5.35 ppm (t, J = 5.6 Hz, 1H) that 
belongs to -CHBr, where the -CH2CO2Et group was observed as a 2H multiple at 
3.00-3.04 ppm and 3.25-3.32 ppm in the 1H-NMR.  
 
Scheme 99: The bromination of 4-oxopimelate 301 
Treatment of 301 with triethylamine led to the elimination of two molecules of 
hydrogen bromide (HBr) at 0 °C with the desired product 302 isolated in 38% 
yield as the second step and this reaction underwent the E1cb elimination, as 
can be seen from the Scheme 100. Spectroscopic analysis confirmed two 
protons with a 2,3‐double bond pattern on the divinyl ketone, i.e. doublets at 
6.81 and 7.23 ppm (J = 15.9 Hz, 2H). Preparation of 302 allowed investigation 
of TOP conditions to be surveyed by NMR and as a substrate to investigate 
triene formation.   
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Scheme 100: The elimination reaction of 302 with its mechanism 
Preparation of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302, allowed us to 
attempt our next objective to prepare cross-conjugated trienes, followed by 
vinylogous Nazarov reaction.(152)  
3.5 Preparation of triene derivatives 
Having 302 compound, triene formation was undertaken with methyl 
(triphenylphosphoranylidene)acetate 52. This ylide was chosen to provide a 
distinction NMR handle for analysis (i.e. the methyl ester). This reaction was 
performed by adding diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302 and 
ylide 52 using 4-nitrobenzoic acid as a catalyst in toluene. After addition of 
ylide the mixture was refluxed and stirred for 15 h; this constituted a general 
procedure for all Wittig reactions attempted. When the reaction mixture was 
analysed by 1H-NMR following evaporation in vacuo a mixture of divinyl ketone 
302, diethyl (E,E)-4-methylacrylate-2,5-diene-1,7-dioate 303 (product), ylide 52 
and catalyst was observed in the crude mixture. Following chromatographic 
separation on silica gel, the spectroscopy analysis of 303 was confirmed by 1H-
NMR where the singlet protons at 3.73 ppm (s, 3H) indicate to methyl group (-
Chapter 3                                                                         Results and Discussion II 
102 | P a g e  
 
CH3) in 79% yield. The proton of the alkene was observed at 6.16 ppm (12-H), 
whereas for the other four protons appear at 6.27 ppm (2H, 4-H, 8-H), 7.42 
ppm (1H, 5-H), and 8.28 ppm (1H, 7-H) respectively (Scheme 101).  
 
Scheme 101: The Wittig reaction of divinyl ketone 302 using Lewis acid 
To examine the steric effects of this definition, the scope was investigated with 
various ylides. Using the same method, other substrates have been 
successfully synthesised under the same conditions (toluene, reflux, 15 h). Four 
commercially available phosphorane ylides featuring electron withdrawing 
substituents: ethyl (triphenylphosphoranylidene)acetate 38, 
(carbethoxyethylidene)triphenylphosphorane 35, (tert-butoxycarbonyl-
methylene)triphenylphosphorane 304, and tert-butyl 2-(triphenyl-
phosphoranylidene)propionate 305, were selected. The transformations were 
determined by examining the 1H-NMR spectra of the products Scheme 102 and 
Table 13. 
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Scheme 102: Preparation of triene derivatives 
Table 13: Preparation of triene derivatives 
Entry Phosphoranes 
[306] 
Products 
[307] 
Yield
% 
 
1 
 
Ph3P=CHCO2Et  
38  
 
308 
 
43 
 
2 
 
Ph3P=C(Me)CO2Et  
35 
 
309 
 
95 
 
3 
 
Ph3P=CHCO2CMe3  
304 
 
310 
 
34 
 
4 
 
Ph3P=C(Me)CO2CMe3  
305 
 
311 
 
47 
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It was gratifying to observe that these reactions had proved successful by 
analysing them by 1H-NMR. The results in general showed the yields to be 
moderate but there was no significant steric effect given the similar results for 
308-311.  
Following optimisation of the Wittig reaction of 294, the TOP reaction was 
investigated (Scheme 103, Table 14) with four alternative ylides. 
Unfortunately, under standard TOP conditions, no reaction occurred when 
dihydroxyacetone 294, phosphorane ylides 306 and 4-nitrobenzoic acid were 
reacted together in dry THF. 
The synthesis of 302, NMR analysis of the reaction mixture demonstrated that 
dihydroxyacetone 294 had transformed to product 302 in 15% yield; thus, the 
remaining alcohol 294 and ylide 38 were recovered unchanged from the 
reaction mixture in high recoveries (Scheme 103). In addition, the use of the 
phosphorane ylide 35 in TOP reaction was therefore examined. Treatment of 
294 with phosphorane 35 proceed to afford 314 in 20%; while a significant 
amount of 294 and ylide 35 remained. NMR analysis of the crude reaction 
mixture showed that proton peaks were observed at 1.43 ppm (t, J = 6.4 Hz) 
and 4.28 ppm (q, J = 6.3 Hz) indicate the ester group (CH3CH2O-), whereas, 
protons at 2.28 ppm (s), 7.20 ppm (s) are related to methyl and alkene groups 
respectively. 
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Scheme 103: Preparation of divinyl ketone derivatives using TOP reaction 
Table 14: Preparation of divinyl ketone derivatives using TOP reaction 
Entry Phosphoranes 
[312] 
Divinyl ketone derivatives  
[313] 
Yield% 
 
1 
 
Ph3P=CHCO2Et  
38 
 
302 
 
15 
(E,E:E,Z) 
(100:0) 
 
2 
 
Ph3P=C(Me)CO2Et  
35  
 
314 
 
20 
(E,E:E,Z) 
(0:0) 
 
3 
 
Ph3P=CHCO2CMe3  
304 
 
315 
 
NR 
 
4 
 
Ph3P-CH2(Br)Ph 
316/MTBD  
89   
317 
 
NR 
 
The reactions with alternative ylides 304 and 316 both proved to be 
unsuccessful. The crude reaction mixture showed in both cases that 
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decomposition had occurred. It is somewhat surprising that unexpected 
product 318 was obtained from the TOP reaction of 294 (Table 14, Entry 3) 
with ylide 304 in dry THF. The key to this unexpected transformation was 
considered to be the olefination step of carbonyl group (C=O) had occurred 
firstly instead of at the alcohol (Scheme 104) and analysis by 13C-NMR 
confirmed that no ketone functionality was present. NMR analysis on this 
material showed the appearance of the signals due to the (-CH2OH) at 4.42 
ppm, and hydroxyl group at 1.83 ppm (br.s).  
 
Scheme 104: The unexpected product 318 of TOP reaction 
3.6 Synthesis of cyclopentenone derivatives 
After the synthesis of divinyl ketones using both Wittig and TOP reactions, the 
next step is the construction of the cyclopentenone ring via Nazarov 
cyclisation. Hence, the precursors 302, 308, and 311 were reacted with a 
variety of Lewis or Brønsted acids, either at room temperature or under reflux 
conditions.  
With the aim to cyclise firstly divinyl ketone 302, treatment of 302 with 1.1 
equiv. of p-TsOH.H2O in dichloromethane was selected, either at ambient 
temperature or under reflux. There was no evidence that p-TsOH.H2O catalyst 
has any influence on the Nazarov cyclisation of 302; divinyl ketone 302 have 
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totally recovered unchanged in the reaction mixture (Scheme 105). It found 
that there was no solvent effect on this reaction; changing from 
dichloromethane to acetonitrile had no effect on the Nazarov reaction rate.   
 
Scheme 105:The Nazarov cyclisation of 302 using p-TsOH.H2O catalyst 
Due to the failure of using p-TsOH.H2O catalyst, several Lewis acids namely zinc 
chloride (ZnCl4), titanium(IV) chloride (TiCl4) and bismuth(III) triflate (Bi(OTf)3) 
were screened. These attempted cyclisations with those catalysts in 
dichloromethane failed to deliver any products.  
The Nazarov cyclisation was not observed; either at ambient temperature or 
under reflux. The successful preparation of cyclopentenones 321 from divinyl 
ketone 320 has been achieved frequently by use of FeCl3 and TiCl4 catalysts by 
Sudhakar et al, as shown in Scheme 106.(154) When the reaction was run for 15 
h at room temperature to heat under reflux further 3 h there was no product 
obtained due to decomposition of 302 
 
Scheme 106: The successful cyclisation of divinyl ketone 320 
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Initially all these catalysts were tested; however, since it proved impossible to 
recognise the cyclopentenone products in any of the spectra of the crude 
reaction, is the use of Brønsted acids as catalysts was considered. Herein, triflic 
acid (F3CSO3H) was examined with divinyl ketone 302 under the same 
conditions previously mentioned (Scheme 107). Unfortunately, no cyclisation 
was observed and NMR analysis confirmed just the presence of peaks that 
related to starting material 302 (Scheme 107). However, Shindo et al (2007) 
carried out a number of investigations into the successful Nazarov cyclisation. 
When treated with F3CSO3H, divinyl ketones were successfully converted into 
cyclic products in 39% yield.(155) 
 
Scheme 107: The Nazarov cyclisation of 302 using Lewis acids 
To confirm that such catalysts are responsible for the control of the reaction 
performance, a reaction of 308 with three Lewis acids was investigated namely 
p-TsOH.H2O, ZnCl4, and FeCl3. The results obtained from this set of 
experiments using these catalysts were eventually disappointing. They showed 
that no cyclopentenones were obtained and only the starting material 308 
could be noticed via NMR analysis of the crude mixture (Scheme 108). 
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Scheme 108: The Nazarov cyclisation of 308 using Lewis acids 
The preparation of desired cyclopentenone 323 proved more troublesome 
using substrate 310. Many procedures have been employed for the synthesis 
of 323 from the reaction of 310 with five catalysts including, p-TsOH.H2O, 
FeCl3, ZnCl4, Bi(OTf)3, and TiCl4. No reaction was observed even after extended 
stirring or under reflux, as shown in Scheme 109.  
 
Scheme 109: The attempted synthesis of cyclopentenone 323 
However, such substituted substrates have been successfully cyclised via a 
Nazarov cyclisation in particular using a TiCl4 catalyst.  When triene 324 was 
treated with Lewis acid (TiCl4), a mixture of cyclopentenone regioisomers was 
formed in 76% yield (Scheme 110).(152) 
 
Scheme 110: An example of the vinylogous Nazarov reaction 
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Table 15 illustrates the summary of TOP reactions with these three substituted 
trienes, from ambient to reflux conditions, for the formation of 
cyclopentenones (Schemes 105-107).    
Table 15: Summery of the attempted synthesis of cyclopentenone derivatives 
Entry Divinylketones Lewis acids Conditions Result 
 
 
1* 
 
302 
p-TsOH.H2O 
FeCl3 
ZnCl4 
Bi(OTf)3 
F3CSO3H 
TiCl4 
CH2Cl2, rt, 
15 h to 
reflux for  
3 h 
 
 
 
NR# 
 
 
2 
 
308 
p-TsOH.H2O 
FeCl3 
ZnCl4 
CH2Cl2, rt, 
15 h to 
reflux for  
3 h 
 
 
 
NR 
 
 
3 
 
310 
p-TsOH.H2O 
FeCl3 
ZnCl4 
Bi(OTf)3 
TiCl4 
CH2Cl2, rt, 
15 h to 
reflux for 
3 h 
 
 
 
NR 
*This reaction was done also under room temperature to reflux conditions in 
acetonitrile. # NR indicates no reaction occurred   
To summarise, the results of vinylogous Nazarov reaction were disappointing. 
1H-NMR analysis of the crude mixtures revealed that no cyclisation of the 
trienes had occurred even under ambient conditions. Most of the reactions 
showed only that the starting material was been unchanged; unfortunately, no 
tractable product could be observed by TLC or NMR spectroscopy and the 
starting material completely decomposed in particular entry 1 (Table 15) when 
FeCl3 as a catalyst was used with the substrate 302.  
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4 Conclusion: 
• Using modified TOP reaction consisting of dihydroxyacetone 294 with a 
variety of phosphorane ylides in toluene at reflux; a successful 
olefination workup process was set up for the construction of trienes.  
• Three substrates have been employed to investigate via Nazarov 
reaction mediated by a variety of Lewis and Brønsted acids. Though in 
all attempts to cyclise synthesised trienes, this method does not form 
substituted cyclopentanones. 
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Chapter 4 Results and Discussion III: Diels-Alder Reaction 
5 Introduction: 
In the history of organic chemistry, the Diels-Alder reaction is one of the most 
important and innovative strategies developed for the synthesis of target 
molecules.(156) The Diels-Alder reaction is a [4+2]-cycloaddition reaction 
between  a conjugated diene (4π) and a dienophile (2π) to produce a 
cyclohexene. The study of the reaction of cyclopentadiene 326 with quinone 
327 , as shown in Scheme 111, was first carried out by Otto Diels and his 
student, Kurt Alder (1928). The importance of the reaction and its utility led to 
the award in 1950 of the Nobel Prize for their achievements in developing the 
reaction.  
 
Scheme 111: The discovery of the Diels-Alder reaction in 1928 
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The Diels-Alder reaction is favoured particularly for the rapid development of 
molecular complexity. Therefore, the use of the Diels-Alder reactions in a 
cascade process to generate multiple rings in tandem reactions is a very 
promising approach for the synthesis of important biological scaffolds.(157, 158)  
5.1 Dienes and Dienophiles 
A variety of conjugated dienes and substituted dienophiles have been the 
subject of studies in the Diels-Alder reaction. It is apparent from the Figure 11 
that various examples have been collected according to their types of chains 
and rings, where conjugated dienes basically comprise two double bonds. Two 
geometries of conjugated dienes are possible; cisoid 332 and transoid dienes 
333. Such studies, however, have shown that the transoid diene is unreactive 
due to the trans arrangement, as shown in Figure 11. In a study which set out 
to determine the reactivity of dienes, Sauer (1967) found that cyclic dienes are 
more reactive than the open chains. Additionally, the electronic impact of 
substituents in the diene have a significant effect on the rate of Diels-Alder 
reaction.(159)   Generally, the presence of electron donating groups in dienes 
accelerate the reaction, as do electron withdrawing groups in dienophiles. 
However, dienophiles bearing electron donating substituents accelerate the 
reaction with electron withdrawing substituents in dienes, and this term called 
‘’inverse electron-demand Diels-Alder reaction’’ (IED-DA).       
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Figure 11: Examples of reactive and unreactive conjugated dienes 
In terms of dienophiles, electron withdrawing groups, a weak π-bond, and the 
release of ring strain increase the reactivity of dienophiles. Some examples of 
dienophile are shown in Figure 12. It is well-known that ethene (C2H4), the 
simplest dienophile, is a poorly reactive dienophile in Diels-alder reactions.(160)     
 
Figure 12: Examples of common dienophiles 
5.2 Mechanistic aspects 
Mechanistic aspects have been the subject of many classic studies in Diels-
Alder reactions; typically, there are many combinations of carbon and hetero 
fragments that lead to formation of cyclic ring systems. This variety of 
combinations illustrates the massive versatility of the Diels-Alder reaction.(161)  
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There are two major classes of Diels-Alder reactions in terms of their 
electronics, one is the inverse electron demand addition and the other is 
normal electron demand addition. This classification depends on the rate of 
reaction in the presence of substituents (electron withdrawing and electron 
donating groups). The presence of electron withdrawing groups on the diene 
and electron donating ones on the dienophile lead to accelerate inverse 
electron demand reactions, while the opposite of these substituents promotes 
the normal electron demand cycloadditions. The effect of these substituents 
on the rate of reaction can be understood through the Frontier Molecular 
Orbital (FMO) theory, which was formulated by Woodward and Hoffmann,(162) 
Fukui(163) and later Houk amongst others.(164)  As can be seen in Figure 13, the 
interaction between the HOMO and LUMO for both the dienophile and diene is 
central to the efficacy of Diels-Alder reactions. In terms of the Woodward and 
Hoffmann rules, the construction of new σ-bonds leads to the conservation of 
the orbital symmetry. Consequently, there are no intermediates formed in 
these pericyclic Diels-Alder reactions. 
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Figure 13: The FMO theory of inverse and normal electron demand reactions 
According to the endo and exo modes, it has been proposed that secondary 
orbital interactions play an important role in Diels-Alder reaction (Figure 14), 
shows such interactions between cyclopentadiene and methyl vinyl ketone. In 
a study conducted by Woodward and Katz (1958),(165) it was shown that the 
possibility of overlap between π-orbitals of the carbonyl group of the 
dienophile and the HOMO-diene in the endo mode is symmetrically allowed. 
Hence, the stabilisation of the endo intermediate led to formation of the endo 
product faster than formation of the exo adduct. Indeed, few studies of Diels-
Alder reactions in the literature show that the exo adduct is the main 
product.(166)  The more surprising aspect is the endo selectivity of some 
reactions of dienophiles that bear substituents with no π-orbitals leading to 
form secondary orbital interactions as well.(167)  
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Figure 14: The explanation of Endo and exo modes of the Diels-Alder reaction 
of cyclopentadiene with methyl vinyl ketone 
5.3 Regiochemistry and Stereochemistry 
Many researchers have invested considerable effort into understanding the 
mechanism for the formation of adducts depending on the orientation of diene 
and dienophile substituents, and on the reaction conditions. This has become 
an area of increasing interest, with regiochemistry and stereochemistry being 
important considerations. 
Typically, two isomeric adducts form based on the orientation of groups in 
these adducts via the reaction between an unsymmetrical diene and 
dienophile. Also, the regiochemistry of the adduct depends on the nature and 
number of substituents on both reactants. In the literature on regiochemistry, 
the relative importance of multi substituents on dienophile and diene has been 
subject to considerable discussion. Consequently, the presence of two 
different groups on the diene means one of them will be the regiodirector 
leading to control of the reaction, depending on the electronic effects of 
substituents. For example, the reaction of acrylic acid derivatives with 1- or 2-
substituted butadienes gives rise to afford 1,3- or 1,4- adducts respectively, 
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however, one adduct often forms in excess in the presence of Lewis acid. For 
example, the reaction of acrolein 334 with isoprene 335 as illustrated in 
Scheme 112, it was noticed that the proportion of the 1,4-adduct 336 increases 
in the presence of SnCl4 compared with other adduct 337.(168)  
 
 
Scheme 112: The effect of Lewis acid in Diels-Alder reaction 
Two empirical rules can be applied to predict the stereochemistry of the 
adduct namely the (cis) principle and the endo rule. The (cis) principle was 
firstly recognised by Alder and Stein (1937),(169) where the suitable explanation 
is that dienes in which the substituents (both groups either outside or inside) 
at the C-1 and C-4 positions occupy the same orientation in the s-cis 
configuration will give the cis product and this applies to dienophile as well.(170) 
In stark contrast, the endo rule depends on the arrangement of both diene and 
dienophiles in parallel planes that can be shown in the transition state. 
Generally, the formed 1:1 adducts are obtained by a reaction of cis- or trans-
dienophiles react with dienes with its retention of the cis or trans arrangement 
of the substituents in the dienophile. These products can include new bicyclic 
structures. In the literature, the terms ‘endo’ or ‘exo’ tend to be used to refer 
to the orientation of the substituted groups on the dienophile with the diene 
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with respect to the diene.  Scheme 113 illustrates that the reaction of 
cyclopentadiene 326 with maleic anhydride 338 almost affords the endo 
isomer 342 while thermodynamically the exo adduct 340 is more a stable 
compound.(159)  
 
Scheme 113: The Alder ‘Endo’ rule in Diels-Alder reaction 
The addition of cyclic dienes to cyclic dienophiles follows the endo rule. In 
contrast, the reaction of 1,2-disubstituted alkenes with cyclic dienes undergoes 
Alder’s endo rule only. In particular, in the study of substituted maleic acid 
derivatives, when X = PhCO or PhSO2 the reactions afford endo product 344 
without any noticeable amounts of exo product whereas, X = CO2CH3 or CN, 
the two adducts 344 and 345 are formed in an approximate ratio of 75:25 
(Scheme 114).(171)  
 
Scheme 114: The exemption of Alder’s endo rule 
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5.4 Project introduction:  
The purpose of this investigation is to explore the possibility of synthesising 
new substrates that could undergo a tandem sequence to make cyclic 
compounds. This strategy is based on a TOP-Diels-Alder sequence, for 
example, if cinnamyl alcohol 346 was treated with phosphorane ylide 52 under 
standard TOP conditions (MnO2 in toluene/THF, reflux) and 2,3-dimethyl-2-
butene 348, it could conceivably react to give the adduct 349. Another 
alternative substrate is 2,3-dihydroxy butane 350, which could react with 
cinnamyl alcohol 346 to form the adduct 353, as shown as in Scheme 115. 
 
Scheme 115: The prospective TOP-Diels-Alder sequence 
In this event, we examined the ability of alcohols 346 and 350 to undergo 
these diene forming reactions, followed by reacting with dienophile such as 
butyl acrylate to afford a final product. The choice of 2,3-dihydroxy butane 
derivatives was upon the basis of availability and stability of the diols; α,β-
diketones are too unstable to undergo this sequence. 
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A third strategy, could be to introduce the intramolecular Diels-Alder tether of 
cinnamyl alcohol 346, where two components are constrained in the same 
molecule and adduct is formed in a single step (Scheme 116).  
 
Scheme 116: The TOP-intramolecular Diels-Alder sequence of 346 
In an initial experiment, alcohol (cyclohexenmethanol) 357 was made from 1-
cyclohexene-1-carboxcylic acid 356 by reduction with LiAlH4 in 46% yield 
(Scheme 117).  The IR spectrum showed absorbance characteristic of hydroxyl 
group at 3325 cm-1.(172) The 1H-NMR spectrum showed a singlet at 3.87 ppm 
which integrated for two protons, indicating a CH2 group at the C-2 position. 
The proposed structure in the 13C-NMR spectrum was proved by the 
appearance of the new methylene group at 67.5 ppm. 
 
Scheme 117: The reduction reaction of 1-cyclohexene-1-carboxcylic acid 356 
With alcohols 346 and 357 in hand, the formation of the diene derivaties via 
TOP reactions involved the reaction of alcohols 346 and 357, phosphorane 
ylides 358 and MnO2 in THF. Allyl-(triphenylphosphoranylidene) acetate 248, 
3'-butyen-1'-yl-2-(triphenylphosphoranylidene)acetate 254 and the readily 
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available bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate 361 
ylides were used to test these reactions (Table 16, Scheme 118).  
 
Scheme 118: TOP reaction of alcohols 346 and 357 
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Table 16: TOP reaction of alcohols 346 and 357 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The initial reaction (Entry 1) with allyl ylide 248 appeared successful, with 13% 
yield of the product 362 observed. Furthermore, a large amount of unreacted 
cyclohexenmethanol 357 was present as well allyl ylide. Homo allyl ylide 254 
was alternatively used for the synthesis of 363 (Entry 2), where it was noticed 
that only 11% yield was afforded after purification using silica gel by column 
chromatography.   
Entry Alcohol Ylide (358) yield% 
 
1 
 
 
357 
 
248 
 
362, 13% 
 
2 
 
 
357 
 
254 
 
363, 11% 
 
3 
 
346 
 
248 
 
353, 32% 
 
4 
 
346 
 
254 
 
364, 31% 
 
5 
 
346 
 
361/  
MTBD 89 
 
 
365, no reaction 
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In terms of entries (3-5), the standard experiments above proved that the allyl 
and homo allyl ylides also reacted poorly with 346 and no reaction was 
observed with Still-Gennari reagent 361. These findings are surprising but 
could be repeated.  
Following the TOP reaction, the IMDA reaction was examined using the 
tethered electron alkene. Unfortunately, with all attempts investigated using 
various Lewis catalysts failing to produce the desired adducts.   
Thus, application of the attempted reaction to a range of catalysts, a variety of 
Lewis catalysts under thermal and ambient conditions illustrated in Scheme 
119 and Table 17 were attempted. 
 
Scheme 119: Attempts for the construction of Diels-Alder adducts 355 and 366 
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Table 17: Attempts for the construction of Diels-Alder adducts 355 and 366 
Entry Cinnamyl esters Conditions/ overnight(a) Result 
1  
 
354 
b LiBF4 (1.0 M MeCN), dry 
benzene, rt 
No reaction 
2 c Ph2O, reflux No reaction 
3 d Hydroquinone, xylene, 
reflux 
No reaction 
4 d Hydroquinone, 
mesitylene, reflux 
No reaction 
5  
 
 
364 
e Bi(OTf)3, toluene, reflux Decomposed 
6 e p-TsOH. H2O, toluene, 
reflux 
Decomposed 
7 e F3CSO3H, toluene, reflux Decomposed 
8 c Ph2O, reflux No reaction 
9 b LiBF4 (1.0 M MeCN), dry 
benzene, rt 
No reaction 
     (a)These reactions were performed using a slight modification of the method 
described in their literatures. (b)Reaction was carried out in 0.06 mmol of LiBF4 
solution with (354) and 0.053 mmol of LiBF4 solution with (364).(173) (c)Reactions 
were carried out on (1 equiv.) scale in diphenyl ether. (d)Reaction was carried out in 
2 mmol scale of hydroquinone.(174) (e)Reaction was carried out in 0.087 mmol scale. 
 
Initial attempts at using LiBF4 (1.0 M MeCN), resulted in no reaction occurring 
(Entries 1 and 9), when 354 and 364 treated with LiBF4 (1.0 M MeCN) in dry 
benzene overnight. Efforts to increase the possibility of promotion of IMDA 
reaction of 354 using five different catalysts were investigated further. The 
thermal IMDA reaction of both of 354 and 364 in diphenyl ether was 
investigated and resulted unchanged in the starting materials. Alternatively, 
treatment of 354 in the presence of the oxygen scavenger hydroquinone, in 
xylene was attempted. However, no adduct was observed, even when 
mesitylene was employed instead Hydroquinone is added to the reaction 
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mixture to inhibit the polymerisation of the participating dienes/ dienophile of 
the substrate in intramolecular Diels-Alder Reaction.(174) 
Due to the failure to make the desired products from the IMDA reaction of 
354, homo allyl ester 364 was instead investigated. It was hoped that the 
formation of a 6.6 fused bicyclic system would be energetically more 
favourable. Therefore, 364 was reacted with Lewis and Brønsted acids such as 
Bi(OTf)3, p-TsOH.H2O and F3CSO3H, but the formation of adduct 366 was 
unsuccessful due to the decomposition of 364.  
Therefore, the observed low reactivity in Lewis acid-catalysed IMDA reaction of 
cinnamyl esters could be probably attributed to the electronic demands of the 
ester group in the transition state (Figure 15). It was thought that conjugation 
of the carbonyl with the diene π-system reduces the electronic demand for 
overlap with the oxygen of the ester group in the transition state could be 
prevented cyclisation. This explanation is consistent with the literature.(175)  
 
Figure 15: The electronic demand for overlap with the oxygen of the ester 
group 
This observation is in agreement with Martin and co-workers (1983) findings 
which showed no cyclisation was observed for the isomer 367 (Figure 16).(176)  
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Figure 16: No cyclisation up to 275   Cͦ 
5.5 Synthesis of diols  
Commercially available diols were employed to undergo TOP reaction, 
including 2,3-butanediol 350, hydrobenzoin 368, 1-phenyl-1,2-ethanediol 369, 
and 1,2-cyclohexanediol 370; whereas others were successfully prepared in the 
lab (Figure 17).  
 
Figure 17: Four commercial diols used in this project 
An improved procedure, published in 2008,(177) involved the use of a 4,4′-
dimethylbenzil and also furoin as starting materials to be reacted with 2.5 
equivalents of NaBH4 to form 1,2-ditolylethane-1,2-diol  372(177)  and 1,2-di-
furan-2-yl-ethane-1,2-diol  374(178)  in 100 and 21% yields respectively (Scheme 
120). In the case of 374, careful purification of the reaction mixture was 
necessary for, 21% of product 374 to be separated.  
Chapter 4                                                                        Results and Discussion III 
128 | P a g e  
 
 
Scheme 120: The reduction reaction of 4,4′-dimethylbenzil 371 and furoin 373 
5.6 Attempted synthesis of diene compounds via TOP reactions  
TOP reaction of vicinal diols with various phosphoranes and in the presence of 
four commercial oxidants: activated manganese dioxide (MnO2),(179) 
Iodoxybenzoic acid (IBX),(180) Dess-Martin periodinane (DMP)(19) and pyridine 
sulfur trioxide complex (SO3Py) have been studied extensively. The most 
elegant example of this type of reaction is the oxidation-Wittig reaction of 
ethylene glycol 42 with MnO2, IBX and DMP oxidants leading to the synthesis of 
α,β-unsaturated diester 43 in 67%, 70% and 27% respectively (Scheme 
121).(76,180)  
 
Scheme 121: The synthesis of dienes via TOP reactions(179, 180, 19) 
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In 1977, Taylor reported two convenient synthetic procedures  to obtain 3,4- 
unsaturated muconates 378 and 379 via the bis-Wittig reaction of butane-2,3-
dione 375.(181) The first procedure relied on the reaction of 1,2-diketone 375 
with phosphorane ylide 38 in benzene at ambient condition affording the 
product 376 in 66% yield, followed by the second procedure Wittig reaction of 
product 376 with Wadsworth-Emmons phosphonate 377 in the presence of 
sodium hydride producing two isomers 378 and 379 in 46% and 4% 
respectively (Scheme 122).  
 
Scheme 122: Taylor’s work in 1977 for the synthesis of 378 and 379 isomers 
5.7 Access to dienes building blocks via Wittig reaction: 
Lewis acids are a common condition which has considerable impact on the 
promotion of Wittig reactions in organic synthesis. Surveys such as that 
conducted by J. O’Brien et al (2013) have shown that 4-nitrobenzoic acid could 
accelerate the rate of Wittig reaction under mild conditions.(182a) Therefore, we 
envisaged that using this additive will be useful to promote our Wittig reaction 
of diketones with a number of phosphorane ylides in toluene under neutral 
conditions. Hence, the increased growth of catalytic approaches for classical 
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Wittig reactions is in high demand by subjecting new catalysts and testing their 
reactivity later. 
Initially, two substrates 375 and 371 were examined to test 4-nitrobenzoic acid 
discussed below with (triphenylphosphoranylidene)acetonitrile 265. With 375 
and 371 in hand the four conditions shown (Table 18) were tested. 
Unfortunately, no evidence was found for the synthesis of desired products 
from these experiments (Scheme 123, Table 18). The treatment of 375 with dry 
benzene resulted no reaction occurring. Diketone 375 was additionally treated 
with the combination 4-nitrobenzoic acid /toluene at room temperature which 
resulted in decomposition of 375. Whereas, under thermal conditions no 
reaction occurred. Attempts of converting 371 into the corresponding 
unsaturated diesters failed even though adding of catalyst (0.4 equiv.).  
 
Scheme 123: Reaction of 1,2-diketones 375 and 371 with cyano ylide 
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Table 18: Reaction of 1,2-diketones 375 and 371 with cyano ylide 
Entry ketone Ylide 
(equiv.) 
Catalyst/Condition Yield 
1 Me  3 No catalyst/dry benzene 
/rt 
NR 
2  
Me  
 
3  
4-nitrobenzoic acid (0.2 equiv.) 
/toluene/rt 
Dec. 
4-nitrobenzoic acid (0.2 equiv.) 
/toluene/ reflux 
NR 
3 p-tolyl  2.5 4-nitrobenzoic acid (0.4 equiv.) 
/ toluene/ reflux 
Dec. 
    NR means No Reaction, Dec. refers to decomposition 
At that point the idea of introducing a cyano ylide via Wittig reaction of 
diketone 371 and 375 was not further pursued. Instead the idea arose of 
synthetically reacting two phosphorane ylides with diketones (371, 375 and 
380). 
In contrast, in the presence of ethyl (triphenylphosphoranylidene)acetate 38 
with or without 4-nitrobenzoic acid catalyst, formed an α,β-unsaturated esters, 
afforded the unexpected products in reasonable to good yields (Scheme 124). 
Diketones 371, 375 and 380 were reacted with two different ylides (381 and 
38). To summarise, it is apparent from all the results, concluded in Table 19, 
that the absence of an acid catalyst is beneficial. Furthermore, the 
phosphorane ester ylides proved to be superior rather than cyano ylide 
systems. Hence, these were used for all future studies.  
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Scheme 124: Attempted Wittig reaction of diketones with and without catalyst 
Table 19: Attempted Wittig reaction of diketones with and without catalyst 
Entry  ketone Workup methods Yield%  
1 Me Ph3P=CHCO2Et 38 (2.2 equiv.)/ 
CH2Cl2/ rt 
376, (100) 
2 Me  PO(OMe)2CHCO2Et 381 (3 equiv.)/ 
MTBD 89 (3.1 equiv.) /toluene/ 
reflux 
NR 
3 Me Ph3P=CHCO2Et 38 (2.2 equiv.)/ 
dry benzene/ rt 
376, (94) 
4 p-tolyl Ph3P=CHCO2Et 38 (2.5 equiv.)/ 4-
nitrobenzoic acid (0.4 equiv.)/ 
toluene/ reflux 
382, (34) 
5 p-tolyl Ph3P=CHCO2Et 38 (2.2 equiv.)/ 
 dry benzene/ rt 
383, (70) 
6 Ph Ph3P=CHCO2Et 38 (2.5 equiv.)/ 4-
nitrobenzoic acid (0.4 equiv.)/  
toluene/ reflux 
NR 
7 Ph Ph3P=CHCO2Et 38 (2.5 equiv.)/ 
 toluene/ reflux 
417, (31) 
 
Scheme 125 illustrated the suitable procedure for the synthesis of diethyl (E,E) 
and (E,Z)-3,4-dimethylmuconate 378 and 379 from 2,3-butanedione 375 via a 
sequence of two Wittig steps using olefinating reagents 38 and 381. By use of 
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Taylor’s procedure, the Wittig reaction was accomplished under the same 
conditions. However, it was somewhat interesting that the resulting yields in 
our investigations were higher compared to those of Taylor’s study.(181) 
 
Scheme 125: Bis-Wittig reaction of 2,3-butanedione 375 in two steps 
A final reaction was used to investigate whether phosphorane ylides were the 
problem. In this regard malonic acid was chosen as an alternative to the Wittig 
reagent, instead phosphorane esters in the presence of triethylamine and 
piperidine, as shown as in Scheme 126. However, no reaction took place; 
presumably enolisation of diketone 375 in basic conditions is a problem here.  
 
Scheme 126: The alternative substrate for the synthesis of 3,4-unsaturated 
acid 385 
Based on the successful literature synthesis of 3,4-unsaturated muconates 378 
and 379, we aimed to employ 2,3-butanediol 350 in TOP reaction using 
different phosphorane ylides in toluene under thermal conditions. 
Initially, TOP transformation of 2,3-butanediol 350 to dienes 388 (Scheme 127, 
Table 20) was investigated as this is a stable and commercially available 
substrate. These reactions were performed under similar conditions 
Chapter 4                                                                        Results and Discussion III 
134 | P a g e  
 
mentioned in Chapter 2 using manganese dioxide MnO2 as the first oxidant. 
However, no reaction was obtained when 2,3-butanediol 350 was treated with 
phosphorane ylides (Entries 1, 3, and 5). It was envisaged that the desired α,β-
unsaturated esters could be observed quickly from 2,3-butanediol 350. 
 When the TOP reaction was attempted with alternative ylides (Entries 2, 4, 
and 6), however, low yields of the products (Entries 2, 4, and 6), were obtained 
with the major product being the α,β-unsaturated ketones 387, unreacted 
starting material 350 and unreacted ylides. Despite changing from THF to 
toluene, this did not increase the yield of products formed. NMR analysis of 
the resulted products was confirmed by 1H-NMR, 13C-NMR and HMRS data.  
 
 
Scheme 127: TOP reaction of 2,3-butanediol 350 by manganese dioxide 
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Table 20: TOP reactions of 2,3-butanediol 350 by manganese dioxide 
Entry Olefinating reagents 
[386] 
Yield%  
[387] 
Yield%  
[388] 
 
1 
 
Ph3P=CHCN  
265 
 
 
389, NR 
 
 
390, NR 
 
2 
 
Ph3P=CHCO2Et  
38 
 
 
376, 32 
 
 
378, NR 
 
3 
 
 
Ph3P=C(Me)CO2Et  
35 
 
 
391, NR 
 
 
392, NR 
 
4 
 
Ph3P=CHCO2CMe3  
304 
 
 
393, 12 
 
 
394, NR 
 
5 
 
Ph3P-CH2(Br)Ph  
316/ MTBD 89 
 
 
395, NR 
 
 
396, NR 
 
6 
 
PO(OMe)2CH2CO2Et  
381/ MTBD 89 
 
 
376, 69 
 
 
378, NR 
   NR= No reaction 
With conditions employed for the synthesis of the α,β-unsaturated keto-
alkenes above, attention was then turned to use different diols to see if these 
proved any better. The driving force in this case is the use of a manganese 
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dioxide where it has found the ability of manganese dioxide to oxidise vicinal 
diols to vicinal diketones by Rice and co-workers.(182b)  
It is interesting to note that in all other substrates (vicinal diols) of this study 
afforded unexpected products via an oxidation-cleavage Wittig reaction. These 
results are consistent with those of Taylor et al (2002) who found that 
hydrobenzoin 368 and trans-1,2-cyclohexanediol 370 can undergo cleavage-
Wittig trapping using phosphorane ylide 38 and manganese dioxide in 
dichloromethane to afford products 397 and 398 in 97% and 20% yields 
respectively (Scheme 128).(183) Scheme 128 shows the general mechanism of 
oxidation-cleavage step, manganese dioxide (MnO2) breaks apart 1,2-diols 
(vicinal diols) to form aldehydes via cleaving a C-C bond and forming two C-O π 
bonds. 
 
Scheme 128: The oxidation-cleavage Wittig reaction of 1,2-diols according to 
Taylor(183) 
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In this project, a variety of 1,2-diols 399 were examined and shown to undergo 
a cleavage-Wittig sequence. The treatment of 399 with MnO2 and a number of 
phosphorane ylides 400 and 381 in toluene furnishes different products 401 
(Scheme 129, Table 21).  
 
Scheme 129: The cleavage-Wittig trapping of vicinal diols 
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Table 21: The cleavage-Wittig trapping of five vicinal diols 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) All reactions were carried out under method A, compound 408 was 
synthesised in both methods A and B; (b) Reactions were carried out 
further with 4-nitrobenzoic acid (0.25 equiv.) in toluene at reflux 
overnight.  
 
It was somewhat surprising that cyano ylide and phenyl phosphonium salt gave 
no expected products using MnO2, while other phosphorane ylides have 
transformed diols to the corresponding enoate adducts in a range of yields (31-
100%), as shown in Table 21. In this line, it was interesting to observe that 2-
phenyl-2-hydroxy ethanol 369 (Entry 4) proved to be entirely unsuccessful in 
this process; in fact, no material could be observed from the reaction, 
Entrya Diol [399] Desired products  Obtained products  
1 
 
368 
 
 
2 
 
372 
 
 
3 
374  
  
4b 
 
369 
 
 
----- 
5b 
 
370 
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presumably due to decomposition, perhaps due to phenyl glyoxal. This has 
been shown previously to react under Wittig conditions only when used with 
4Aͦ sieves.(184) Most of these repeated reactions showed the presence of a small 
amount of starting materials and also unreacted phosphoranes besides the 
final products.  
In addition to above, cyclic diols such as 1,2-cyclohexanediol 370 (Entry 5), 
utilised in this reaction produced only deca-2,8-dienedinitrile 419 in a 37% 
yield, but the other expected products were not obtained under these 
conditions.  
Though these results indicated that alternative diols and phosphoranes could 
function in the system, it was apparent that these reactions represented no 
improvement upon TOP reaction even with the use of 4-nitrobenzoic acid. The 
search for a new oxidant then moved towards a focused screen of oxidants 
instead of manganese dioxide that do not promote vicinal diol cleavage.  
Iodoxybenzoic acid (IBX), pyridine sulfur trioxide complex (SO3Py) and Dess-
Martin periodinane (DMP) have all been shown in the literature as suitable for 
the oxidation of 1,2-diols to α,β-diketones. To improve the TOP reaction using 
these oxidants two substrates were employed and their results compared with 
manganese dioxide namely 2,3-butanediol 350 and 1,2-diphenylethane-1,2-
diol 369. 
 As can be seen in Scheme 130 and Table 22, most of the attempted 
procedures failed to afford the expected products. However, it was found that 
2,3-butanediol 350 substrate was successfully reacted in one case with Dess-
Martin periodinane (DMP) and ethyl (triphenylphosphoranylidene)-acetate 38 
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in dichloromethane. The reaction was complete after 15 h to give product 376 
in an 11% yield where starting material 350 and ylide 38 were recovered in a 
large amount compared with the product. This compares to the 32% yield 
obtained for the synthesis of 376 with MnO2. Other phosphoranes did not 
undergo TOP reaction with 2,3-butanediol 350; no reaction was observed 
under their reaction conditions.  
 
 
Scheme 130: Three attempted procedures for the construction of desired 
products via TOP reaction of 2,3-butanediol 350 using three different oxidants 
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Table 22: Three attempted procedures for the construction of desired products 
via TOP reaction of 2,3-butanediol 350 using three different oxidants 
 
 
 
 
 
 
                  
 
 
 
 
 
 
 
 
 
 
 
                             NR= No Reaction 
Despite these initially disappointing, results the more reactive (and more 
stable) substrate 1,2-diphenylethane-1,2-diol 368 was examined to see if this 
was more successful. In the TOP reaction of 1,2-diphenylethane-1,2-diol 368 
with pyridine sulfur trioxide complex (SO3Py), (4-oxo-3,4-diphenylbut-2-enoic 
acid ethyl ester 421 was obtained in 60% (E-alkene) yield. No reaction was 
Entry Olefinating 
reagents 
 
Oxidants Products 
SO3Py 
/Et3N 
IBX DMP 
1 Ph3P=CHCN 
265 
 
NR 
 
NR 
 
NR  
390 
2 Ph3P=CHCO2Et 
38 
 
NR 
 
NR 
 
11%  
376 
3 Ph3P=C(Me)CO2Et 
35 
 
- 
 
- 
 
NR 
392 
4 Ph3P=CHCO2C(CH3)3 
304 
 
- 
 
- 
 
NR 
 
394 
5 
 
Ph3P-CH2(Br)Ph 
316/MTBD 89 
 
- 
 
- 
 
NR  
396 
6 PO(OMe)2CH2CO2Et 
381/MTBD 89 
 
NR 
 
- 
 
- 
378 
7 PO(OEt)2CH2CN 
420/MTBD 89 
 
NR 
 
- 
 
-  
390 
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observed using IBX, as shown in Scheme 131. Despite this promising result no 
further investigation of these reactions was attempted. 
 
Scheme 131: The TOP reaction of 1,2-diphenylethane-1,2-diol 368 
To summarise, all the above procedures allow a number of diols to react and 
generate different products according to the reactivity of these reactions, 
whereas some of them underwent oxidation and Wittig reactions on both sides 
and others gave cleavage Wittig reaction affording unexpected products.   
The next step, the synthesis of such products using 1,2-diketones via Wittig 
reaction will be briefly investigate later.  
5.8 Conclusion: 
• IMDA-TOP reaction are not feasible due to entropic constraints. 
• Tandem TOP-Diels-Alder reactions are not feasible due to difficulty in 
combining oxidation and olefination for diketones. 
• Tandem methods are not more beneficial than stepwise methods in this 
project.  
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Chapter 5 Results and Discussion IV: The Pictet-Spengler Cyclisation 
6 Introduction: tetrahydro-β-carbolines (THβCs): 
Tetrahydro-β-carboline moieties are one of the most widely used groups of 
indole alkaloids and have been extensively used as biologically active 
compounds; these compounds comprise tricyclic components in its structures. 
This diversity of ring systems is highlighted by the isolation of tetrahydro-β-
carbolines from natural products. Plant and animal systems are the main 
sources of THβC compounds, where its biological activities are seen via the 
effect of benzodiazepine receptors on monoamine oxidases.(185)  The main aim 
in this work is to synthesise THβCs with different substitution patterns to 
probe the structure-activity relationships (SAR) via the Pictet-Spengler 
reaction, followed by assaying their biological activities and then comparing 
them with other alkaloids such as  MMV008138 (422).(186)  
 
Figure 18: MMV008138 422 as a THβC 
6.1 Previous studies about tetrahydro-β-carbolines: 
Previous studies on the construction of THβCs demonstrated that the most 
successful approach was the Pictet-Spengler reaction system, a first application 
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of this reaction was formulated by Tatsui for the synthesis of 1-methyl 
tetrahydro-β-carboline 424 in the presence of acid catalyst (sulfuric acid); a 
reaction of tryptamine 148 with acetaldehyde 423 was attempted (Scheme 
132).(187)   
 
Scheme 132: The prime example of the synthesis of tetrahydro-β-carboline 
424 using the Pictet-Spengler reaction 
In chapter one, several popular methodologies were described for synthesising 
the THβC system. However, the scope and success of the Pictet-Spengler 
reaction means other approaches can be. Furthermore, modern conditions 
reveal the many advantages of using microwave methodology such as short 
reaction times, ease of isolation and purification, and higher yields. In 2004, 
Grieco et al reported this technique by a reaction of L-tryptophan methyl ester 
425 with a variety of aldehydes such as formaldehyde 426 in the presence of 
methanol and hydrochloric acid (Scheme 133).(188) It was noticed that the 
yields are decreased when using other aldehydes such as (4-Cl)-C6H4, (4-CN)-
C6H4, (3-NO2)-C6H4 instead of formaldehyde 426.  
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Scheme 133: Microwave-assisted Pictet-Spengler reaction 
1, 2, 3, 4-Tetrahydro-β-carbolines are one of the most widely used of the 
indole alkaloids compounds and have been extensively used for 
pharmacological applications. The past thirty years have seen increasingly 
rapid advances in the field of the use of THβCs in the drug market, therefore, 
these alkaloids have been in the focus of synthetic efforts for a long time by 
researchers,(195) and THβCs target the mevalonic acid pathway as reported by 
Odom. (196a) 
The investigation of THβCs as antimalarial agents has been an interesting area 
of interest in our laboratory and around the world. Previous SARs had shown that 
there is a hydrophobic packet into which the carboxylic acid side chain is orientated 
and that electron withdrawing groups are required on the phenyl ring(196a), but little 
investigation has been made of amides in comparison to others. It was therefore 
decided to synthesise a seires of methylamides with electron withdrawing groups 
on the phenyl ring to compare their activity to the lead compound 428 (Figure 19).  
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Figure 19: Tetrahydro-β-carbolines 428 
6.2 The Pictet-Spengler Reaction: 
Evidence suggests that the Pictet–Spengler reaction is among the most 
efficient methodologies for two direct steps of the synthesis of tetrahydro-β-
carbolines and this has attracted lots of scientists to apply it in organic 
synthesis.(189, 185) In particular, the chiral centre at C-1 allows the 
stereochemistry at C-3 to be controlled.   
Many factors could affect the determination of the stereochemistry at the new 
C-3 chiral centre according to indole alkaloid numbering, as shown in Figure 20.  
 
Figure 20: Examples of tetrahydro-β-carbolines 
These factors include; the substitution at the β-position of aryl ring, type of 
both the nucleophilic aromatic species and the amine, the nature of carbonyl 
compound, the amino group, and finally reaction conditions used.  
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Basically, the Pictet–Spengler reaction consists of two stages. The first one is 
the construction of the imine intermediate (Schiff base) through the acid-
catalysed imination reaction of β-arylethylamine with carbonyl compounds. 
Then this imine intermediate undergoes an acid-catalysed cyclisation to afford 
β-arylethylamide. 
As mentioned, the main target in this chapter is to examine the SAR of 
derivatievs of (MMV008138) 422, the Pictet–Spengler reaction was used to 
synthesise possible stereoisomers and then assay their biological activities 
using Plasmodium falciparum. The focus was the use of a methyl amine 
replacement of the carboxylic acid to see this will enhance activity or not. In 
addition, a variety of electron withdrawing and donating groups such as Cl, CF3, 
F, and OCH3 were investigated to test their effects on the activity of final 
products. 
6.3 The synthesis of L-tryptophan methylamide 
There is a significant body of literature that recognises the importance of the 
formation of tetrahydro-β-carbolines via the Pictet–Spengler reaction, L-
tryptophan methyl ester hydrochloride 430. Surveys such as that conducted by 
Rashid (2012), have shown high yields afforded from the reaction of substrate 
430 with different aldehydes for the synthesis of cis/trans diastereomers.(190)    
This chapter has been divided into three parts. The first part deals with the 
synthesis of L-tryptophan methylamide 432, followed by the Pictet-Spengler 
cyclisation of the compound 429 to form 1, 2, 3, 4-tetrahydro-β-carbolines. 
Chapter 5                                                                         Results and Discussion IV 
148 | P a g e  
 
Finally, test the biological evaluation (antimalarial activity) by measuring IC50 of 
synthesised compounds using Plasmodium Falciparum. 
The initial challenge faced was the difficulty of synthesising L-tryptophan 
methylamide 432 from L-tryptophan methyl ester hydrochloride 430 through a 
reaction of this ester with ethanolic methylamine solution. Therefore, to 
examine the effect of the solvent upon the reaction, methylamine was 
examined in a range of solvents (Scheme 134). It was observed that no 
significant difference between the two solutions was evident from the yield of 
product, where both experiments afforded disappointing yields of about 20 
and 35% (Scheme 134).(191) Several repeated experiments  revealed low 
conversion with the starting materials being recovered easily from the reaction 
via column chromatography. 
 
Scheme 134: Initial attempts to synthesise L-tryptophan methylamide 432 
An alternative strategy that could serve to circumvent or at least increase the 
reactivity of starting material, was employed for the formation the same 
product in excellent yield. To facilitate this pathway and to maximise the 
preparation of L-tryptophan methylamide 432, L-Tryptophan 144 and thionyl 
chloride was allowed to react in methanol in situ by stirring overnight prior to 
the addition of ethanolic solution of methylamine to afford L-tryptophan 
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methylamide 432 in a 95% yield according to Tomkinson’s procedure (Scheme 
135).(192)  
 
Scheme 135: Alternative method for the synthesis of L-tryptophan 
methylamide 432 
6.4 The Pictet-Spengler cyclisation reaction of L-Tryptophan methylamide  
After the successful formation of L-tryptophan methylamide 432, the Pictet-
Spengler cyclisation was examined through the reaction of amide 432 with a 
variety of aldehydes in the presence of trifluoroacetic acid and 3 Aͦ molecular 
sieves in CH2Cl2 to form novel indole alkaloids in disappointing yields (5-13%). 
The reaction was performed on a 1 equiv. of L-tryptophan methylamide 432 
with 1.1 equiv. of aldehydes 433 in dichloromethane, stirred at room 
temperature overnight and then followed by TLC to check the completion of 
the imine forming step; the next day the reaction was stirred for 4h after 
adding 2 equiv. of trifluoroacetic acid. After work-up, the crudes were 
separated by flash column chromatography to give the tetrahydro-β-carboline 
products 434, as shown in Scheme 136 and Table 23.  
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Scheme 136: The Pictet-Spengler reaction of L-tryptophan methylamide 432 
Table 23: The Pictet-Spengler reaction of L-tryptophan methylamide 432 
Entry Aldehyde 
[433]/R 
Product 
[434] 
1H-NMR/ 
C-3, 1H 
Yield
% 
Recovery/ 
SM% 
1 4-CF3 435 436 5.25 (s) 13 49 
2 3-CF3 437 438 5.23 (t, J = 2.2 Hz) 5 80 
3 2,4-(Cl)2 439 440 5.68 (br.s) 7 70 
4 4-F 441 442 5.69 (s) 7 42 
5 4-Cl 443 444 5.17 (s) 7 34 
6 3-Cl 445 446 5.20 (s) 13 52 
7 2,4-(CF3)2 447 448 5.30 (s) 6 29 
8 4-OCH3 449 450 ---- 0 0 
 
As can be noticed from Table 23 above, with the exception of the 4-methoxy 
benzaldehyde, which decomposed (entry 8, Table 23), it reveals that exclusive 
cis-selectivity (>30:1) and slight improvements in the yield of the products 434 
were found under the modified Pictet-Spengler reaction conditions.  
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All the experiments reviewed above (Scheme 136, Table 23), proved the poor 
reactivity of the starting material (amide 432) through resulting low yields of 
the final products even when stirring for extended time. Contrary to 
expectations, the single most striking observation to emerge from the data 
comparison with other studies found that just one isomer was isolated and 
analysed by 1H-NMR from all these reactions. The NMR spectra of the crude 
reactions confirmed the appearance of L-tryptophan methylamide 432, other 
materials such as aldehydes, a significant amount of impurities and the desired 
products. Most of the crude mixtures were purified using dichloromethane and 
diethyl ether as an eluent via column chromatography and only diethyl ether 
solvent was used with the remaining crude reactions. The 1H-NMR spectrum 
showed different peaks at a range of 5.17-5.69 ppm. For instance, the bridging 
CH (C-3 position) group of the product 436 was observed as singlet peaks at 
5.25 ppm and 58.1 ppm by NMR analysis. 
The final area of work upon Pictet-Spengler reactions examined 2-acetamino-
5-chlorobenzaldehyde 452 as an alternative aldehyde. At the beginning, a 
procedure was adapted to synthesise the new aldehyde 452 from the reaction 
of 2-amino-5-chlorobenzaldehyde 451 with acetic acid in pyridine via 
acetylation reaction, after stirring overnight, affording 2-acetamino-5-
chlorobenzaldehyde 452 in a 75% yield, as shown in Scheme 137.(193)  
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Scheme 137: The attempted synthesis of 2-acetamino-5-chlorobenzaldehyde 
via acetylation reaction 
Unfortunately, 1H-NMR analysis of this crude mixture of the Pictet-Spengler 
reaction showed only that decomposition of starting material occurred.  
It was thought these obtained results related to the poor reactivity of starting 
material 432. However, the excellent diastereoselectivity seems to be 
consistent with the findings of Massiot and Mulamba (1983),(194) who obtained 
that a pure cis-diastereoisomer 456 as the sole product from the reaction of L-
tryptophanamide 454 with aldehyde 455, as shown in Scheme 138.  
 
Scheme 138: The exceptional cis-selectivity of L-tryptophanamide 456 
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An alternative route would be to carry out a Pictet-Spengler cyclisation on the 
methyl ester and then convert this to the amide. Carlier et al (2015) showed 
that L-tryptophanmethyl ester salt 457 underwent the Pictet-Spengler 
cyclisation with 2,4-dichlorobenzaldehyde 439, followed by treatment of the 
methyl ester 458 with methylamine to afford good to excellent yields, as 
shown in Scheme 139.(186) However, such an approach would significantly 
increase the number of synthetic steps needed so it was discounted. 
 
Scheme 139: the Pictet-Spengler reaction of L-tryptophanmethyl ester salt 457 
6.5 Antimalarial activities of synthesised products 
The products synthesised were then screened for antimalarial activity using a 
48-hour Dd2Luc Plasmodium Falciparum growth inhibition assay, as shown in 
Figure 21 and Table 24.  
 
Figure 21: A novel of tetrahydro-β-carboline derivatives 
Chapter 5                                                                         Results and Discussion IV 
154 | P a g e  
 
Table 24: A novel of tetrahydro-β-carboline derivatives 
Entry Compounds R IC50 /µM 
1 436 4-CF3 > 200 
2 438 3-CF3 > 200 
3 440 2,4-Cl2 8.8 
4 442 4-F > 200 
5 444 4-Cl 173 
6 446 3-Cl > 200 
7 448 2,4-(CF3)2 > 200 
 
The results obtained were ultimately disappointing. None of the synthesised 
compounds showed antimalarial activity, with IC50 values greater than 200µM 
these hold of the Dd2Luc assay. This indicates that irrespective of the phenyl 
substitution pattern, or the EWG present, the amide substituent leads to lower 
activity than either the lead compound 428 or the original MMV compound 
460 (Figure 22). This is somewhat consistent with the observation that 
examined the replacement of methyl ester precursor with amide group at C-1 
substituent was found to be unimportant and no effect on growth inhibitory 
activity.(186) However, these results were helpful in demonstrating that the 
amide series of THβCs is not a useful avenue of investigation, hence this SAR 
study was successful. 
Chapter 5                                                                         Results and Discussion IV 
155 | P a g e  
 
 
Figure 22: (1R,3S)-MMV008138 stereoisomer 460 
6.6 Conclusion: 
• Despite the poor reactivity obtained during the synthesis of L-
tryptophanamide 432, the Pictet-Spengler reactions of L-tryptophanamide 
were pursued to prepare a novel of indole compounds that examined via 
studying the potency of these substrates against Plasmodium Falciparum. 
• The results in this chapter indicate that potent antimalarial activity requires 
a carboxylate/carboxylic acid rather than amide functionality at C-1.  
• These results seem to be consistent with Carlier’s research which found at 
least one sterically small, electron-withdrawing group at 2’ and/or 4 were 
potent Plasmodium Falciparum growth inhibitors.(186)   
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Chapter 6 Experimental section 
7 Experimental section 
7.1 General experimental details 
All commercial solvents were purchased from Sigma Aldrich or Fisher Scientific 
or VWR chemicals. Anhydrous tetrahydrofuran (THF), N,N-dimethylformamide 
(DMF) and dichloromethane were purchased in anhydrous form. TLC plates 
used were silica gel 60 F254 (Merck) and detection was conducted by UV light 
or visualised by potassium permanganate stain followed by gentle warming. 
Routinely, organic layers were dried over anhydrous MgSO4 and evaporated 
using a Büchi evaporator. The determination of melting point (uncorrected) 
was measured using a Bibby Stuart Scientific Melting point apparatus. All 
apparatus and metal needles were oven-dried. Most of reactions were 
conducted under an inert atmosphere using a positive pressure of dry nitrogen 
or argon gas (using a balloon or bubbler apparatus). In terms of Infrared 
spectra, the results were recorded on Thermo Nicolet FT-IR Nexus with an 
Avatar Smart Omni Sampler and diamond crystal. 1H-NMR and 13C-NMR 
spectra were run either Avance 300 or Avance 400 instruments in CDCl3, d6-
DMSO or d4-MeOH where the results recorded at proton (1H-300/400 MHz), 
carbon (13C-75.4/100.5 MHz), phosphorus(31P{1H}-121.4/161.9 MHz) 
frequencies. Multiplicity is denoted by: d = doublet; t = triplet; q = quartet; m = 
multiplet; dd = double doublet; etc. Coupling constants (J values) are listed in 
Hertz (Hz). For the purposes of assignment, the numbering used does not 
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conform to IUPAC nomenclature. Electrospray mass spectroscopy was 
performed on an Agilent Technology 6530 Accurate-Mass Q-TOF LC/MS 
machine. Data are reported in the form of (m/z). 
For antimalarial activity, 48-hour growth inhibition assays were conducted on 
the novel compounds to determine their inhibitory concentration (IC50) values. 
These assays utilised trophozoite stage Dd2Luc Plasmodium falciparum 
parasites. MSF assays were carried out on the candidate compounds that were 
diluted in a two-fold dilution series using a 60 μM starting concentration. The 
data was normalised and plotted as a log-dose response curve to generate IC50 
values. For all derivatives three independent biological replicates were carried 
out on assay plates bearing three technical repeats. 
7.2 Experimental procedures: Chapter 2 
7.2.1 Preparation of esters and amides 
Preparation of allyl glycolate 237 
 
Glycolic acid 233 (5.00 g, 65.7 mmol, 1 equiv.) was dissolved in toluene (100 
mL), and allyl alcohol 231 (4.15 g, 71.5 mmol, ƿ = 0.854 gmL-1, 4.86 mL, 1 
equiv.) added. The solution was acidified with trifluoroacetic acid (149 mg, 
1.31 mmol, ƿ = 1.478 gmL-1, 100 µL, 0.02 equiv.) added. The resulting mixture 
was heated to reflux for 3 h with a Dean-Stark head to remove water. The 
solution was then concentrated to a small volume and then extracted with 
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saturated sodium bicarbonate (250 mL). The organic layer was washed by 
water (250 mL), saturated brine (250 mL). The resulting organic layer was dried 
(MgSO4) and concentrated in vacuo. Drying under high pressure gave yellow oil 
(3.43 g, 29.6 mmol, 45%). 237: 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 2.87 (br.s, 
1H, H6), 4.20-4.32 (m, 2H, H5), 4.67-4.72 (m, 2H, H3), 5.27-5.39 (m, 2H, H1a, H1b), 
5.93 (ddt, J = 16.8, 11.1, 5.8 Hz, 1H, H2); 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 
60.6 (C5), 61.1 (C3), 117.7 (C2), 132.2 (C1), 167.5 (C4); Attempts to get high 
resolution mass spectrometry data failed. 
Preparation of allyl chloroacetate 236: 
 
To a slurry of allyl alcohol 231 (6.30 g, 110 mmol, ƿ = 0.854 gmL-1, 7.48 mL, 1 
equiv.) in dichloromethane at 0 °C was added pyridine (8.85 g, 112 mmol, ƿ = 
0.981 gmL-1, 9 mL, 1.01 equiv.) followed by the dropwise addition of 
chloroacetyl chloride 232 (11.3 g, 100 mmol, ƿ = 1.418 gmL-1, 7.96 mL, 0.9 
equiv.) over 30 min. The resulting solution was stirred at 0 °C for 15 min and 
then warmed to room temperature. After the mixture was stirred at room 
temperature for 24 h, saturated sodium bicarbonate (150 mL) was added. The 
two layers were stirred for 40 min, and then were separated. The aqueous 
layer was extracted with dichloromethane (3 × 150 mL). The organic layers 
were individually washed with 2 M hydrochloric acid (150 mL) and saturated 
brine (150 mL), dried (MgSO4) to afford the product as a yellow oil (7.25 g, 53.8 
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mmol, 50%). 236:(197) 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 4.08 (s, 2H, H5), 
4.60-4.64 (m, 2H, H3), 5.19-5.35 (m, 2H, H1a, H1b), 5.80-5.94 (m, 1H, H2); 13C-
NMR (75 MHz, CDCl3, 25 °C): δ = 40.8 (C5), 65.3 (C3), 118.5 (C1), 132.5 (C2), 
167.3 (C4); IR (KBr): ѵmax (cm-1) = 3092, 2960, 2923, 2872, 1759, 1645, 1420, 
1382, 1276, 1190, 1090, 988; MS (ESI), 152 (MNH4+), HRMS (ESI, m/z %) calcd. 
for C5H1135ClNO2 [(M+ NH4)+]:152.0478; found: 152.0493,   ̶1.95 ppm error. 
Preparation of allyl bromoacetate 238: 
 
Procedure A:(198)   
Bromoacetic acid 234 (20.0 g, 143 mmol, 10.3 mL, 1 equiv.) was dissolved in 
toluene (250 mL), and allyl alcohol 231 (9.13 g, 157 mmol, ƿ = 0.854 gmL-1, 10.6 
mL, 1.1 equiv.) added. The solution was acidified with trifluoroacetic acid (326 
mg, 2.86 mmol, ƿ = 1.489 gmL-1, 220 µL, 0.02 equiv.). The resulting mixture was 
heated to reflux for 3 h with a Dean-Stark head to remove water. The solution 
was then concentrated to a small volume and then extracted with saturated 
sodium bicarbonate (250 mL). The organic layer was washed by water (250 mL) 
and then saturated brine (250 mL). The resulting organic layer was dried 
(MgSO4) and concentrated in vacuo and then dried under high pressure to 
obtain yellow oil (12.7 g, 70.7 mmol, 45%). 
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Procedure B:(199)                                                                                          
A solution of allyl alcohol 231 (2.00 g, 3.59 mmol, ƿ = 0.854 gmL-1, 2.4 mL, 1 
equiv.) and bromoacetic acid 234 (5.00 g, 35.9 mmol, 10 equiv.) was cooled to 
0 °C in acetonitrile (200 mL), and 4-(dimethylamino)pyridine (890 mg, 7.19 
mmol, 0.2 equiv.) and then dicyclohexylcarbodiimide (8.16 g, 39.6 mmol, 1.1 
equiv.) was added. The resulting solution was stirred at room temperature for 
24 h. After stirring, the solid was filtered off, washed with acetonitrile (50 mL), 
and the excess of acetonitrile was evaporated in vacuo. The residue was 
dissolved in dichloromethane (100 mL) and extracted with saturated sodium 
bicarbonate (100 mL). The organic layer was washed with 2 M hydrochloric 
acid (100 mL), and then water (100 mL) and finally with saturated brine (100 
mL). The final organic layer was dried (MgSO4) to give the product (40%). 
Procedure C:(200)                                                                                         
To a solution of allyl alcohol 231 (10.0 g, 172.1 mmol, ƿ = 0.854 gmL-1, 11.7 mL, 
1 equiv.) and pyridine (13.6 g, 172.1 mmol, ƿ = 0.981 gmL-1, 14.0 mL, 1 equiv.) 
in dichloromethane (150 mL) at 0 °C, bromoacetyl bromide 235 (34.7 g, 172.1 
mmol, ƿ = 2.317 gmL-1, 15.0 mL, 1 equiv.) was added dropwise. The white 
suspension was stirred at 0 °C for 20 min, followed by 24 hours at room 
temperature. Water (50 mL) was added to the reaction mixture and the 
organic layer was separated. The aqueous layer was extracted with 
dichloromethane (2 × 20 mL) and then the combined organic layers were 
washed with saturated brine (40 mL), dried (MgSO4), and filtered. The filtrate 
was then concentrated to give the α-bromoester as yellow oil (30 g, 167.5 
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mmol, 100%). 238:(197b) 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 3.85 (s, 2H, H5), 
4.61 (d, J = 5.8 Hz, 2H, H3), 5.23 (d, J = 10.4 Hz, 1H, H1), 5.32 (ddt, J = 17.2 2.5, 
2.5 Hz, 1H, H1), 5.88 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H, H2); 13C-NMR (75 MHz, 
CDCl3, 25 °C): δ = 42.9 (C5), 64.8 (C3), 119.0 (C1), 132.0 (C2), 165.0 (C4); IR 
(KBr): ѵmax (cm-1) =  2962, 1738, 1421, 1279, 1165, 987; GCMS:(197b) tR = 5.00 
min, m/z 180/178 (<1, M+), 123/121 (100, M+-allylO•), 99 (88, M+-HBr), 95/93 
(53, BrCH2+), 85 (53, M+-BrCH2•), 58 (75, C3H6O+), and 57 (90, C3H5O+); MS (ESI), 
178 (MH+), HRMS (ESI, m/z %) calcd. for C5H879BrO2 [(M+H)+]: 178.9707; found: 
178.9747, 7.74 ppm error.  
Preparation of 3-butenyl bromoacetate 240:(201)   
 
To a solution of 3-buten-1-ol 239 (10 g, 138.7 mmol, ƿ = 0.838 gmL-1, 11.9 mL, 
1 equiv.) and pyridine (10.971 g, 138.7 mmol, ƿ = 0.978 gmL-1, 11.2 mL, 1 
equiv.) in dichloromethane (100 mL) at 0 °C, bromoacetyl bromide 235 (27.995 
g, 138.7 mmol, ƿ = 2.317 gmL-1, 12 mL, 1 equiv.) was added dropwise. The 
suspension was stirred at 0 °C for 20 min, followed by 24 h at room 
temperature. Water (50 mL) was added to the mixture and the organic layer 
was separated. The aqueous layer was extracted with dichloromethane (2 × 20 
mL) and then the combined organic layers were washed with brine (40 mL), 
dried (MgSO4) and filtered. The solvent was then removed to give 3-butenyl 
bromoacetate as yellow oil (23.5 g, 116.8 mmol, 88%). 240: 1H-NMR (400 MHz, 
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CDCl3, 25 °C): δ = 2.43 (q, J = 6.7 Hz, 2H, H3), 3.84 (s, 2H, H6),4.23 (t, J = 6.7 Hz, 
2H, H4), 5.09-5.16 (m, 2H, H1), 5.74-5.84 (m, 2H, H2); 13C-NMR (100 MHz, CDCl3, 
25 °C): δ = 25.9 (C6), 32.8 (C3), 65.2 (C4), 117.6 (C1), 133.40(C2), 167.1 (C5). IR 
(neat): ѵmax (cm-1) = 2980, 1740, 1430, 1290, 1170, 1118; MS (ESI), 192 (MH+), 
HRMS (ESI, m/z %) calcd. for C6H1079BrO2 [(M+H)+]: 192.9864; found: 192.9806, 
7.70 ppm error. 
Preparation of N-allyl chloroacetamide 245:  
 
To a slurry of allylamine 241 (6.28 g, 110 mmol, ƿ = 0.761 gmL-1, 8.25 mL, 1 
equiv.) in dichloromethane (100 mL) 0   ͦC was added pyridine (8.85 g, 112 
mmol, ƿ = 0.981 gmL-1, 9 mL, 1.01 equiv.) followed by the dropwise addition of 
chloroacetyl chloride 232 (11.3 g, 100 mmol, ƿ = 1.418 gmL-1, 7.96 mL, 0.9 
equiv.) over 30 min. The resulting solution was stirred at 0  ͦC for 15 min and 
then warmed to room temperature. After the mixture was stirred at room 
temperature for 24 hours, saturated sodium bicarbonate (150 mL) was added. 
The two layers were stirred for 40 min, and then were separated. The aqueous 
layer was extracted with dichloromethane (3 × 150 mL). The organic layers 
were individually washed with 2 M aq. hydrochloric acid (150 mL) and 
saturated brine (150 mL), combined, dried (MgSO4) to afford the product as 
yellow oil (9.69 g, 72.5 mmol, 66%). 245:(202) 1H-NMR (300 MHz, CDCl3, 25 °C), 
NMR showed the presence of a 59:41 mixture of rotamers: δ = 3.75-3.80 (m, 
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2H, H3 major, H3 minor), 3.92 (s, 2H, H6 major), 3.93 (s, 2H, H6 minor), 4.00 (s, 2H, H6), 
4.98-5.12 (m, 2H, H1a major, H1a minor,  H1b major, H1b minor), 5.19 (s, 1H, H4 major ), 5.20 
(s, 1H, H4 minor), 5.63-5.77 (m, 1H, H2 major, H2 minor). 13C-NMR (75 MHz, CDCl3, 25 
°C): δ = 42.1 (C3), 42.4 (C6), 116.5 (C1), 133.4 (C2), 166.1 (C5); IR (KBr): ѵmax 
(cm-1) = 3296, 3083, 1664, 1545, 1419, 1324, 1261, 1240, 1154, 990, 923, 788, 
696, 651, 565; MS (ESI), 134 (MH+), HRMS (ESI, m/z %) calcd. for C5H935ClNO 
[(M+H)+]: 134.0372; found: 134.0373,  ̶  3.56 ppm error. 
Preparation of N,N-diallyl chloroacetamide 246:  
 
To a slurry of diallylamine 242 (10.7 g, 110 mmol, 13.6 mL, 1 equiv.) in 
dichloromethane (100 mL) at 0   ͦC was added pyridine (8.85 g, 112 mmol, ƿ = 
0.981 gmL-1, 9 mL, 1.01 equiv.) followed by the dropwise addition of 
chloroacetyl chloride 232 (11.3 g, 100 mmol, ƿ = 1.418 gmL-1, 7.96 mL, 0.9 
equiv.) over 30 min. The resulted solution was stirred at 0 °C for 15 min and 
then warmed to room temperature. After the mixture was stirred at room 
temperature for 24 h, saturated sodium bicarbonate solution (150 mL) was 
added. The two layers were stirred for 40 min, and then were separated. The 
aqueous layer was extracted with dichloromethane (3 × 150 mL). The organic 
layers were individually washed with 2 M aq. hydrochloric acid (150 mL) and 
saturated brine (150 mL), combined, dried (MgSO4) to afford the product as 
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yellow oil (13.3 g, 76.9 mmol, 70%). 246:(203) 1H-NMR (300 MHz, CDCl3, 25 °C): δ 
= 3.79-3.86 (m, 4H, H3), 3.95 (s, 2H, H5), 4.97-5.12 (m, 2H, H1a, H1b), 5.53-5.75 
(m, 2H, H2). 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 41.2 (C5), 50.0 (C6), 118.9 
(C1), 132.7 (C2), 166.3 (C4); IR (KBr): ѵmax (cm-1) = 1660, 1630, 990, 925; MS 
(ESI), 174 (MH+), HRMS (ESI, m/z %) calcd. for C8H13N35ClO [(M+H)+]: 174.0685; 
found: 174.0681,  ̶ 1.47 ppm error. 
Preparation of N-benzylallyl amine 244: (204a)   
 
To a suspension of K2CO3 (6.98 g, 50.5 mmol, 1.2 equiv.) in allylamine 241 (19.2 
g, 337 mmol, ƿ = 0.761 gmL-1, 25.3 mL, 8 equiv.) was added benzyl bromide 
243 (7.20 g, 42.1 mmol, ƿ = 1.438 gmL-1, 5 mL, 1 equiv.) slowly via syringe 
addition over a period of 45 minute. The resulting solution was stirred at room 
temperature for 24 h. The insoluble solids were filtered off through a celite pad 
and then rinsed with dichloromethane (100 mL), and the filtrate was then 
concentrated in vacuo to obtain oil. Purification by column chromatography 
eluting with (hexane/ethyl acetate; 10:1 to 2:1) provided pure N-benzylallyl 
amine as a clear oil (4.33 g, 29.4 mmol, 70%). 244:(204a, 204b) 1H-NMR (300 MHz, 
CDCl3, 25 °C): δ = 2.03 (s, 1H, H4), 3.30 (d, J = 5.9 Hz, 2H, H3), 3.81 (s, 2H, H5), 
5.15 (d, J = 10.3 Hz, 1H, H1a), 5.24 (d, J = 17.1Hz, 1H, H1b), 5.93-6.02 (m, 1H, H2), 
7.26-7.28 (m, 1H, H9), 7.36 (d, J = 4.6 Hz, 4H, H7, H8); 13C-NMR (75 MHz, CDCl3, 
25 °C): δ = 51.9 (C3), 53.3 (C5), 115.9 (C1), 127.0 (C2) 128.2 (C7), 128.4 (C8), 
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137.0 (C9) 140.4 (C6); IR (neat): ѵmax (cm-1) = 2925, 2854, 1736, 1454, 1258, 
1155, 1104, 1009, 993, 954, 905, 875, 802, 756, 728, 675, 530, 474;  MS (ESI), 
147(MH+); HRMS (ESI, m/z %) calcd. for C10H13N [(M+H)+]: 147.1126; found 
147.1132,  ̶  7.17 ppm Error. 
Preparation of N-allyl-N-benzyl chloroacetamide 247: 
 
To a slurry of N-benzylallyl amine 244 (3.00 g, 20.4 mmol, 1 equiv.) in 
dichloromethane (50 mL) at 0 °C was added pyridine (1.61 g, 20.4 mmol, ƿ = 
0.981 gmL-1, 1.65 mL, 1.01 equiv.) followed by the dropwise addition of 
chloroacetyl chloride 232 (20.9 g, 18.5 mmol, ƿ = 1.418 gmL-1, 1.47 mL, 0.9 
equiv.) over 30 min. The resulting solution was stirred at 0 °C for 15 min and 
then warmed to room temperature. After the mixture was stirred at room 
temperature for 24 hours, saturated sodium bicarbonate (75 mL) was added. 
The two layers were stirred for 40 min, and then were separated. The aqueous 
layer was extracted with dichloromethane (3 × 75 mL). The organic layers were 
individually washed with 2 M hydrochloric acid (75 mL) and saturated brine (75 
mL), dried (MgSO4), filtered and finally concentrated under vacuum to afford 
the product as a yellow oil (2.73 g, 12.2 mmol, 60%). 247:(205) 1H-NMR (400 
MHz, CDCl3, 25 °C) NMR showed the presence of a 63:37 mixture of rotamers: 
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δ= 3.89 (dt, J = 5, 1.6 Hz, 1H, H3a), 4.01 (d, J = 5.8 Hz, 1H, H3b), 4.08 (s, 1H, H4 
minor), 4.12 (s, 1H, H4 major), 4.57 (s, 1H, H6 minor), 4.60 (s, 1H, H6 major), 5.15-5.17 
(m, 1H, H1a), 5.18-5.23 (m, 1H, H1b), 5.70-5.81 (m, 1H, H2 major, H2 minor), 7.18 (d, 
J= 6.8 Hz, 1H, H10), 7.28-7.30 (m, 2H, H8 major, H8 minor), 7.32-7.37 (m, 2H,H9 major, 
H9 minor); 13C- NMR (75 MHz, CDCl3, 25 °C): δ = 41.3 (C4 major), 41.4 (C4 minor), 48.4 
(C3b minor), 48.7 (C6 major), 49.4 (C3a major), 50.4 (C6 minor), 117.5 (C1a major), 118.0 
(C1b minor), 126.4 (C10), 127.6 (C8 minor or C9 minor), 128.1 (C8 major or C9 major), 128.9 
(C8 minor or C9 minor), 129.0 (C8 major or C9 major), 132.0 (C2 minor), 132.3 (C2 major), 
135.9 (C7 minor), 136.7 (C7 major), 166.8 (C5 minor),, 170.0 (C5 major); IR (KBr): ѵmax 
(cm-1) =  3064, 3029, 2921, 1653, 1605, 1451, 1244, 1140, 1028, 993, 954, 926, 
860, 794; MS (ESI), 224 (MH+), HRMS (ESI, m/z %) calcd. for C12H15N35ClO 
[(M+H)+]: 224.0842; found: 224.0830, 3.16 ppm error. 
Preparation of tert-butyl 2-bromopropionate 247a: 
 
Procedure A:(206) 
 To a cooled 0  ͦC solution of 2-bromopropionic acid (2.00 g, 13.07 mmol, ƿ = 
1.70 gmL-1, 1.17 mL, 1 equiv.), 4-(dimethylamino)pyridine (1.27 g, 10.4 mmol, 
0.8 equiv.) and tert-butyl alcohol (2.90 g, 39.21 mmol, ƿ = 1.387 gmL-1, 200 µL, 
3 equiv.) were dissolved in dichloromethane (30 mL). The mixture was stirred 
vigorously at 0 °C, and then a solution of DCC (2.96 g, 14.3 mmol, 1.1 equiv.) in 
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dichloromethane (5 mL) was added slowly. The resulted solution was stirred at 
room temperature for 15 h. The precipitate formed was filtered through celite 
and washed with dichloromethane (50 mL). The extract was washed with 
saturated sodium bicarbonate (100 mL), brine (150 mL), dried (MgSO4), filtered 
and then concentrated in vacuo to afford the crude 247a, as yellow oil, which 
was used without further purification. No characterisation of 247a was 
attempted in this procedure.        
Procedure B: 
To a cooled (-78 °C) round flask of a dry ice/acetone bath, Isobutylene was 
bubbled into this round until collecting (10 mL) of liquid isobutylene. A solution 
of 2-bromopropionic acid (5.00 g, 32.6 mmol, ƿ = 1.70 gmL-1, 2.9 mL, 1 equiv.) 
was dissolved in dichloromethane (80 mL) then added dropwise to liquid 
isobutylene. After 5 min, concentrated sulphuric acid (500 µL) was added. The 
resulting solution was stirred for 16 hours. Saturated aq. sodium bicarbonate 
(50 mL) was added. The extract was separated and washed with saturated 
sodium bicarbonate solution (50 mL), water (50 mL) and brine (50 mL), then 
dried (MgSO4). The filtrate was concentrated in vacuo to give a pure colourless 
liquid 247a (4.0 g, 19.2 mmol, 58.8%). 247a:(207) 1H-NMR (300 MHz, CDCl3, 25 
°C): δ = 1.48 (s, 9H, H1), 1.79 (d, J = 6.9 Hz, 3H, H4), 4.27 (q, J = 6.9 Hz, 1H, H5); 
13C-NMR (75 MHz, CDCl3, 25 °C): δ = 21.6 (C1), 27.7 (C4), 41.9 (C5), 82.1 (C2), 
169.2 (C3); IR (neat): ѵmax (cm-1) = 3342, 2974, 2930, 2900, 1734, 1457, 1370, 
1236, 1148, 1046, 844, 755, 714, 683; MS (ESI), 207 (MH-), HRMS (ESI, m/z %) 
calcd for C7H1279BrO2 [(M-H)–]:(206) 207.0021, found 207.0023.   
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7.2.2 Preparation of phosphorane ylides 
General procedure 1:  
Halo ester (1 equiv.) was dissolved in acetonitrile and triphenylphosphine (1.02 
equiv.) was added. The mixture was stirred and heated at reflux under 
nitrogen pressure for (16 hours) after that cooled to room temperature and 
concentrated in vacuo. The resulting viscous reside was dissolved in a mixture 
of benzene (50 mL) and hexane (50 mL) and washed with water (150 mL). Two 
drops of alcoholic phenolphthalein were added as an indicator and then the 
solution was extracted with ether (150 mL). The aqueous solution was stirred 
vigorously and cooled in an ice bath. Drops of 2 M sodium hydroxide solution 
were added slowly until the pink end-point was reached (pH 8–10). The solid 
was collected by filtration, washed thoroughly with cold water, and dried over 
phosphorus pentoxide to obtain the desired phosphoranes. Conversion was 
determined by analysis of the 1H-NMR spectrum. 
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Preparation of N-allyl(triphenylphosphoranylidene) acetamide 251: 
 
According to general procedure 1 using allyl chloroacetate 245 (1.33 g, 9.95 
mmol, 1equiv.), acetonitrile (25 mL) and triphenylphosphine (2.66 g, 10.15 
mmol, 1.02 equiv.) were combined to give the crude 251, as white solid, which 
was used without further purification. No characterisation of 251 was 
attempted in this procedure because of its decomposition. 
Preparation of N,N-diallyl(triphenylphosphoranylidene) acetamide 252: 
 
According to general procedure 1 using N,N-diallyl chloroacetamide 246 (1.73 
g, 9.99 mmol, 1 equiv.), acetonitrile (50 mL) and triphenylphosphine (2.67 g, 
10.2 mmol, 1.02 equiv.) were combined. The title compound 252 was obtained 
Chapter 6                                                                                              Experimental 
170 | P a g e  
 
as faint white solid (2.58 g, 6.43 mmol, 65%). 252:(208) m.p. 95-96 °C; 1H-NMR: 
(400 MHz, CDCl3, 25 °C): δ = 2.87 (d, JPH = 22.4 Hz, 1H, H5), 3.97 (d, J = 5.4 Hz, 
2H, H3), 5.11 (d, J = 10.3 Hz, 2H, H1a), 5.17 (d, J = 17.4 Hz, 2H, H1b), 5.88 (ddt, J = 
17.4, 10.3, 5.4 Hz, 2H, H2), 7.43-7.48 (m, 6H, H8), 7.53 (td, J = 7.1, JPH = 1.1 Hz, 
3H, H9), 7.69 (dd, JPH = 12.3, J = 7.1 Hz, 6H, H7); 13C-NMR (100 MHz, CDCl3, 25 
°C): δ =  31.1 (d, JPC = 131 Hz, C5), 48.9 (s, C3), 115.2 (s, C1), 128.5 (d, JPC = 12.0 
Hz, C7), 131.4 (d, JPC = 2.8 Hz, C9), 132.1 (d, JPC = 9.9 Hz, C6), 133.0 (d, JPC = 9.9 
Hz, C8), 135.9 (s, C2), 172.0 (s, C4); 31P{1H}-NMR (162 MHz, CDCl3, 25 °C): δ = 
17.7 (s). IR (neat): ѵmax (cm-1) = 696, 720, 779, 856, 922, 984, 1072, 1118, 1142, 
1359, 1437, 1470, 1495, 1633, 2914; MS (ESI), 400 (MH+), HRMS (ESI, m/z %) 
calcd. for C26H27NOP [(M+H)+]: 400.1830; found: 400.1838,  ̶ 2.37 ppm error.  
Preparation of N-allyl-N-benzyl (triphenylphosphoranylidene) acetamide 253:  
 
According to general procedure 1 using N-allyl-N-benzyl chloroacetamide 247 
(4.3 g, 19.2 mmol, 1 equiv.), acetonitrile (100 mL) and triphenylphosphine 
(4.78 g, 19.6 mmol, 1.02 equiv.) were combined to afford the product as thick 
yellow oil (2.84 g, 6.53 mmol, 34%). 253:(208); 1H-NMR (400 MHz, CDCl3, 25 °C): 
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δ = 2.93 (br. s, 1H, H10), 3.93-3.97 (m, 2H, H3), 4.60 (s, 2H, H5), 5.09-5.19 (m, 2H, 
H1a, H1b), 5.88 (ddt, J = 16.4, 10.7, 5.2 Hz, 1H, H2), 7.22-7.33 (m, 5H, H7, H8, H9), 
7.42-7.49 (m, 6H, H12), 7.51-7.57 (m, 3H, H14), 7.66-7.74 (m, 6H, H13); 13C-NMR 
(100 MHz, CDCl3, 25 °C): δ = 48.1 (C3), 49.1 (C5), 115.6 (C1), 126.5 (C9), 127.7 
(C7), 128.2 (C8), 128.5 (JPC = 3.3 Hz, C13), 128.7 (JPC = 3.3 Hz, C13), 129.9 (C11), 
131.5 (C14), 133.1 (JPC = 9.9 Hz, C12), 135.4 (C2), 140.2 (C6), 172.2 (C4); 31P{1H}-
NMR (162 MHz, CDCl3, 25 °C): δ = 17.8 (s); IR (neat): ѵmax (cm-1) = 3060, 2951, 
1636, 1496, 1438, 1356, 1246, 1195, 1121, 997, 911, 742, 695; MS (ESI), 450 
(MH+), HRMS (ESI, m/z %) calcd. for C30H29NOP [(M+H)+]: 450.1986; found: 
450.2016,  ̶  4.92 ppm error. 
Preparation of tert-butyl 2-(triphenylphosphoranylidene)propionate 305: 
 
According to general procedure 1 using tert-butyl-2-bromopropionate 247a 
(4.0 g, 19.13 mmol, 1 equiv.), acetonitrile (100 mL) and triphenylphosphine 
(5.11 g, 19.51 mmol, 1.02 equiv.) were combined to afford the product as thick 
red oil (2.5 g, 6.4 mmol, 33%). 305:(209a); 1H-NMR (400 MHz, CDCl3, 25 °C): δ = 
0.96 (s, 9H, H1), 1.63 (m, 3H, H4), 7.41-7.48 (m, 6H, H7), 7.50-7.57 (m, 3H, H9), 
7.60-7.66 (m, 6H, H8); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 12.6 (C4), 28.6 
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(C1), 55.3 (C2), 97.3 (C5), 128.3 (d, J= 11.7 Hz, C7), 131.4 (d, J = 2.9 Hz, C9), 
133.7 (d, J = 9.5 Hz, C8); IR (neat): ѵmax (cm-1) = 3049, 2977, 2900, 1712, 1590, 
1474, 1439, 1252, 1182, 1025, 844, 785, 752, 712, 697; MS (ESI), 391 (MH+), 
HRMS (ESI, m/z %) calcd. for C25H28O2P [(M+H)+]: 391.1826; found: 391.1823,   ̶ 
0.63 ppm error. 
7.2.3   The preparation of phosphorane ylides 
General procedure 2:  
To a solution of triphenylphosphine (1 equiv.) in toluene, halo ester (1 equiv.) 
was added dropwise to form a slurry. This slurry was stirred overnight and then 
filtered and washed with toluene (30 mL) and hexane (50 mL) to give the 
corresponding phosphonium salt as a white solid. The salt was dissolved in 
water (100 mL) and 2 M sodium hydroxide solution was added to keep the 
aqueous solution at a pH < 7, while a white precipitate formed. The reaction 
mixture was then stirred for 30 min and then dichloromethane (50 mL) was 
added to dissolve the precipitate. The organic layer was separated, washed 
with brine (50 mL), dried (MgSO4) and filtered. The filtrate was then 
concentrated and dried to give the desired phosphorane. 
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Preparation of allyl (triphenylphosphoranylidene) acetate 248: 
 
Procedure A:  
According to General procedure 2 using triphenylphosphine (47.39 g, 180.7 
mmol, 1equiv.), toluene (50 mL) and allyl bromoacetate 238 (32.36 g, 180.7 
mmol, 1 equiv.) The phosphorene was obtained as thick red oil (44.9 g, 124.6 
mmol, 70%). 248: 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 3.23 (br. s, 1H, H5), 4.45 
(d, J = 4 Hz, 2H, H3), 4.94-5.22 (m, 2H, H1), 5.70-5.79 (m, 1H, H2), 7.43-7.49 (m, 
6H, H8), 7.54-7.58 (m, 3H, H9), 7.64-7.71 (m, 6H, H7); 13C-NMR (75 MHz, CDCl3, 
25 °C): δ = 53.6 (C5), 63.5 (C3), 116.5 (C1), 128.9 (JPC = 12.1 Hz, C7), 132.3 (C9), 
133.0 (JPC = 9.9 Hz, C8), 134.3 (C6), 137.8 (C2), 170.4 (C4); IR (neat): ѵmax (cm-1) 
=  3052, 2978, 2925, 1716, 1587, 1477, 1436, 1364, 1102, 1062, 871, 749, 732, 
691; MS (ESI), 361 (MH+), HRMS (ESI, m/z %) calcd. for C23H22O2P [(M+H)+]: 
361.1357; found: 361.1370,   ̶ 4.74 ppm error. 
Procedure B: 
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To a solution of triphenylphosphine (4.96 g, 0.018 mmol, 1equiv.) in 
trifluoroacetic acid (7 mL), allyl glycolate 237 (2.0 g, 0.017 mmol, 1 equiv.) was 
added dropwise. This solution was stirred overnight at reflux and then added 
and water (30 mL) and dichloromethane (50 mL). The organic layer was 
separated and dried (MgSO4), the filtrate was then concentrated in vacuo to 
give the crude 248, as white solid, which was used without further purification. 
No characterisation of 248 was attempted in this procedure because its 
decomposition. 
Preparation of 3'-butyen-1'-yl 2-(triphenylphosphoranylidene)acetate  
254:(209b) 
 
According to General procedure 2 using triphenylphosphine (31.9 g, 122 
mmol, 1 equiv.), toluene (50 mL) and 3-butenyl bromoacetate 240 (23.5 g, 122 
mmol, 1 equiv.) to afford the phosphorane as thick red oil (31.97 g, 85.4 
mmole, 70%). 254: 1H-NMR (400 MHz, CDCl3, 25 °C): δ = 2.14-2.18 (m, 2H, H3), 
2.93 (br.s, 1H, H6), 3.97 (t, J = 6.8 Hz, 2H, H4), 4.89-4.98 (m, 2H, H1), 5.65 (br.s, 
1H, H2), 7.42-7.70 (m, 15H, H8, H9, H10); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 
30.2 (d, 124 Hz, C1), 33.9, 61.5, 116.0, 124.5, 128.6, 128.8, 131.9, 132.0, 132.1, 
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133.0, 133.1, 135.5, 171.1 (C5); 31P{1H}-NMR (162 MHz, CDCl3, 25 °C): δ = 18.04 
(s); IR (neat): ѵmax (cm-1) = 3058, 2941, 1726, 1482, 1455, 1435, 1394, 1334, 
1144, 1105, 1063, 997, 880, 717, 689; MS (ESI), 375 (MH+), HRMS (ESI, m/z %) 
calcd. for C24H24O2P [(M+H)+]: 375.1513; found: 375.1529,   ̶5.28 ppm error. 
Preparation of 1-(triphenylphosphoranylidene)-5-hexen-2-one 444:(210a)  
 
To a cooled solution of triphenylphosphoranyliden acetone (2.5 g, 7.85 mmol, 
1 equiv.) in anhydrous THF (125 mL), n-butyllithium solution [1.6 M in hexanes] 
(5.88 mL, 9.42 mmol, 1.2 equiv.) was added at   ̶ 78 °C and the mixture was 
stirred for 30 min. Allyl bromide (1.139 g, 9.42 mmol, ƿ = 1.398 gmL-1, 810 µL, 
1.2 equiv.) was then added and the reaction left to warm to room temperature 
slowly. The reaction mixture was quenched with water (100 mL) and extracted 
was dichloromethane (2 × 100 mL), washed with brine (300 mL), dried over 
(MgSO4) and concentrated under reduced pressure affording white solid. No 
characterisation of desired ylide was attempted. 
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Preparation of (cyanomethyl)triphenylphosphonium bromide 265: 
 
To a solution of bromoacetonitrile (10.00 g, 166.7 mmol, ƿ = 1.722 gmL-1, 5.80 
mL, 1 equiv.) in toluene (150 mL) was added a solution of triphenylphosphine 
(21.86 g, 166.7 mmol, 1 equiv.) in toluene (50 mL). The reaction was set aside 
for 3 days at room temperature. The white precipitate was filtered and washed 
thoroughly with toluene (2 × 50 mL) and then hexane (3 × 50 mL) to give the 
phosphonium salt. The salt (5.00 g, 13.08 mmol, 1 equiv.) was dissolved in 
dichloromethane (100 mL) and then extracted with 2 M potassium hydroxide 
solution (3 × 50 mL). The collected organic layers washed with saturated brine 
(100 mL), dried (MgSO4), filtered and concentrated in vacuo to afford the 
desired ylide 265 as a white solid (3.8 g, 12.6 mmol, 96%) which was 
recrystallised from (10 mL) of boiling hexane. 265:(210b) m.p. 178-183 °C; 1H-
NMR (300 MHz, CDCl3, 25 °C): δ = 7.43-7.54 (7H, m, H2, H5), 7.56-7.69 (9H, m, 
H6, H4); 13C-NMR (75.4 MHz, CDCl3, 25 °C): δ = -2.0 (d, JPC = 135 Hz, C5), 127.4 
(d, JPC = 91.8 Hz, C4), 128.1 (d, JPC = 7.7 Hz, C6), 129.1 (d, JPC = 12.4 Hz, C3), 
132.6 (d, JPC = 3.1 Hz, C1), 132.8 (d, JPC = 9.9 Hz, C2); 31P{1H}-NMR (121.4 MHz, 
CDCl3, 25 °C): δ = 24.18 (s); IR (KBr): ѵmax (cm-1) = 3054, 3012, 2987, 2138, 1583, 
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1483, 1435, 1334, 1310, 1260, 1190, 1187, 1147, 1105, 1067, 1028, 997, 842, 
765, 715, 693; MS (ESI), 302 (MH+), HRMS (ESI+) calcd. for C20H17NP [(M+H)+]: 
302.1098; found 302.1103,   ̶0.66 ppm error. 
7.2.4 Preparation of ester derivatives 
Preparation of tetraethylpyromellitate 210:(114) 
 
Pyromellitic acid 209 (5.00 g, 3 mol, 1 equiv.) was esterified with ethanol (11 
mL), toluene (40 mL) and sulphuric acid (60 µL) using a Dean-Stark head to 
remove water, heating at 165  Cͦ for (2-15 h). Then after the mixture was 
cooled to room temperature, water (100 mL) was added and the solution was 
extracted with a further dichloromethane (3 × 100 mL). The extracts were 
washed with saturated sodium bicarbonate solution (100 mL) and water (100 
mL), and then dried over (MgSO4). The solvent was removed under higher 
vacuum to give a yellow liquid (2.16 g, 5.89 mmol, 30%). 210:(211a); 1H-NMR 
(300 MHz, CDCl3, 25   ͦC): δ = 1.39 (t, J = 7.0 Hz, 4CH3, H1), 4.36 (q, J = 7.0 Hz, 
4CH2, H4), 8.02 (s, 2H, H5); 13C-NMR (75 MHz, CDCl3, 25  ͦC): δ = 14.1  (C1), 62.1 
(C2), 134.2 (C2), 137.8 (C5), 165.0 (C3); IR (KBr): ѵmax (cm-1) = 3055, 2985, 2941, 
1717, 1497, 1393, 1244, 1129, 1096, 948, 838, 787, 742; MS (ESI), 367 (MH+), 
HRMS (ESI, m/z %) calcd. for C18H23O8 [(M+H)+]: 367.1392; found: 367.1398, 
1.25 ppm error. 
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Preparation of methyl-N-methyl-2-indole-carboxylate 212:(211b)  
 
Methyl iodide (11.4 g, 80 mmol, ƿ = 2.28 gmL-1, 5.0 mL, 18.6 equiv.) was added 
to a stirred suspension of anhydrous potassium carbonate (6.30 g, 45,6 mmol, 
10.1 equiv.) and 1H-indole-2-carboxylic acid 211 (850 mg, 4.3 mmol, 1 equiv.) 
in anhydrous THF (6 mL) and the mixture was stirred at 80   ͦC for (3–4) days. 
Upon cooling to room temperature, the suspension was partitioned between 
ethyl acetate (75 mL) and water (75 mL). The aqueous layer was extracted with 
ethyl acetate (2 × 100 mL) and the combined organic layers were dried 
(MgSO4), concentrated under reduced pressure to obtain the desired ester as 
yellow solid (900 mg, 4.76 mmol, 90%). 212:(125) m.p. 99-101   ͦC; 1H-NMR (400 
MHz, CDCl3, 25   ͦC): δ = 3.95 (s, 3H, H1), 4.12 (s, 3H, H11), 7.19 (t, J= 7.2 Hz, 1H, 
H9), 7.33 (s, 1H, H4), 7.37-7.44 (m, 2H, H7, H8), 7.72 (d, J = 7.8 Hz, 1H, H6); 13C-
NMR: (100 MHz, CDCl3, 25   ͦC): δ = 31.5 (C11), 51.2 (C1), 110.3 (C4,C7), 120.6 
(C9), 122.6 (C6), 125.0 (C8), 125.9 (C3), 127.7 (C5), 139.7 (C10), 162.7 (C2); IR 
(neat): ѵmax (cm-1) = 3056, 2848, 1662, 1534, 1471, 1395, 1321, 1232, 1155, 
1090, 968, 838; MS (ESI), 190 (MH+), HRMS (ESI, m/z %) calcd. for C11H12NO2 
[(M+H)+]: 190.0868; found: 190.0868, 0 ppm error.  
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Preparation of 2-(N-methyl)indolylmethylacetate 216: (119b) 
 
Procedure A:  
To a solution of 2-hydroxymethyl-1-methyl indole 214 (2 g, 12.40 mmol, 1 
equiv.) in acetic anhydride (2.53 g, 24.8 mmol, ƿ = 1.08 gmL-1, 2.4 mL, 2 equiv.), 
was added lithium chloride (50 mg, 1.19 mmol, 0.09 equiv.). The resulted 
solution was stirred at room temperature for 15 hours, after that added diethyl 
ether (16 mL), washed twice with saturated sodium carbonate solution (8 mL). 
The aqueous layer was extracted with further diethyl ether (3 × 15 mL), and 
then the extracts combined to dry (MgSO4). Concentration in vacuo afforded 
the starting material, a white solid, which was used without further 
purification. No characterisation of 216 was attempted. 
Procedure B: 
 2-Hydroxymethyl-1-methyl indole 214 (1.46 g, 9.05 mmol, 1 equiv.) was 
dissolved in ether (30 mL), triethylamine (1.09 g, 10.9 mmol, ƿ = 0.726 gmL-1, 
1.5 mL, 1.2 equiv.), 4-(dimethylamino)pyridine (110 mg, 0.9 mmol, 0.1 equiv.) 
after that acetic anhydride (1.01 g, 9.96 mmol, ƿ = 1.08 gmL-1, 940 µL, 1.1 
equiv.) was added. The resulting mixture was stirred overnight and hydrolysed 
by the addition of saturated sodium carbonate solution (50 mL). The organic 
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phase was washed twice with saturated sodium carbonate solution (25 mL), 
dried (MgSO4) and concentrated in vacuo to obtain a yellow solid (1.54 g, 7.60 
mmol, 84%). 216:(119) Rf = 0.56 (8:2 hexane/ethyl acetate, det:KMnO4); m.p. 73-
75   ͦC; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 1.99 (s, 3H, H1), 3.55 (s, 3H, H5), 
5.16 (s, 2H, H3), 6.45 (s, 1H, H12), 6.97-7.01 (m, 1H, H7), 7.10-7.18 (m, 2H, H9, 
H10), 7.48 (d, J = 7.8 Hz, 1H, H8); 13C-NMR (100 MHz, CDCl3, 25   ͦC): δ = 20.9 (C1), 
29.8 (C5), 58.2 (C3), 103.9 (C12), 109.3 (C10), 119.8 (C7), 121.1 (C8), 122.4 (C9), 
127.2 (C11), 133.7 (C6), 138.0 (C4), 171.5 (C2); IR (neat): ѵmax (cm−1) = 3056, 
2937, 1729, 1601, 1556, 1436, 1339, 1250, 1146, 1021, 922, 752, 642, 568; MS 
(ESI), 204 (MH+), HRMS (ESI, m/z %) calcd. for C12H14NO2 [(M+H)+]: 204.1024; 
found: 204.1012, 3.06 ppm error. 
Preparation of methyl-2-indole carboxlyate 223:(212a) 
 
To a stirred suspension of sodium bicarbonate (3.18 g, 37.8 mmol, 1.5 equiv.) 
and indole-2-carboxylic acid 212 (3.98 g, 24.7 mmol, 1 equiv.) in anhydrous 
DMF (20 mL), Methyl iodide (13.68 g, 96.4 mmol, ƿ = 2.28 gmL-1, 6 mL, 4 
equiv.) was added to and the mixture was stirred at room temperature for 3 
days. The resulted solution was extracted with further diethyl ether (3 × 100 
mL) and water (50 mL). The extracts were combined, dried (MgSO4), and 
concentrated under reduced pressure to obtain the desired ester as yellow 
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solid (4.0 g, 22.8 mmol, 92%). 223:(212b) Rf = 0.52 (7:3 petroleum ether (b.p. 40-
60 °C)/ethyl acetate, det: KMnO4); m.p. 151-152 °C; 1H-NMR (400 MHz, CDCl3, 
25   ͦC): δ = 3.95 (s, 3H, H1), 7.13-7.18 (m, 1H, H7), 7.22-7.24 (m, 1H, H11), 7.30-
7.35 (m, 1H, H6), 7.42-7.45 (m, 1H, H9), 7.70 (dt, J = 8.1, 0.9, 0.9 Hz, 1H, H8), 
8.85 (br.s, 1H, H4); 13C-NMR (100 MHz, CDCl3, 25   ͦC): δ = 52.7 (C1), 108.8 (C11), 
111.9 (C6), 120.8 (C8), 122.6 (C9), 125.4 (C6), 127.1 (C3), 127.4 (C10), 136.1 
(C5), 162.7 (C2); IR (film): ѵmax (cm-1) = 3316, 2952, 1686, 1527, 1439, 1312, 
1252, 1209, 773, 747; MS (ESI), 175 (M+), HRMS (ESI, m/z %) calcd. for 
C10H10NO2 [M+]:175.0711; found: 175.0685, 11.46 ppm error. 
Preparation of methyl N-tosyl-2-indole carboxylate 226: (213)   
 
To a nitrogen purged round bottom flask containing a solution of sodium 
hydride (380 mg, 9.57 mmol, 1.3 equiv.) in anhydrous DMF (15 mL), a solution 
of methyl-2-indole carboxylate 223 (1.29 g, 7.36 mmol, 1 equiv.) in anhydrous 
DMF (15 mL) was added. The mixture was stirred vigorously for an hour, 
followed by a solution of p-toluenesulfonyl chloride (1.82 g, 9.57 mmol, 1.3 
equiv.). The mixture was stirred at room temperature for 24 hours, poured into 
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water (50 mL), and extracted with further diethyl ether (3 × 50 mL), washed 
with water (2 × 40 mL), and washed with saturated brine (50 mL). The extract 
was combined, dried (MgSO4), and concentrated in vacuo to afford the desired 
ester 226 (790 mg, 2.4 mmol, 33%). 226: Rf = 0.5 (9.5:0.5 toluene/ethyl acetate, 
det: KMnO4);  m.p. 82-83 °C; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 2.38 (s, 3H, 
H1), 3.94 (s, 3H, H8), 7.17 (d, J = 0.7 Hz, 1H, H12), 7.25-7.26 (m, 1H, H15), 7.27-
7.30 (m, 2H, H6, H9), 7.44 (ddd, J = 8.7, 7.3, 1.2 Hz, 1H, H13), 7.57 (d, J = 7.8 Hz, 
1H, H14), 7.90-7.93 (m, 2H, H5, H10), 8.11-8.14 (m, 1H, H17); 13C-NMR (100 MHz, 
CDCl3, 25   ͦC): δ = 21.6 (C1), 52.7 (C8), 115.4 (C17), 116.8 (C12), 122.5 (C14), 
124.1 (C15), 127.1 (C13), 127.4 (C5,10), 128.2 (C3), 129.5 (C6,9), 131.5 (C11), 
134.9 (C16), 138.9 (C7), 145.0 (C4), 161.7 (C2); IR (thin film): ѵmax (cm−1) = 2952, 
1734, 1434, 1374, 1341, 1309, 1202, 677, 578; MS (ESI), 330 (MH+), HRMS (ESI, 
m/z %) calcd. for C17H16NO4S [(M+H)+]:330.0800; found 330.0807,   ̶ 0.88 ppm 
error.   
Preparation of methyl N-tert-butoxycarbonyl-2-indole-carboxylate 224:  
 
A 100-mL round bottomed flask, the reaction of methyl-2-indole carboxlyate 
223 (1 g, 5.7 mmol, 1 equiv.) with acetonitrile (70 mL) was fitted with a 
magnetic stirrer. Subsequently, di-tert-butyl dicarbonate (0.14 mg, 1.12 mmol, 
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0.2 equiv.) was added, immediately turning to red solution. The resulted 
solution was allowed to heat at 90 °C for 24 hours. At this time, isopropyl 
amine (344 mg, 5.8 mmol, ƿ = 0.688 gmL-1, 0.5 mL, 1.02 equiv.) was added the 
solution to remove excess of anhydride. The mixture was stirred further 15 
min, and the evaporated in vacuo to give a thick oil that dissolved in water 
(100 mL), extracted with ethyl acetate (150 mL), washed with brine (150 mL), 
and the dried (MgSO4) to give the product 224 as yellow solid (1 g, 5.7 mmol, 
63%). 214:(214) m.p. 62-65   ͦC; 1H-NMR (300 MHz, CDCl3, 25   ͦC): δ = 1.55 (s, 9H, 
H6), 3.84 (s, 3H, H1), 7.03 (s, 1H, H13), 7.16-7.21 (m, 1H, H8), 7.31-7.34 (m, 1H, 
H11), 7.52 (dd, J = 7.9, 0.8 Hz, 1H, H9), 8.00-8.03 (m, 1H, H10);  13C-NMR (75 
MHz, CDCl3, 25   ͦC): δ = 27.9 (C6), 52.4 (C1), 84.7 (C5), 115.0 (13), 122.3 (C8), 
123.4 (C10), 126.9 (C9), 127.6 (3), 130.5 (11), 137.9 (C12), 149.3 (C7), 162.5 
(C2, C4); IR (KBr): ѵmax (cm-1) = 3019, 2981, 1745, 1712, 1556; MS (ESI), 298 
(MNa+), HRMS (ESI, m/z %) calcd. for C15H17NNaO4 [(M+Na)+]:(214) 298.1050, 
found 298.1039. 
7.2.5 The preparation of 3-formyl indoles via Vilsmeier reaction 
General procedure 3:  
Phosphorus (V) oxychloride [POCl3] (1.05 equiv.) was added dropwise to cooled 
ice bath dimethylformamide [DMF] (3.65 equiv.). A solution of N-indole 
derivatives (1 equiv.) in DMF (3 mL) was added and the resulting mixture was 
stirred at room temperature for 30 min and at 60   ͦC for 24 h. The reaction 
mixture was poured into ice (20 mL) and neutralised with 2 M sodium 
hydroxide. The yellow solid was collected by filtration to give:- 
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Preparation of methyl 3-formyl-1-methyl-2-indole carboxylate 213: 
 
According to general procedure 3 using methyl-N-methyl-2-indole carboxylate 
21 (1.0 g, 5.71 mmol, 1 equiv.), POCl3 (910 mg, 6 mmol, ƿ = 1.645 gmL-1, 550 
µL, 1.05 equiv.) and DMF (1.53 g, 21 mmol, ƿ = 0.944 gmL-1, 1.62 mL, 3.65 
equiv.) were combined to afford the desired product as yellow solid (610 mg, 
2.85 mmol, 50%). 213:(215) m.p. 150-151   ͦC; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ 
= 4.09 (s, 3H, H4), 4.13 (s, 3H, H1), 7.38-7.42 (m, 1H, H6), 7.46-7.48 (m, 2H, H7, 
H8), 8.55 (d, J = 8.1 Hz, 1H, H9), 10.62 (s, 1H, H12); 13C-NMR (100 MHz, CDCl3, 25   
ͦC): δ = 32.4 (C1), 52.7 (C4), 110.2 (C8), 119.0 (C11), 123.0 (C9), 124.1 (C6), 
124.6 (C3), 126.5 (C7), 133.1 (C10), 138.3 (C5), 161.5 (C2), 188.3 (C12); IR (KBr): 
ѵmax (cm-1) = 1750, 1680; MS (ESI), 218 (MH+), HRMS (ESI, m/z %) calcd. for 
C12H12NO3 [(M+H)+]: 218.0817; found: 218.0813,   ̶0.67 ppm error. 
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Preparation of N-methyl-3-formyl-2-indolylmethylacetate 217: 
 
According to general procedure 3 using 2-(N-methyl)indolylmethylacetate 
216(1.55 g, 7.62 mmol, 1 equiv.), POCl3 (1.22 g, 8 mmol, ƿ = 1.645 gmL-1, 740 
µL, 1.05 equiv.) and DMF (2.04 g, 27.9 mmol, ƿ = 0.944 gmL-1, 2.16 mL, 3.65 
equiv.) were combined to afford the desired product 217 as yellow solid (960 
mg, 4.19 mmol, 55%). 217:  m.p. 127-128.5   ͦC; 1H-NMR (400 MHz, CDCl3, 25   
ͦC): δ = 2.05 (s, 3H, H1), 3.77 (s, 3H, H5), 5.51 (s, 3H, H3), 7.26-7.32 (m, 3H, H7, H8, 
H9), 8.27 (d, J = 7.6 Hz, 1H, H10), 10.24 (s, 1H, H13); 13C-NMR (100 MHz, CDCl3, 
25   ͦC): δ = 20.7 (C1), 30.3 (C5), 54.3 (C3), 109.5 (C7), 116.0 (C12), 121.8 (C10), 
124.4 (C9), 125.1 (C8), 123.4 (C11), 137.0 (C6), 141.3 (C4), 170.2 (C2), 184.5 
(C13); IR (neat): ѵmax (cm-1) = 3049, 3019, 2942, 2861, 1743, 1647, 1536, 1473, 
1444, 1403, 1335, 1252, 1162, 1049, 978, 911, 767, 753, 728; MS (ESI), 232 
(MH+), HRMS (ESI, m/z %) calcd. for C13H14NO3 [(M+H)+]: 232.0976; found: 
232.0967, 0.45 ppm error. 
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Preparation of N-methyl-3-formyl-2-chloromethyl indole 215:  
 
According to general procedure 3 using 2-hydroxymethyl-1-methyl indole 214 
(3.00 g, 18.6 mmol, 1 equiv.), POCl3 (2.99 g, 19.5 mmol, ƿ = 1.645 gmL-1, 1.82 
mL, 1.05 equiv.) and DMF (4.99 g, 68.29 mmol, ƿ = 0944 gmL-1, 2.59 mL, 3.65 
equiv.) were combined to afford the product as yellow solid (1.33 g, 7.44 
mmol, 40%). 215: m.p. 122-124   ͦC; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 3.79 
(s, 3H, H3), 5.05 (s, 2H, H1), 7.27-7.36 (m, 3H, H5, H6, H7), 8.18 (d, J = 7.8 Hz, 1H, 
H8), 10.24 (s, 1H, H11); 13C-NMR (100 MHz, CDCl3, 25   ͦC): δ =  30.0 (C3), 33.5 
(C1), 108.9 (C5), 114.5 (C10), 121.0 (C8), 123.3 (C7), 124.5 (C6), 125.6 (C4), 
137.4 (C9), 142.0 (C2), 183.8 (C11); IR (neat): ѵmax (cm-1) = 3028, 1641, 1577, 
1476, 1375, 1251, 975, 939, 780, 755, 681, 649; MS (ESI), 208 (MH+), HRMS 
(ESI, m/z %) calcd. for C11H11N35ClO [(M+H)+]: 208.0529; found: 208.0525,  ̶ 0.99 
ppm error. 
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Preparation of methyl-3-formyl-1H-indole-2-carboxlyate 229: (216)   
 
According to general procedure 3 using methyl-N-methyl-2-indole carboxylate 
223 (4.1 g, 23.4 mmol, 1 equiv.), POCl3 (3.76 g, 24.57 mmol, ƿ= 1.645 gmL-1, 2.3 
mL, 1.05 equiv.) and DMF (6.25 g, 85.41 mmol, ƿ= 0.944 gmL-1, 6.63 mL, 3.65 
equiv.) were combined to afford the desired product as yellow solid (4.05 g, 
20.1 mmol, 85%). 229:(216) Rf = 0.56 (5:5 hexane/ethyl acetate, det: KMnO4); 
m.p. 199-201   ͦC; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 4.07 (s, 3H, H1), 7.36-
7.38 (m, 1H, H7), 7.42-7.45 (m, 1H, H8), 7.46-7.49 (m,1H, H6), 8.90 (dd, J = 8.2, 
0.9 Hz, 1H, H9), 9.39 (br.s, 1H, H4), 10.75 (s, 1H, H12); 13C-NMR (100 MHz, CDCl3, 
25   ͦC): δ = 53.0 (C1), 111.8 (C6), 115.2 (C7), 119.8 (8), 122.7 (C9), 124.0 (C11), 
125.6 (C10), 126.9 (C5), 136.8 (C3), 161.0 (C2), 188.2 (C12); MS (ESI), 204 
(MH+), HRMS (ESI, m/z %) calcd. for C11H10NO3 [(M+H)+]: 204.0660; found: 
204.0656,  ̶ 0.31 ppm error. 
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Preparation of methyl-3-formyl-N-(tert-butyloxycarbonyl)-2-indole 
carboxlyate 225: (216) 
 
Procedure A: 
According to general procedure 3 using methyl N-tert-butoxycarbonyl-2-
indole-carboxylate 224 (1.00 g, 3.63 mmol, 1 equiv.), POCl3 (584 mg, 3.8 mmol, 
ƿ = 1.645 gmL-1, 350 µL, 1.05 equiv.) and DMF (970 g, 13.2 mmol, ƿ = 0944 
gmL-1, 100 µL, 3.65 equiv.) were combined to afford the 225, which was used 
without further purification (800 mg, 2.63 mmol, 73%) as yellow solid. No 
characterisation of 225 was attempted.    
Procedure B: 
To a stirred solution of methyl-3-formyl-1H-indole-2-carboxlyate 229 (1.2 g, 
5.91 mmol, 1 equiv.) in dichloromethane (60 mL), di-tert-butyl dicarbonate 
(1.55 g, 7.10 mmol, 1.2 equiv.), triethylamine (598 mg, 5.91 mmol, ƿ = 0.726 
gmL-1, 820 µL, 1 equiv.) and 4-(dimethylamino)pyridine (140 mg, 1.15 mmol, 
0.19 equiv.) were added, and the solution was allowed to stir at room 
temperature for 5 h. After completion of the reaction, the mixture was poured 
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into saturated sodium bicarbonate (50 mL), extracted with further 
dichloromethane (2 × 40 mL), and dried (MgSO4). The resulting residue was 
purified by column chromatography on silica gel (Rf = 0.53 in 2:8 ethyl 
acetate/hexane) to give the desired product as yellow solid 225 as yellow solid 
(1.5 g, 4.9 mmol, 83%). 225:(217) Rf = 0.53 (SiO2, 8:2 hexane/ethyl acetate, det: 
KMnO4); m.p. 70-73   ͦC; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 1.67 (s, 3H, H6), 
4.04 (s, 3H, H1), 7.42 (dd, J = 7.8, 1.0 Hz, 1H, H11), 7.47 (dd , J = 8.4, 1.3 Hz, 3H, 
H9), 8.10 (d, J = 8.6 Hz, 1H, H8), 8.35 (d, J = 8.2 Hz, 1H, H10), 10.21 (s, 1H, H14); 
13C-NMR (100 MHz, CDCl3, 25   ͦC): δ = 27.9 (C6), 53.249 (C1), 86.7 (C5), 114.9 
(C8), 121.0 (C13), 122.9 (C10), 124.8 (C3), 125.2 (C11), 135.8 (C12), 137.6 (C7), 
148.3 (C4), 161.6 (C2), 186.0 (C14); IR (KBr): ѵmax (cm-1) = 3445, 3007, 2973, 
2869, 1750, 1729, 1666, 1559, 1436, 1396, 1237, 1111, 748, 695; MS (ESI), 304 
(MH+), HRMS (ESI, m/z %) calcd. for C16H18NO5 [(M+H)+]: 304.1184; found: 
304.1188,  ̶ 1.51 ppm error. 
 
 
 
 
 
 
 
 
Chapter 6                                                                                              Experimental 
190 | P a g e  
 
Preparation of methyl-3-formyl-N-Ts-2-indole carboxylate 227:  
 
 
Procedure A:  
According to general procedure 7 using of methyl N-Ts-indole-2-carboxylate 
226 (330 mg, 1.00 mmol, 1 equiv.), POCl3 (160 mg, 1.05 mmol, ƿ = 1.645 gmL-1, 
100 µL, 1.05 equiv.) and DMF (267 mg, 3.65 mmol, ƿ = 0.944 gmL-1, 280 µL, 
3.65 equiv.) were combined to afford the desired product as yellow solid (99 
mg, 0.27 mmol, 20%). 227: Rf = 0.53 (9:1 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4).  
Procedure B:  
To a stirred solution of sodium hydride (58 mg, 1.48 mmol, 1.2 equiv.) in 
anhydrous DMF (1 mL) at 0   ͦC was added a solution of methyl-3-formyl-1H-
indole-2-carboxlyate 229 (250 mg, 1.23 mmol, 1 equiv.) in anhydrous DMF (1 
mL) with stirring for 30 min., and then a solution of tosyl chloride (468 mg, 2.46 
mmol, 2 equiv.) was added to the previous mixture. The resulting solution was 
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allowed to stir at room temperature for 24 hours, poured into water (50 mL), 
extracted with further ethyl acetate (3 × 50 mL), washed with water (50 mL), 
saturated brine (50 mL), and dried (MgSO4). Purification of the residue via flash 
chromatography on silica using 70:30 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate as the eluent afforded the desired product 227 (130 mg, 0.36 mmol, 
30%). 227: Rf = 0.50 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4). 
Procedure C:(115b) 
A solution of dichloromethyl methyl ether (114 mg, 2.26 mmol, ƿ = 1.271 gmL-
1, 200 µL, 3 equiv.) in (1.5 mL) of anhydrous dichloromethane was added 
dropwise to a cooled (-78  ͦC) solution of methyl N-tosyl-indole-2-carboxylate 
226 (250 mg, 0.76 mmol, 1 equiv.) and silver triflate (585 mg, 2.28 mmol, 3 
equiv.) in anhydrous dichloromethane (10 mL). The resulted solution was 
stirred at -78  ͦC for 10 min, added saturated sodium bicarbonate solution (40 
mL), and then stirred further 30 min at 0oC. The mixture was filtered through a 
pad of celite, extracted with ethyl acetate (2x 50 mL), washed with brine (50 
mL) and dried (MgSO4). Purification of the residue via flash chromatography on 
silica using 80:20 hexane/ethyl acetate as the eluent afforded the desired 
product 227 (250 mg, 0.7 mmol, 92%). 227: Rf = 0.43 (8:2 hexane/ethyl 
acetate, det: KMnO4); m.p. 120-122   ͦC; 1H-NMR (300 MHz, CDCl3, 25   ͦC): δ = 
2.38 (s, 3H, H8), 4.11 (s, 3H, H1), 7.29-7.32 (m, 2H, H6), 7.35-7.40 (m, 1H, H12), 
7.43-7.49 (m, 1H, H10), 7.97 (d, J = 8.5 Hz, 2H, H5), 8.01 (d, J = 8.3 Hz, 1H, H11), 
8.26-8.29 (m, 1H, H13), 10.13 (s, 1H, H16); 13C-NMR (75 MHz, CDCl3, 25   ͦC): δ = 
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21.8 (C8), 54.008 (C1), 114.1 (C10), 121.0 (C15), 123.0 (C13), 125.1 (C11), 127.4 
(C5), 127.7 (C6), 130.2 (C14), 134.1 (C9), 135.2 (C4), 138.6 (C7), 146.4 (C3), 
161.5 (C2), 185.2 (C16); IR (neat): ѵmax (cm−1) = 2952, 2852, 2764, 1724, 1676, 
1434, 1370, 1339, 1325, 1140, 1086, 960, 717, 666, 569; MS (ESI), 358 (MH+), 
HRMS (ESI, m/z %) calcd. for C18H16NO5S [(M+H)+]: 358.0749; found: 358.0746, 
  ̶1.02 ppm error. 
7.2.6 Preparation of diols  
Preparation of benzene-1,2-dimethanol 202: 
 
A solution of phthaldialdehyde 208 (200 mg, 1.49 mmol, 1 equiv.) in methanol 
(50 mL) was cooled to (0–5 °C) and then sodium tetrahydroborate added (846 
mg, 2.24 mmol, 1.5 equiv.) slowly. After 30 min, the reaction was acidified with 
glacial acetic acid (1 mL), and the solution was stirred for 10 min and then 
evaporated to a small amount. The residue was suspended in saturated 
sodium bicarbonate (100 mL) and the mixture extracted with dichloromethane 
(3 × 100 mL). The organic layer was dried (MgSO4), and evaporated to dryness 
in vacuo to afford white solid (660 mg, 4.77 mmol, 33%). 202:(113a) m.p. 62-65  
°C; 1H-NMR (300 MHz, CDCl3, 25 °C) δ = 3.07 (s, 2H, H5), 4.76 (s, 4H, H4), 7.33-
7.39 (m, 4H, H1, H2); 13C-NMR (75 MHz, CDCl3, 25 °C) δ = 64.1 (C4), 128.5 (C1), 
129.7 (C2), 139.4 (C3); IR (neat): ѵmax (cm-1) = 3325, 2878, 1619, 1453, 1366, 
1290, 1219, 1184, 1106, 998, 911, 733; GC-MS (EI, 70 eV):  m/z (%) = 120 (100), 
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91 (83), 77 (29), 65 (16), 51 (9), 39 (7), 29 (3); MS (ESI), 139 (MH+), HRMS (ESI, 
m/z %) calcd. for C8H10O2 [(M+H)+]: 139.0759; found: 139.0572, 3.85 ppm 
error. 
Preparation of 1,2,4,5- tetrakis(hydroxymethyl) benzene 203: (115) 
 
To a cooled (0 °C) suspension of Lithium aluminum hydride (1.24 g, 32.7 mmol, 
6 equiv.) in anhydrous THF (50 mL) under nitrogen pressure, a solution of 
tetraethyl pyromellitate 210 (2.00 g, 5.45 mmol, 1.5 equiv.) in anhydrous THF 
(50 mL) was added slowly. The reaction mixture was stirred at room 
temperature for 24 h. Then the mixture was acidified with 10% sulfuric acid. 
The solid formed was removed by filtration and heated to reflux in pyridine (20 
mL) for an hour then filtered. The crude was evaporated to a small volume. 
Addition of hexane (30 mL) precipitated a white solid (330 mg, 1.66 mmol, 
50%) which collected by filtration. 203: m.p. 189-191 °C; 1H-NMR (300 MHz, 
D6-DMSO, 25 °C): δ = 4.50 (s, 8H, H3), 7.40 (s, 2H, H1); 13C- NMR (75 MHz, D6-
DMSO, 25 °C): δ = 61.0 (C3), 126.2 (C2), 147.0 (C1); IR (neat): ѵmax (cm-1) = 3189, 
2888, 1636, 1466, 1305, 1211, 1185, 1132, 1049, 993, 818, 758, 657; MS (ESI), 
198 (MH+),  HRMS (ESI, m/z %) calcd. for C10H15O4 [(M+H)+]: 198.0970; found: 
199.0953, 11.39 ppm error.   
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7.2.7 The reduction of indole derivatives    
General procedure 4:  
To a solution of the indole derivative (1 equiv.) in anhydrous THF (20 mL) 
cooled to -10 °C was added lithium aluminum hydride (5.3 equiv.) after that 
the solution was stirred for the time stated. The unreacted lithium aluminum 
hydride was quenched by gradually adding ethyl acetate (20 mL) followed by 
water (17 mL). The organic layer was separated and the aqueous layer 
extracted again with ethyl acetate (50 mL). The combined extracts were dried 
(MgSO4) and concentrated to obtain diols.  
Preparation of N-methyl-2, 3-dimethanol indole 205:  
 
According to general procedure 4 using methyl-3-formyl-1-methyl-2-indole 
carboxylate 213 (1.62 g, 7.45 mmol, 1 equiv.) and lithium aluminum hydride 
(1.49 g, 39.5 mmol, 5.3 equiv.) were combined to afford the desired product as 
yellow solid (570 mg, 2.98 mmol, 40%). 205: m.p. 99-100 °C; 1H-NMR (400 
MHz, CDCl3, 25 °C): δ = 1.98 (s, 1H, H1), 2.6 (s, 1H, H13), 3.78 (s, 3H, H10), 4.82 (s, 
2H, H2), 4.87 (s, 2H, H12), 7.16 (d, J = 7.6 Hz, 1H, H6), 7.20-7.23 (m, 1H, H8), 7.30-
7.32 (m, 1H, H7), 7.66 (d, J = 7.8 Hz, 1H, H5); 13C-NMR (100 MHz, CDCl3, 25 °C): δ 
=  29.8 (C10), 54.4 (C12), 55.46 (C2), 108.9 (C8), 112.9 (C3), 118.7 (C5), 119.9 
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(C6), 122.5 (C7), 126.4 (C4), 128.6 (C9), 137.1 (C11); IR (neat): ѵmax (cm-1) = 
3280, 2971, 2877, 1451, 1381, 1094, 1056, 1005, 885, 776, 750, 680, 636; MS 
(ESI), 192 (MH+), HRMS (ESI, m/z %) calcd. for C11H14O2 [(M+H)+]: 192.1024; 
found: 192.1020,  ̶  0.04 ppm error. 
Preparation of 2-hydroxymethyl-1-methyl indole 214: (119)   
 
According to general procedure 4 using methyl-N-methyl-2-indole carboxylate  
212 (2.85 g, 15.1 mmol, 1 equiv.) and lithium aluminum hydride (3.03 g, 79.8 
mmol, 5.3 equiv.) were combined to afford the desired product as yellow solid 
(2.20 g, 13.6 mmol, 90%). 214:(218) m.p. 100-101 °C; 1H-NMR (400 MHz, CDCl3, 
25 °C): δ = 3.74 (s, 3H, H4), 4.74 (s, 2H, H2), 6.39 (s, 1H, H11), 7.01-7.05 (m, 1H, 
H8), 7.14-7.18 (m, 1H, H6), 7.24-7.26 (m, 1H, H7), 7.52 (d, J = 7.3 Hz, 1H, H9); 13C-
NMR (100 MHz, CDCl3, 25 °C): δ = 29.8 (C3), 57.6 (C2), 101.4 (C11), 109.2 (C6), 
119.6 (C7), 120.8 (C8), 122.0 (C9), 127.2 (C10), 138.2 (C5), 138.7 (C3); IR (neat): 
ѵmax (cm-1) = 3515, 3053, 2873, 1701, 1612, 1548, 1431, 1365, 1217, 1137, 
1008, 962, 778; MS (ESI), 162 (MH+), HRMS (ESI, m/z %) calcd. for C10H12NO 
[(M+H)+]: 162.0918; found: 162.0915,  ̶ 0.62 ppm error. 
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Prepartion of N-(tert-butyloxycarbonyl)- 2,3-bis(hydroxylmethyl)-indole (206) 
and 1-(tert-butyl) 2-methyl 3-(hydroxymethyl)-1H-indole-1,2-dicarboxylate 
(230):  
  
Procedure A:  
According to general procedure 4 using methyl 3-formyl-1-(tert-
butyloxycarbonyl)-1H-indole-2-carboxylate 225 (1.00 g, 3.29 mmol, 1 equiv.) 
and lithium aluminum hydride (624 g, 16.45 mmol, 5.3 equiv.) were combined 
to afford the desired product as white solid (50 mg, 0.18 mmol, 5.5%). 206: Rf = 
0.5 (5:5 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4). 
Additionally, unexpected product 230 was found as white solid (180 mg, 0.59 
mmol). The product 230 (180 mg, 0.59 mmol, 1 equiv.) was reacted again 
according to general procedure 6 with lithium aluminum hydride (118 mg, 3.13 
mmol, 5.3 equiv.) to afford the desired product 225 as white solid (10 mg, 
0.036 mmol, 6.13%). 225: Rf = 0.5 (1.5:8.5 petroleum ether (b.p. 40-60 
°C)/ethyl acetate, det: KMnO4). 
 
Chapter 6                                                                                              Experimental 
197 | P a g e  
 
Procedure B:  
Using the same general procedure 4 using methyl 3-formyl-1-(tert-
butyloxycarbonyl)-1H-indole-2-carboxylate 225 (1.00 g, 3.29 mmol, 1 equiv.) 
and lithium aluminum hydride (624 g, 16.45 mmol, 5.3 equiv.) were combined. 
The resulted solution after adding a solution of indole in anhydrous THF, was 
heated at 70 ͦC for 24 h, followed by doing its workup to afford the desired 
product as white solid (100 mg, 0.36 mmol, 11%). 206: Rf = 0.5 (2:8 petroleum 
ether (b.p. 40-60 °C)/ethyl acetate, det:KMnO4). 
Procedure C:  
To a cooled  solution of diisobutylaluminum hydrid (1.0 M in Toluene, 1.08 mL, 
6.55 mmol, 4 equiv.) in dichloromethane (7 mL), was added slowly a solution of 
methyl 3-formyl-1-(tert-butyloxycarbonyl)-1H-indole-2-carboxylate 225 (500 
mg, 1.63 mmol, 1 equiv.) in anhydrous THF (7 mL). The resulted solution was 
stirred at room temperture for 3-5 h, followed by adding methanol (70 mL). 
This solution was cooled at 0   ͦC then 2 N hydrochoric acid (5 mL) was added. 
The solution was further stirred for 1 h, separated the organic layer. 
Concentration in vacuo afforded the starting material. No characterisation of 
206 was attempted by this methodolgy.     
Procedure D:  
Lithium borohydride (570 mg, 26.4 mmol, 4 equiv.) was added in a three 
portions to a solution of methyl 3-formyl-1-(tert-butyloxycarbonyl)-1H-indole-
2-carboxylate 225 (2.0 g, 6.6 mmol, 1 equiv.) in anhydrous THF (80 mL). The 
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mixture was stirred vigorously for 22 h at room temperature under a N2 
atmosphere.  The mixture was cooled at 0 °C then saturated ammonium 
chloride (15 mL) was added, and then extracted with ethyl acetate (2 × 100 
mL). The combined ethyl acetate extracts were dried (MgSO4), filtered and 
concentrated in vacuo to afford the crude product. Purification via flash 
chromatography on silica gel using 8:2 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate as the eluent afforded 206 as a yellow  solid (820 mg, 2.94 mmol, 46%). 
206: Rf = 0.56 (8:2 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 
m.p. 111-113 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.75 (s, 9H, H15), 2.10 
(br.s, 1H, H12), 3.99 (s, 1H, H1), 4.85 (s, 2H, H2), 4.90 (s, 2H,  H11), 7.27-7.33 (m, 
2H, H6, H7), 7.70-7.73 (m, 1H, H5), 8.00 (dd, J = 15.2, 7.6 Hz, 1H, H8); 13C-NMR 
(100 MHz, CDCl3, 25 °C) δ= 28.3 (C15), 55.1 (C2), 55.2 (C11), 115.7 (C8), 119.5 
(C5), 120.6 (C14), 123.2 (C6), 125.1 (C7), 128.8 (C3), 135.4 (C4), 136.6 (C10), 
151.5 (C13); IR (neat): ѵmax (cm-1) = 3504, 2990, 2951, 1702, 1577, 1478, 1386, 
1258, 1156, 1118, 1034, 1007, 985, 933, 771, 749, 535; MS(ESI), 300 (MNa+), 
HRMS (ESI, m/z %) Calcd for C15H19NNaO4 [(M+Na)+] 300.1211; found 300.1179, 
9.6 ppm. 
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Preparation of N-(toluene-4-sulfonyl)-2,3-bis(hydroxymethyl)  indole 207: 
 
To a stirred solution of 3-formyl-methyl N-tosylindole-2-carboxylate 227 (300 
mg, 0.84 mmol, 1 equiv.) in anhydrous THF (20 mL) at room temperature under 
a N2 atmosphere was added lithium borohydride (73 mg, 3.36 mmol, 4 equiv.) 
in portions. The resultant solution was stirred for 24 h after which time the 
mixture had cooled,  saturated ammonium chloride (12 mL), extracting with 
ethyl acetate ( 2 × 50 mL). The extracts were dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified via flash chromatography on 
silica gel using 9.5:0.5 ichloromethane/methanol as the eluent gave the title 
diol 207 as a white solid (200 mg, 0.60 mmol, 71%). 207: m.p. 173-175 °C; Rf = 
0.16 (9.5:0.5 dichloromethane/ methanol, det: KMnO4); 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.61 (s, 2H, H1, H12), 2.34 (s, 3H, H17), 4.84 (s, 2H, H11), 4.98 (s, 
2H, H2), 7.20 (d, J = 7.3 Hz, 2H, H15, H18), 7.29 (d, J= 7.5 Hz, 1H, H6), 7.34 (d, J = 
7.3 Hz, 1H, H7), 7.65 (d, J = 7.3 Hz, 1H, H5), 7.74 (d, J = 7.0 Hz, 2H, H14, H19), 8.11 
(d, J = 7.8 Hz, 1H, H8); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 21.6 (C17), 55.0 
(C11), 55.3 (C2), 114.6 (C8), 119.8 (C5), 122.0 (C3), 123.9 (C6), 125.7 (C7), 128.5 
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(C10), 128.9 (C14, C19), 130.0 (C15, C18), 135.7 (C16), 136.2 (C4), 137.1 (C9), 
145.3 (C13); IR (neat): ѵmax (cm-1) = 3669, 2970, 2901, 1557, 1453, 1393, 151, 
1165, 1033, 980; MS (ESI), 354 (MNa+), HRMS (ESI, m/z %) Calcd for 
C17H17NNaO4S [(M+Na)+] 354.0776; found 354.0749, 5.77 ppm error.   
Preparation of N-methyl-3-methanol-2-indolylmethylacetate 219:       
 
A solution of N-methyl-3-formyl-2-indolylmethylacetate 217 (750 mg, 3.24 
mmol, 1 equiv.) in methanol (50 mL) was cooled to (0-5 °C) and then sodium 
borohydride was added (180 mg, 4.86 mmol, 2 equiv.) slowly. After 30 min, the 
reaction was acidified with glacial acetic acid (2 mL), and the solution was 
stirred for 10 min and then evaporated to a small amount. The residue was 
suspended in saturated sodium bicarbonate solution (100 mL) and the mixture 
extracted with dichloromethane (100 mL). The organic layer was dried 
(MgSO4), and evaporated to dryness in vacuo to afford white solid, which was 
used without further purification (700 mg, 3.00 mmol, 93%). No 
characterisation of 219 was attempted (no reaction). 
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7.2.8 Preparation of trienes via TOP reaction:  
General procedure 5:  
Activated manganese dioxide (10 equiv.) was added to a stirred solution of diol 
(1 equiv.) and ylide (2.5-5 equiv.) in anhydrous THF (20 mL). The resulting 
solution was stirred and heated to reflux for 24 h. The manganese dioxide was 
removed by filtration through a celite pad, washed with THF (50 mL) and then 
concentrated under higher vacuum.  The crudes were purified by column 
chromatography to give the desired trienes. Conversion was determined by 
analysis of the 1H-NMR spectrum. 
Preparation of (2E,2’E)-dimethyl-3,3’-(1,2-phenylen)diacrylate 256:  
 
According to general procedure 5 using benzene-1,2-dimethanol 202 (200 mg, 
1.45 mmol, 1 equiv.), manganese dioxide (1.25 g, 14.5 mmol, 10 equiv.) and 
methyl (triphenylphosphoranylidene) acetate 52 (1.20 g, 3.62 mmol, 2.5 
equiv.) were combined to afford the desired product as white solid (175 mg, 
0.71 mmol, 50%). 256:(219) Rf = 0.54 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4); m.p. 71-73   ͦC;  1H-NMR (300 MHz, CDCl3, 25 °C): δ = 3.78 
(s, 6H, H7), 6.33 (d, J = 15.8 Hz, 2H, H5), 7.37 (m, 2H, H1), 7.54 (m, 2H, H2), 8.01 
(d, J = 15.8 Hz, 2H, H4); 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 51.7 (C7), 121.6 
Chapter 6                                                                                              Experimental 
202 | P a g e  
 
(C5), 127.6 (C1), 130.1 (C2), 134.3 (C3), 141.5 (C4), 166.8 (C6); IR(neat): ѵmax 
(cm-1) = 2951, 1712, 1312, 1168, 975; MS (ESI), 246 (MH+), HRMS (ESI+ m/z%): 
calcd for C14H15O4 [(M+H)+]: 246.0970, found 246.0976,  ̶ 3.95 ppm error.  
Preparation of (E)-3-{o-[(E)-3-(diallylamino)-3-oxo-1-propenyl]-phenyl}-1-
(diallylamino)-2-propen-1-one 257: 
 
According to general procedure 5 using benzene-1,2-dimethanol 202 (200 mg, 
1.45 mmol, 1 equiv.), manganese dioxide (1.25 g, 14.5 mmol, 10 equiv.) and 
N,N-diallyl (triphenylphosphoranylidene) acetamide 252 (1.48 g, 3.6 mmol, 2.5 
equiv.) were combined to afford the desired product as white solid (220 mg, 
0.57 mmol, 40%). 257:  m.p. 150-151  ͦC;  Rf = 0.39 (5:5 petroleum ether (b.p. 
40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (400 MHz, CDCl3, 25 °C): δ = 
4.03-4.05 (m, 2H, H7), 4.09 (d, J = 6.0 Hz, 2H, H7), 5.17 (s, 2H, H9), 5.22 (s, 2H, 
H9/), 5.83-5.87 (m, 2H, H8), 6.61 (d, J = 15.7 Hz, 1H, H5), 7.35 (dd, J = 5.7, 3.2 Hz, 
1H, H2), 7.44-7.49 (m, 1H, H1), 7.98 (d, J = 14.9 Hz, 1H, H4); 13C-NMR (100 MHz, 
CDCl3, 25 °C): δ = 48.3 (C7), 49.8 (C3/), 116.7 (C9), 117.5 (C9/), 122.1 (C5), 128.4 
(C1), 129.4 (C2), 133.3 (C8), 135.4 (C3), 140.7 (C4), 169.2 (C6); IR (neat): ѵmax 
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(cm-1) = 3073, 2979, 2925, 1649, 1639, 1604, 1458, 1032, 998, 954, 929, 775, 
731; MS (ESI), 377 (MH+), HRMS (ESI+ m/z%): calcd for C24H29N2O2 [(M+H)+]: 
377.2229, found 377.2244,   ̶4.47 ppm error. 
Preparation of (E)-3-(o-{(E)-3-[(benzyl)-N-allylamino]-3-oxo-1-
propenyl}phenyl)-1-[(benzyl)-N-allyl-amino]-2-propen-1-one  258:  
 
According to general procedure 5 using benzene-1,2-dimethanol 202 (500 mg, 
3.62 mmol, 1 equiv.), manganese dioxide (3.15 g, 36.2 mmol, 10 equiv.) and N-
allyl-N-benzyl (triphenylphosphoranylidene) acetamide 253 (3.62 g, 9.05 mmol, 
2.5 equiv.) were combined. NMR of the mixture following chromatography 
showed an inseparable mixture of the intermediate dialdehyde 
(phthaldialdehyde) to the desired product in an ~ 4:1 ratio. No further 
purification was attempted. 258: Rf = 0.39 (5:5 petroleum ether (b.p. 40-60 
°C)/ethyl acetate, det: KMnO4);  1H-NMR (300 MHz, CDCl3, selected signals only, 
25 °C), NMR showed the presence of a 55:45 mixture of rotamers: δ = 3.99-
4.01 (m, 2H, H7 major), 4.10-4.13 (m, 2H, H7 minor), 4.68 (s, 2H, H10 minor), 4.70 (s, 
2H, H10 major), 5.10-5.30 (m, 4H, H9a major, H9a minor, H9b major, H9b minor), 5.75-5.90 
(m, 2H, H8a major, H8a minor), 6.75 (d, J = 15.2 Hz, 2H, H5 minor, H5 major), 8.48 (d, J = 
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15.2 Hz, 2H, H4 minor, H4 major); MS (ESI), 477 (MH+),  HRMS (ESI, m/z %) calcd. for 
C32H33N2O2 [M + H+]: 477.2542; found: 477.2536, 0.19 ppm error. 
Preparation of dimethyl-2,4,6-octatrienedioate 261:  
 
According to general procedure 5 using (Z)-2-butene-1,4-diol 260 (200 mg, 
2.26 mmol, ƿ= 1.072 gmL-1, 180 µL, 1 equiv.), manganese dioxide (1.96 g, 22.6 
mmol, 10 equiv.) and methyl (triphenylphosphoranylidene)acetate 52 (1.89 g, 
5.65 mmol, 2.5 equiv.) were combined to afford the desired product as yellow 
solid (400 mg, 2.04 mmol, 90%). 261:(220) m.p. 112-116   ͦC; Rf = 0.50 (9.5:0.5 
petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, 
CD3OD, 25 °C), NMR showed the presence of a 3:1 mixture of (2E,4E,6E: 
2E,4Z,6E) isomers: δ = 3.78 (s, 3H, H5 EZE), 3.81 (s, 3H, H5 EEE), 6.01 (d, J = 15.2 
Hz, 2H, H3EEE), 6.03 (d, J = 15.2 Hz, 2H, H3EZE), 6.40 (dd, J = 8.6, 2.3 Hz, 2H, H1 
EEE), 6.62 (dd, J = 7.5, 3.2 Hz, 2H, H1 EZE), 7.32 (ddd, J = 15.2, 7.5, 3.2 Hz, 2H, H2 
EZE), 7.81 (ddd, J = 15.2, 8.6, 2.3 Hz, 2H, H2 EEE);  13C-NMR (75 MHz, CD3OD, 25 
°C): δ = 50.9 (C5), 124.2 (C1), 133.4 (C3), 137.7 (C2), 167.2 (C4); IR (KBr): ѵmax 
(cm-1) = 2919, 2850, 1708, 1624, 1464, 1367, 1318, 1270, 1164, 1025, 982, 727; 
MS (ESI), 197 (MH+), HRMS (ESI, m/z %) calcd. for C10H13O4 [(M+H)+]: 197.0813; 
found: 197.0806, 1.70 ppm error. 
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Preparation of dimethyl (2E,6E)-2,6-octadien-4-ynedioate 263: 
 
According to general procedure 5 using 2-butyne-1,4-diol 262 (200 mg, 2.32 
mmol, 1 equiv.), manganese dioxide (200 mg, 23.2 mmol, 10 equiv.) and 
methyl (triphenylphosphoranylidene)acetate 52 (1.9 g, 5.8 mmol, 2.5 equiv.) 
were combined to afford the desired product as white solid (60 mg, 0.3 mmol, 
13%). 263:(205) Rf = 0.54 (9:1 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4); m.p. 106-110   ͦC; 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 3.72 (s, 3H, H5), 
6.25 (d, 2H, J = 14.9 Hz, H3), 6.83 (d, J = 16.1 Hz, 2H, H2); 13C-NMR (75 MHz, 
CDCl3, 25 °C): δ = 53.6 (C5), 68.0 (C1), 128.6 (C3), 132.0 (C2), 157.7 (C4); IR 
(KBr): ѵmax (cm-1) = 2924,  2853,  2200,  1715,  1610,  1467,  1317,  1273, 1167, 
978.  
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Preparation of dimethyl 3,3'-(1-methyl-1H-indole-2,3-diyl)diacrylate 267: 
  
According to general procedure 5 using N-methyl-2,3-dimethanol indole 205 
(990 mg, 5.17 mmol, 1 equiv.), manganese dioxide (4.49 g, 51.7 mmol, 10 
equiv.) and methyl (triphenylphosphoranylidene)acetate 52 (8.64 g, 25.85 
mmol, 5 equiv.) were combined to afford the desired product as yellow oil (300 
mg, 1.00 mmol, 19%). 267:(221) Rf = 0.50 (7:3 petroleum ether (b.p. 40-60 
°C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 3.75 (s, 
3H, H1), 3.76 (s, 3H, H17), 3.79 (s, 3H, H6), 6.25 (d, J = 16 Hz, 1H, H3), 6.50 (d, J = 
16 Hz, 1H, H15), 7.16-7.22 (m, 2H, H8, H9), 7.29-7.30 (m, 2H, H10, H11), 7.82 (d, J = 
16 Hz, 1H, H14), 7.93 (d, J = 16 Hz, 1H, H4); 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 
31.3 (C6), 51.6 (C1), 52.1 (C17), 110.1 (C), 114.1 (CH), 116.2 (CH), 121.1 (CH), 
122.7 (CH), 124.1 (CH), 124.7 (C), 125.4 (CH), 131.3 (CH), 136.8 (C), 139.0 (C), 
143.2 (CH), 166.5 (C2), 168.3 (C16); IR (KBr): ѵmax (cm-1) = 2948, 2841 ,1702, 
1618, 1433 , 1410, 1372, 1341 , 1269, 1190, 1165, 1132, 1035, 1013, 967 , 739 , 
648, 560; GC-MS (EI, 70 eV): m/z (%) = 299 (M+, 60), 240 (67), 209 (64), 181 
(100), 120 (32), 77 (19), 41 (19).  
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Preparation of dimethyl 3,3'-(N-(tert-butoxycarbonyl)-1H-indole-2,3-
diyl)diacrylate 268:  
 
According to general procedure 5 using N-(tert-butyloxycarbonyl)-2,3-
bis(hydroxylmethyl) indole 206 (590 mg, 2.12 mmol, 1 equiv.), manganese 
dioxide (1.84 g, 21.2 mmol, 10 equiv.) and methyl 
(triphenylphosphoranylidene)acetate 52 (2.83 g, 8.48 mmol, 4 equiv.) were 
combined to afford the desired product as yellow solid (150 mg, 0.39 mmol, 
18%). 268: Rf = 0.55 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4); m.p. 143-145   ͦC; 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.68 (s, 9H, H8), 
3.85 (s, 6H, H1, H19), 6.08 (d, J = 16 Hz, 1H, H17), 6.66 (d, J = 16 Hz, 1H, H3), 7.36 
(d, J = 7.1 Hz, , 1H, H10), 7.42 (d, J = 7.8 Hz, 1H, H11), 7.81 (d, J = 16.1 Hz, 1H, 
H11), 7.89 (d, J = 7.8 Hz, 1H, H16), 8.07 (d, J = 15.2 Hz, 1H, H14), 8.25 (d, J = 16 Hz, 
1H, H4); 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 28.2 (C8), 51.8 (C1), 52.0 (C19), 
85.7 (C7), 115.9 (C4), 118.2 (C14), 120.2 (C16), 120.6 (C3), 124.1 (C11), 124.8 
(C17), 126.3 (C12), 126.9 (C15), 135.4 (C13), 136.3 (C10), 136.7 (C9), 137.0 (C8), 
149.6 (C6), 166.3 (C1, 19); IR (KBr): ѵmax (cm-1) = 3009, 2988, 2953, 2900, 1728, 
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1629, 1453, 1394, 1370, 1341 , 1332, 1272, 1154, 1035, 970, 895 , 865 , 731; 
MS (ESI), 386 (MH+), HRMS (ESI) m/z: calcd for C21H24NO6 [M+]: 386.1603, 
found: 386.1606,  ̶ 1.84 ppm error.  
Preparation of N,N-diallyl-3,3'-(N-(tert-butoxycarbonyl)-1H-indole-2,3-diyl) 
diacetamide 269:  
 
According to general procedure 5 using N-(tert-butyloxycarbonyl)-2,3-
bis(hydroxylmethyl) indole 206 (500 mg, 1.8 mmol, 1 equiv.), manganese 
dioxide (1.56 g, 18 mmol, 10 equiv.) and of N,N-
diallyl(triphenylphosphoranylidene) acetamide 252 (3.6 g, 9 mmol, 5 equiv.) 
were combined to afford the desired product as yellow oil (270 mg, 0.92 mmol, 
29%). 269: Rf = 0.56-0.6 (1:1 to 6:4 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4); 1H-NMR (400 MHz, CDCl3, 25 °C): δ = 1.6 (s, 9H, H10), 
4.07-4.12 (m, 8H, H3, H21), 5.19-5.31 (m, 8H, H1,  H23), 5.82-5.88 (m, 4H, H2, H22), 
6.87 (d, J = 14.9 Hz, 1H, H5), 6.94 (d, J = 15.4 Hz, 1H, H19), 7.29-7.33 (m, 1H, H13), 
7.38-7.40 (m, 1H, H14), 7.74 (d, J = 7.3 Hz, 1H, H12), 7.8 (d, J = 8.3 Hz, 1H, H18), 
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7.88 (d, J = 14.9 Hz, 1H, H6), 8.27 (d, J = 8.1 Hz, 1H, H15); 13C-NMR (100 MHz, 
CDCl3, 25 °C): δ = 28.2 (C10), 48.9, 49.0, 49.4, 49.5 (C3, C3/, C21, C21/), 83.3 
(C9), 115.4 (C5), 115.9 (C15), 116.9, 116.8, 117.7 (C1, C1/, C23, C23/), 119.6 
(C19), 120.0 (C12), 120.5 (C18), 123.7 (C13), 125.3 (C16), 125.7 (C17), 125.8 
(C14), 133.1, 133.4 (C2, C22), 134.3 (C11), 134.8 (C6), 136.2 (C7), 166.7 (C8), 
167.5 (C4, 20); MS (ESI), 515 (MH+), HRMS (ESI) m/z: calcd for C31H37N3O4 
[(M+H)+]: 515.2784, found: 516.2878, 0.58 ppm error. 
Preparation of N-allyl-N-benzyl 3,3'-(N-(tert-butoxycarbonyl)-1H-indole-2,3-
diyl)diacetamide 270:  
 
According to general procedure 5 using N-(tert-butyloxycarbonyl)-2,3-
bis(hydroxylmethyl) indole 206 (370 mg, 1.33 mmol, 1 equiv.), manganese 
dioxide (1.15 g, 13.3 mmol, 10 equiv.) and N-allyl-N-benzyl 
(triphenylphosphoranylidene) acetamide 253 (2.98 g, 6.65 mmol, 5 equiv.) 
were combined to afford the crude as yellow oil, which was used without 
further purification. No characterisation of 270 was attempted. 
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Preparation of dimethyl 3,3'-(N-(toluene-4-sulfonyl)-1H-indole-2,3-
diyl)diacrylate 271: 
 
According to general procedure 5 using N-(toluene-4-sulfonyl)-2,3-
bis(hydroxymethyl) indole 207 (220 mg, 0.66 mmol, 1 equiv.), manganese 
dioxide (573 g, 6.6 mmol, 10 equiv.) and methyl (triphenylphosphoranylidene)-
acetate 52 (551 mg, 1.65 mmol, 2.5 equiv.) were combined to afford the 
desired product as yellow oil (150 mg, 0.34 mmol, 51.7%). NMR of the mixture 
following chromatography showed an inseparable mixture of the intermediate 
to the desired product in a ~ 4:1 ratio. 271: Rf = 0.48 (1:1 petroleum ether (b.p. 
40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, selected 
signals only, 25 °C): δ = 2.33 (s, 3H, H16), 3.82 (s, 6H, H1,), 3.89 (s, 3H, H21), 6.06 
(d, J = 15.8 Hz, 1H, H3), 6.57 (d, J = 16.2 Hz, 1H, H19), 7.15 (d, J = 8.7 Hz, , 2H, 
H14), 7.33-7.35 (m, 1H, H9), 7.60-7.62 (m, 1H, H18), 7.71-7.73 (m, 2H, H13), 7.96 
(d, J = 7.3 Hz, 1H, H10), 8.31-8.35 (m, 2H, H4, H8), 8.68 (s, 1H, H7); 13C-NMR (75 
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MHz, CDCl3, 25 °C): δ = 21.6 (C16), 52.2 (C1), 52.8 (C21), 115.3 (C3), 120.9 
(C10), 121.3 (C7), 124.9 (C19), 126.6 (C5), 126.8 (C9), 130.0 (C8), 131.2 (C13), 
133.4 (C6), 134.5 (C14), 135.9 (C18), 138.5 (C12), 140.1 (C11), 140.5 (C4), 142.0 
(C17), 142.1 (C15), 165.9 (C1, 21);  IR (neat): ѵmax (cm-1) = 2972, 2879, 1709, 
1626, 1487, 1441, 379, 127, 1195, 1050, 986, 881, 802, 661, 618, 585, 537; 
Attempts to get high resolution mass spectrometry data failed.  
Preparation of 3,3'-(N-( toluene-4-sulfonyl)-1H-indole-2,3-diyl)diacrylnitrile 
272:  
 
According to general procedure 5 using N-(toluene-4-sulfonyl)-2,3-
bis(hydroxymethyl) indole 207 (256 mg, 0.77 mmol, 1 equiv.), manganese 
dioxide (670 g, 67.7 mmol, 10 equiv.) and (triphenylphosphoranylidene)-
acetonitrile 265 (580 mg, 1.93 mmol, 2.5 equiv.) were combined to afford the 
crude 272 as yellow oil, which was used without further purification. No 
characterisation of 272 was attempted. 
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7.2.9 Electrocyclisation of trienes 
Preparation of dimethyl-2,3-naphthalenedicarboxylate 274:  
 
Procedure A: 
 The (2E,2’E)-dimethyl-3,3’-(1,2-phenylen)diacrylate 256 (50 mg) was added to 
two separate Microwave Biotage Vials with toluene (3 mL). 50 mg of 
manganese dioxide was added to one of the vials. The vials were sealed and 
irradiated in a Biotage microwave at 175   Cͦ for 15 min using variable 
irradiation. Upon completion the vials were cooled to room temperature, 
unsealed and concentrated in vacuo to afford the crude 274. NMR analysis in 
both solutions showed no reaction and decomposed of the starting material.  
Procedure B: 
 Two solutions of (2E,2’E)-dimethyl-3,3’-(1,2-phenylen)diacrylate 256 (50 mg) 
in 7 mL of diphenyl ether were heated at 250   ͦC from 15 min to 2 hours. 50 mg 
of manganese dioxide was added to one of the solutions. The resulted 
solutions were cooled to room temperature, concentrated in vacuo to afford 
the crude 274. NMR analysis of the crude 274 in both solutions showed no 
reaction and decomposed of the starting material. 
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Preparation of dimethyl carbazole-2,3-dicarboxylate 275:  
 
Procedure A: 
 The dimethyl 3,3'-(N-(tert-butoxycarbonyl)-1H-indole-2,3-diyl)diacrylate 268 
(50 mg) was added to a Microwave Biotage Vial with toluene (3 mL). The vial 
was sealed and irradiated in a Biotage microwave at 175   ͦC for 15 min using 
variable irradiation. Upon completion the vial was cooled to room 
temperature, unsealed and concentrated in vacuo to afford the products. NMR 
analysis showed no reaction and decomposed of the starting material.  
Procedure B:  
10% palladium on carbon (190 mg, 0.182 mmol, 1.4 equiv.) was suspended in 
bromobenzene (12 mL), followed by adding dimethyl 3,3'-(N-(tert-
butoxycarbonyl)-1H-indole-2,3-diyl)diacrylate 268 (50 mg, 0.13 mmol, 1 
equiv.). The resulting solution was stirred and heated at reflux for 15 hours and 
then concentrated in vacuo. The residue was heated again with further of 10% 
Palladium on carbon in bromobenzene for 5 hours, the solvent evaporated, 
and the residue purified by column chromatography on silica gel using 6:4 
petroleum ether (b.p. 40-60 °C)/ethyl acetate as the eluent to afford the title 
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compound 275 (25 mg, 0.08 mmol, 69%). 275:(135) Rf = 0.50 (6:4 petroleum 
ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); m.p. 220-225 °C; 1H-NMR 
(400 MHz, CDCl3, 25 °C): δ = 3.93 (s, 3H, H17), 3.95 (s, 3H, H1), 7.27-7.32 (m, 1H, 
H9), 7.47 (d, J = 0.9 Hz, 1H, H8), 7.8 (dd, J = 2.6, 0.9 Hz, , 1H, H11), 7.66 (d, J = 0.6 
Hz, 1H, H14), 8.08 (dd, J = 7.7, 0.8 Hz, 1H, H10), 8.52 (s, 1H, H14), 8.63 (br.s, 1H, 
H6); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 52.6 (C17), 52.8 (C1), 111.2 (C11), 
111.3 (C14), 120.6 (C9), 121.0 (C10), 121.8 (C15), 122.5 (C4), 124.4 (C13), 127.4 
(C8), 129.7 (C12), 130.6 (C7), 133.6 (C13), 140.6 (C5), 168.3 (C1,17); IR (KBr): 
ѵmax (cm-1) = 3375, 2939, 2675, 1686, 1601, 1434, 1317, 1263, 1074, 728; MS 
(ESI), 284 (MH+), HRMS (ESI+ m/z%): calcd for C16H14NO4 [(M+H)+]: 284.0923, 
found 284.0925,   ̶0.69 ppm error.  
Preparation of dimethyl N-(toluene-4-sulfonyl) carbazole-2,3-dicarboxylate 
276: 
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Procedure A:  
The dimethyl 3,3'-(N-(toluene-4-sulfoyll)-1H-indole-2,3-diyl)diacrylate 271 (50 
mg) was added to a Microwave Biotage vial with toluene (3 mL). The vial was 
sealed and irradiated in a Biotage microwave at 175   Cͦ for (15, 30 min) using 
variable irradiation. Upon completion the vial was cooled to room 
temperature, unsealed and concentrated in vacuo to afford the products. NMR 
analysis showed decomposition of the starting material.  
Procedure B:  
10% Palladium on carbon (670 mg, 0.34 mmol, 1.88 equiv.) was suspended in 
anhydrous xylene (5 mL), followed by adding dimethyl 3,3'-(N-(toluene-4-
sulfoyll)-1H-indole-2,3-diyl)diacrylate 271 (150 mg, 0.63 mmol, 1 equiv.). The 
resulting solution was stirred and heated at reflux for 24 hours and then 
filtered through celite, washed with hot xylene (5 mL), and concentrated in 
vacuo. The solid residue was crashed with methanol to get the crude. No 
characterisation of 276 was attempted (decomposition).   
Procedure C:  
To a solution of dimethyl 3,3'-(N-(toluene-4-sulfoyll)-1H-indole-2,3-
diyl)diacrylate 271 (150 mg, 0.34 mmol, 1 equiv.) in bromobenzene (7 mL), was 
added DDQ (154 mg, 0.68 mmol, 2 equiv.) slowly. The resulted solution was 
heated at reflux for 3 h, filtered through silica gel, evaporated by rotary to give 
the crude, and then purified using column chromatography on silica gel 95:50 
dichloromethane/ methanol as affording the title product 276 as colorless oil 
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(100 mg, 0.22 mmol, 71%). 276:(135) Rf = 0.59 (9.5:0.5 
dichloromethane/methanol, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 
2.28 (d, J = 6.4 Hz, 3H, H16), 3.95 (d, J = 6.4 Hz,3H, H1), 4.00 (d, J = 6.4 Hz, 3H, 
H21), 7.14 (t, J = 7.2 Hz, 2H, H14), 7.38-7.45 (m,1H, H10), 7.54-7.61 (m, 1H, H8), 
7.68-7.73 (m, 1H, H13), 7.95 (t, J = 6.8 Hz, 1H, H9), 8.29-8.35 (m, 2H, H7, H18), 
8.67 (d, J = 6.8 Hz, 1H, H4); 13C-NMR (75 MHz, CDCl3, 25 °C): δ = 21.5 (C16), 52.7 
(C1), 52.9 (C21), 115.1 (C18), 115.5 (C10), 120.7 (C7), 121.3 (C4), 124.5 (C5), 
124.9 (C6), 126.4 (C8), 126.5 (C19), 127.2 (C3), 127.9 (2xC13), 128.9 (C9), 129.9 
(2xC14), 131.2 (C17), 134.5 (C11), 139.1 (C12), 139.4 (C15), 167.8 (C1), 168.1 
(C21); IR (KBr): ѵmax (cm−1)= 3744, 2950, 1732, 1593, 1456, 1377, 1268, 1122, 
745; MS (ESI), 438 (MH+), HRMS (ESI) m/z calcd for C23H20NO6S [(M+H)+] 
438.1011, found 438.1009,   ̶0.95 ppm error.  
7.3 Experimental procedures: Chapter 3 
7.3.1 Wittig reaction of divinyl ketones: 
Preparation of diethyl-3,5-dibromo-4-oxoheptadioate 301: (207)  
 
To a stirred solution of diethyl 4-oxopimelate 300 (5.0 g, 21.7 mmol, ƿ = 1.073 
gmL-1, 4.66 mL, 1 equiv.) in anhydrous dichloromethane (10 mL), cooled to 0 
°C, a solution of bromine (6.9 g, 43.4 mmol, ƿ = 3.119 gmL-1, 2.22 mL, 2 equiv.) 
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in anhydrous dichloromethane (5 mL) was added dropwise. The mixture was 
stirred at room temperature for 10 min, and then dichloromethane (50 mL) 
was added, washed with 1 M sodium thiosulfate (50 mL), dried (MgSO4) and 
then concentrated in vacuo to afford the title compound 301 as a thick oil (6.7 
g, 17.3 mmol, 80%). 301: 1H-NMR (400 MHz, CDCl3, 25  Cͦ): δ = 1.27 (t, J = 6 Hz, 
6H, H1, H11), 3.00-3.04 (m, 2H, H4), 3.25-3.32 (m, 2H, H8), 4.18 (dd, J = 6.5, 4.8 
Hz, H2, H10), 5.35 (t, J = 5.6 Hz, 2H, H5, H7); 13C-NMR (100.6 MHz, CDCl3, 25  Cͦ): δ 
= 14.1 (C1, C11), 38.2 (C4, C8), 41.6 (C5, C7), 61.3 (C2, C10), 169.3 (C3, C9), 
194.3 (C6); IR (KBr): ѵmax (cm-1) = 2985, 2940, 1725, 1460, 1375, 1200, 1030, 
960, 940, 865, 830, 785, 665; CI-MS (NH3): 389 (1, M+H+), 343 (17, M+−OEt), 
315 (7), 263, 261 (33, M+−OEt−Br), 209, 207 (90), 183, 181 (28), 127 (100), 99 
(63). 
Preparation of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302: (222)  
 
Triethylamine (3.5 g, 34.6 mmol, ƿ = 0.725 gmL-1, 4.83 mL, 2 equiv.) was added 
to a stirred solution of 301 (6.7 g, 17.3 mmol, 1 equiv.) in anhydrous 
dichloromethane (15 mL) cooled to 0 °C. The resultant mixture was vigorously 
stirred at 0 °C for 30 min, then water (60 mL) and dichloromethane (50 mL) 
were added. The organic extract was washed with water (2 × 100 mL), dried 
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(MgSO4), and evaporated the solvent in vacuo. Purification via flash 
chromatography on silica using 8:2 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate obtained 302 as yellow solid (1.5 g, 6.6 mmol, 38%). 302: Rf = 0.5 (8:2 
petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); m.p. 49-50 °C; 1H-
NMR (400 MHz, CDCl3, 25  ͦC): δ = 1.34 (t, J = 7.1 Hz, 6H, H1, H11), 4.29 (q, J = 7.2 
Hz, 4H, H2, H10), 6.81 (d, J = 15.9 Hz, 2H, H4, H8), 7.23 (d, J = 15.9 Hz, 2H, H5, H7); 
13C-NMR (100 MHz, CDCl3, 25  ͦC): δ = 14.1 (C1, 11), 61.6 (C2, C10), 133.2 (C4, 
C8), 137.5 (C5, C7), 165.1 (C3, C9), 189.3 (C6); IR (KBr) : ѵmax (cm-1) = 3070, 
2985, 1725, 1675, 1285, 1195, 1090, 1000, 865, 805, 775, 705, 635; CI-MS 
(NH3): 226 (34, M+), 197 (16, M+−Et), 181 (56, M+−OEt), 153 (29, M+−COOEt), 
127 (70), 99 (100); MS (ESI), 227 (MH+), HRMS (ESI+ m/z%): calcd for C11H14O5 
[(M+H)+]: 226.0841; found 227.0934,  ̶ 11.78 ppm error.  
7.3.2 TOP for the preparation of dienes: 
General procedure 6:  
Activated manganese dioxide (10 equiv.) was added to a stirred solution of diol 
(1 equiv.) and ylide (2.5 equiv.) in anhydrous THF (20 mL). The resulting 
solution was stirred and heated at reflux for 24 hours. The manganese dioxide 
was removed by filtration through a celite pad, washed with THF (50 mL) and 
the crude was concentrated under higher vacuum, purified by flash 
chromatography on silica gel using different eluents gave products. Conversion 
was determined by analysis of the 1H-NMR spectrum. 
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Preparation of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302:  
 
According to general procedure 6 activated manganese dioxide (2.41 g, 27.8 
mmol, 10 equiv.) was added to a stirred solution of dihydroxyacetone 294 (0.5 
g, 2.78 mmol, 1 equiv.) and ethyl (triphenylphosphoranylidene)acetate 38 
(2.42 g, 6.95 mmol, 2.5 equiv.) in anhydrous THF (20 mL). The resulting 
solution was concentrated under higher vacuum, purified by flash 
chromatography on silica gel using 5:5 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate obtained 302 as yellow solid (90 mg, 0.39 mmol, 15%). Data as 
recorded in 7.3.1. 
Preparation of diethyl (E,E)-4-oxohepta-2,5-diene-2,5-dimethyl-1,7-dioate 
314:  
 
According to general procedure 6 activated manganese dioxide (0.97 g, 11.1 
mmol, 10 equiv.) was added to a stirred solution of dihydroxyacetone 294 (200 
Chapter 6                                                                                              Experimental 
220 | P a g e  
 
mg, 1.11 mmol, 1 equiv.) and (carbethoxyethylidene)triphenylphosphorane 35 
(1 g, 2.78 mmol, 2.5 equiv.) in anhydrous THF (20 mL). The resulting solution 
was concentrated under higher vacuum, purified by flash chromatography on 
silica gel using 1:9 petroleum ether (b.p. 40-60 °C)/ethyl acetate obtained 314 
as yellow solid (53 mg, 0.20 mmol, 20%). 314: Rf = 0.6 (1:9 petroleum ether 
(b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (400 MHz, CDCl3, 25  ͦC): δ 
= 1.43 (t, J = 6.4 Hz, 6H, H1, H11), 2.28 (s, 6H, H12, H13), 4.28 (q, J = 6.3 Hz, 4H, 
H2, H10), 7.20 (s, 2H, H5, H7); 13C-NMR (100 MHz, CDCl3, 25  ͦC): δ = 14.1 (C1, 
C11), 14.5 (C12, C13), 61.7 (C2, C10), 125.5 (C5, C7), 141.9 (C4, C8), 165.2 (C3, 
C9), 190.4 (C6); IR (KBr): ѵmax (cm-1) = 2981, 1773, 1627, 1367, 1243, 1173, 
1092, 1020, 986, 909, 864; MS (ESI), 255 (MH+), HRMS (ESI+ m/z%): calcd for 
C13H19O5 [(M+H)+]: 255.1232, found 255.1230,  ̶ 1.86 ppm error. 
Preparation of (E,E)-4-oxohepta-2,5-diene-1,7-di(tert-butyl ester) (315) and β-
hydroxy-methyl-(E,E)-muconsaeure-di-tert-butyl ester (318):  
 
According to general procedure 6 activated manganese dioxide (0.97 g, 11.1 
mmol, 10 equiv.) was added to a stirred solution of dihydroxyacetone 294 (200 
mg, 1.11 mmol, 1 equiv.) and (tert-butoxycarbonylmethylene)-
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triphenylphosphorane 304 (1.04 g, 2.78 mmol, 2.5 equiv.) in anhydrous THF 
(20 mL). The resulting solution was concentrated under higher vacuum which 
was used without further purification, afforded yellow oil. TOP reaction of 
dihydroxyacetone 294 leads to no amounts of 315 compound was isolated.  
Instead, the compound 318 was found as a thick oil (70 mg, 0.24 mmol, 22%). 
318: Rf = 0.46 (8.5:1:0.5 toluene/dichloromethane/acetone, det: KMnO4); 1H-
NMR (300 MHz, CDCl3, 25 °C): δ = 1.51 (d, J = 3.9 Hz, 18H, H7, H12), 1.83 (br.s, 
1H, H1), 4.42 (br.s, 2H, H2), 6.03 (d, J = 16.6 Hz, 1H, H8), 6.17 (s, 1H, H4), 8.32 (d, 
J = 16.6 Hz, 1H, H9); 13C-NMR (75 MHz, CDCl3, 25  ͦC): δ = 28.2 (C7, C12), 62.6 
(C2), 80.9 (C6), 81.3 (C11), 123.4 (C4), 124.6 (C8), 137.0 (C9), 142.2 (C3), 165.0 
(C5), 165.7 (C10). 
Attempted preparation of 4-oxohepta-2,5-diene-1,7-diphenyl 317:  
 
According to general procedure 6 activated manganese dioxide (965 g, 11.1 
mmol, 10 equiv.) was added to a stirred solution of dihydroxyacetone 294 (200 
mg, 1.11 mmol, 1 equiv.) and benzyltriphenylphosphonium bromide 316 (2.40 
g, 5.55 mmol, 5 equiv.) and 7-methyl-1,5,7-triazabicyclo[4.4.0]-dec-5-ene 
[MTBD] 89 (850 mg, 5.55 mmol, ƿ = 1.067 gmL-1, 790 µL, 5 equiv.) were 
combined in anhydrous THF (25 mL) were combined. The resulting solution 
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was concentrated under higher vacuum which was used without further 
purification, afforded yellow oil. No characterisation of 317 was attempted. 
7.3.3 Wittig reaction using 4-nitrobnzoic acid (Lewis acid) 
General procedure 7:  
Diethyl (E,E)-4-oxohepta-2,5-dienedioate 302 (1 equiv.), 4-nitrobenzoic acid 
(0.2 equiv.) and ylides (1.25 equiv.) were combined together in toluene (20-35 
mL) and stirred at reflux for 15 hours. The solvent was evaporated in vacuo 
with purification step required by flash chromatography on silica gel using 
different eluents gave desired products. Conversion was determined by 
analysis of the 1H-NMR spectrum. 
Preparation of diethyl (E,E)-4-methylacrylate -2,5-diene-1,7-dioate 303: 
 
According to General procedure 7 using diethyl (E, E)-4-oxohepta-2,5-
dienedioate 302 (100 mg, 0.44 mmol, 1 equiv.), 4-nitrobenzoic acid (13 mg, 
0.08 mmol, 0.2 equiv.) and methyl (triphenylphosphoranylidene)acetate 52 
(183 mg, 0.55 mmol, 1.25 equiv.) in toluene (20 mL). The title diene was 
obtained as yellow oil following chromatographic purification from (8:2) 
petroleum ether (b.p. 40-60 °C)/ethyl acetate (99 mg, 0.35 mmol, 79%). 303: Rf 
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= 0.6 (8:2, petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR 
(400 MHz, CDCl3, 25  ͦC): δ = 1.33 (t, J = 7.1 Hz, 6H, H1, H11), 3.73 (s, 3H, H14), 
4.26 (q, J = 7.2 Hz, 4H, H2, H10), 6.16 (s, 1H, H12), 6.27 (d, J = 15.7 Hz, 2H, H4, H8), 
7.42 (d, J = 15.7 Hz, 1H, H5), 8.28 (d, J = 15.9 Hz, 1H, H7); 13C-NMR (100 MHz, 
CDCl3, 25   ͦC): δ = 14.2 (C1), 15.3 (C11), 52.0 (C14), 61.6 (C2, C10), 124.0 (C5), 
125.9 (C12), 126.4 (C4), 138.2 (C8), 141.6 (C7), 145.9 (C6), 165.4 (C13), 165.7 
(C9), 165.8 (C3); IR (neat): ѵmax (cm-1) = 2983, 2905, 1712, 1165, 1576, 1444, 
1367, 1250, 1166, 1035, 980, 747, 712, 559; MS (ESI), 283 (MH+), HRMS (ESI+ 
m/z%): calcd for C14H19O6 [(M+H)+]: 283.1181, found 283.1176,  ̶ 2.8 ppm error.  
Preparation of diethyl (E, E)-4-allylacrylate-2,5-diene-1,7-dioate 308: 
 
According to General procedure 7 using diethyl (E,E)-4-oxohepta-2,5-
dienedioate 302 (500 mg, 2.21 mmol, 1 equiv.), 4-nitrobenzoic acid (73.8 mg, 
0.44 mmol, 0.2 equiv.) and ethyl (triphenylphosphoranylidene)acetate 38 (961 
mg, 2.76 mmol, 1.25 equiv.) in toluene (30 mL). Purification by flash 
chromatography on silica using 8:2 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate afforded the desired compound 308 as yellow oil (286 mg, 0.96 mmol, 
43%). 308: Rf = 0.62 (8:2 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
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KMnO4); 1H-NMR (400 MHz, CDCl3, 25  Cͦ): δ = 1.33 (t, J = 7.1 Hz, 6H, H1, H11, 
H15), 4.25-4.29 (m, 6H, H2, H10, H14), 6.15 (s, 1H, H12), 6.19 (d, J = 16.4 Hz, 1H, 
H4), 6.27 (d, J = 15.7 Hz, 1H, H8), 7.42 (d, J = 15.7 Hz, 1H, H7), 8.29 (d, J = 16.4 
Hz, 1H, H5); 13C-NMR (100 MHz, CDCl3, 25   Cͦ): δ = 14.2 (C15), 14.2 (C1), 14.3 
(C11), 60.9 (C14), 61.0 (C2), 61.0 (C10), 124.6 (C12), 125.7 (C4), 126.2 (C8), 
138.4 (C5), 141.7 (C7), 145.5 (C6), 165.0 (C13), 165.7 (C3), 165.8 (C9); IR (KBr): 
ѵmax (cm-1) = 2984, 2936, 2905, 1717, 1638, 1466, 1368, 1268, 1183, 1030, 986, 
738, 668, 570; MS (ESI), 297 (MH+), HRMS (ESI+ m/z%): calcd for C15H21O6 
[(M+H)+]: 297.1338, found 297.1336,  ̶ 1.58 ppm error. 
Preparation of diethyl (E,E)-4-ethyl methacrylate-2,5-diene-1,7-dioate 309: 
 
According to General procedure 7 using diethyl (E,E)-4-oxohepta-2,5-
dienedioate 302 (500 mg, 2.21 mmol, 1 equiv.), 4-nitrobenzoic acid (73.8 mg, 
0.44 mmol, 0.2 equiv.) and (carbethoxyethylidene)triphenylphosphorane 35 (1 
g, 2.75 mmol, 1.25 equiv.) in toluene (30 mL) are combined and purified by 
flash chromatography on silica using 8:2 dichloromethane / diethyl ether to 
afford the desired compound 309 as yellow oil (650 mg, 2.09 mmol, 95%). 309: 
Rf  = 0.6 (8:2 dichloromethane/diethyl ether, det: KMnO4); 1H-NMR (400 MHz, 
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CDCl3, 25   ͦC): δ = 1.29-1.35 (m, 9H, H1, H11, H15), 2.12 (s, 3H, H13), 4.20-4.30 (m, 
6H, H2, H10, H15), 5.94 (d, J = 16.1 Hz, 1H, H4), 6.07 (d, J = 16.1 Hz, 1H, H8), 7.52 
(d, J = 16.1 Hz, 1H, H7), 7.75 (d, J = 16.1 Hz, 1H, H5); 13C-NMR (100 MHz, CDCl3, 
25  ͦC): δ = 14.1 (C16), 14.3 (C1), 17.3 (C11), 60.7 (C15), 60.9 (C2), 61.5 (C10), 
123.8 (C4), 126.3 (C8), 135.6 (C12), 138.2 (C6), 139.5 (C7), 141.1 (C5), 166.0 
(C14), 166.2 (C3), 168.2 (C9); IR (neat): ѵmax (cm-1) = 2974, 1711, 1364, 1159, 
1025, 971, 770, 663, 444; MS (ESI), 311 (MH+), HRMS (ESI+ m/z%): calcd for 
C16H23O6 [(M+H)+]: 311.1494, found 311.1505,  ̶ 4.75 ppm error 
Preparation of diethyl (E, E)-4-tert-butoxycarbonyl-2,5-diene-1,7-dioate 310: 
 
According to General procedure 7 using diethyl (E,E)-4-oxohepta-2,5-
dienedioate 302 (500 mg, 2.21 mmol, 1 equiv.), 4-nitrobenzoic acid (73.8 mg, 
0.44 mmol, 0.2 equiv.) and (tert-
butoxycarbonylmethylene)triphenylphosphorane 304 (1.3 g, 2.76 mmol, 1.25 
equiv.) in toluene (30 mL) were combined and purified by flash 
chromatography on silica using 8:2 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate to afford the desired compound 310 as yellow oil (241 mg, 0.74 mmol, 
34%). 310: Rf =  0.5 (8:2 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
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KMnO4);  1H-NMR (400 MHz, CDCl3, 25  ͦC): δ = 1.32 (t, J = 7.2 Hz, 6H, H1, H11), 
1.51 (s, 9H, H15), 4.25-4.29 (m, 4H, H2, H10), 6.14 (d, J = 16.4 Hz, 1H, H4), 6.24 (d, 
J = 15.8 Hz, 1H, H8), 7.39 (d, J = 15.9 Hz, 1H, H5), 8.24 (d, J = 16.4 Hz, 1H, H7); 
13C-NMR (100 MHz, CDCl3, 25  Cͦ): δ = 14.3 (C1), 15.3 (C11), 28.9 (C15), 60.9 
(C2), 61.0 (C10 ), 125.3 (C6), 125.6 (C4), 126.4 (C8), 138.7 (C7), 142.0 (C5), 
144.0 (C6), 164.3 (C13), 165.8 (C9), 165.9 (C3); IR (neat): ѵmax (cm-1) = 2989, 
2942, 1718, 1623, 1393, 1271, 1183, 1114, 1027, 980, 918, 774,739, 574; MS 
(ESI), 325 (MH+), HRMS (ESI+ m/z%): calcd for C17H25O6 [(M+H)+]: 325.1573, 
found 325.1561,   ̶5.70 ppm error. 
Preparation of diethyl (E,E)-4-[tert-butyl 2-methyl-2-propionate]-2,5-diene-
1,7-dioate 311: 
 
According to General procedure 7 using diethyl (E,E)-4-oxohepta-2,5-
dienedioate 302 (230 mg, 1.02 mmol, 1 equiv.), 4-nitrobenzoic acid (34 mg, 0.2 
mmol, 0.2 equiv.) and tert-butyl 2-(triphenylphosphoranylidene)propionate 
305 (500 mg, 1.28 mmol, 1.25 equiv.) were mixed in toluene (10 mL). 
Purification by flash chromatography on silica using 1:1 petroleum ether (b.p. 
40-60 °C)/ethyl acetate afforded the desired compound 311 as yellow oil (160 
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mg, 0.47 mmol, 47%). 311: Rf = 0.45 (1:1 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25  ͦC): δ = 1.28-1.35 (m, 6H, 
H1, H11), 1.52 (s, 9H, H16), 2.10 (s, 3H, H13), 4.20-4.29 (m, 4H, H2, H10), 5.94 (d, J = 
16.1 Hz, 1H, H4), 6.06 (d, J = 16 Hz, 1H, H8), 7.51 (d, J = 16 Hz, 1H, H7), 7.71 (dd, 
J= 15.9, 0.8 Hz, 1H, H5); 13C-NMR (75 MHz, CDCl3, 25  Cͦ): δ = 14.2 (C1), 14.2 
(C11), 17.2 (C13), 28.0 (16), 60.6 (C2), 60.8 (C10), 82.6 (C15), 123.2 (C4), 125.66 
(C8), 134.0 (C12), 137.7 (C6), 139.5 (C7), 141.2 (C5), 166.0 (C14), 166.2 (C3), 
167.8 (C9); IR (neat): ѵmax (cm-1) = 2983, 2938, 2906, 1713, 1622, 1477, 1393, 
1255, 1160, 1118, 1031, 979, 932, 773, 672, 564; MS (ESI), 339 (MH+), HRMS 
(ESI+ m/z%): calcd for C18H27O6 [(M+H)+]: 339.1807, found 339.1809,  ̶ 4.55 ppm 
error. 
7.3.4 Nazarov cyclisation of divinyl ketones 
Attempted Preparation of diethyl-4-oxocyclopent-2-ene-1,2-dicarboxylate 
319: 
 
Procedure A:  
To a solution of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302 (50 mg, 0.22 
mmol, 1 equiv.),in anhydrous dichloromethane (5 mL) was added p-
toluenesulfonic acid monohydrate (41.8 mg, 0.22 mmol, 1 equiv.) or zirconium 
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tetrachloride (51.2 mg, 0.22 mmol, 1 equiv.). The resulted solution was stirred 
at room temperature or 50   ͦC under a nitrogen pressure. After 15 hours, the 
reaction mixture was poured into water (20 mL). The aqueous layers were 
extracted with diethyl ether (3 × 15 mL), washed with saturated brine (50 mL), 
and then dried (MgSO4). The filtrate was concentrated in vacuo.  
Procedure B:  
To a solution of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302 (50 mg, 0.22 
mmol, 1 equiv.),in anhydrous dichloromethane (5 mL) was added ferric 
chloride (35.6 mg, 0.22 mmol, 1 equiv.). The resulted solution was stirred at 
room temperature or 50   ͦC under a nitrogen pressure. After 15 hours, the 
reaction mixture was poured into water (20 mL). The aqueous layers were 
extracted with ethyl acetate (3 × 15 mL), and then dried (MgSO4). The filtrate 
was concentrated in vacuo.  
Procedure C:  
To a cooled solution at 0   ͦC of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 
302 (50 mg, 0.22 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), 
titanium tetrachloride [1M in dichloromethane] (260 µL, 0.22 mmol, 1 equiv.) 
was added. The resulted solution was stirred at room temperature for 15 h, 
further heating was required. Saturated sodium bicarbonate (5 mL) was added. 
The aqueous layers were extracted with dichloromethane (3 × 5 mL). The 
organic layers were combined and dried (MgSO4). The filtrate was 
concentrated in vacuo.  
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Procedure D:  
To a solution of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302 (50 mg, 0.22 
mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), bismuth(III) triflate (144 
mg, 0.22 mmol, 1 equiv.) was added. The resulted solution was stirred at room 
temperature for 15 h, further heating was required. The resulted mixture was 
poured into water (20 mL). The aqueous layers were extracted with diethyl 
ether (3 × 15 mL), washed with saturated brine (50 mL), and then dried 
(MgSO4). The filtrate was concentrated in vacuo. 
Procedure E:  
To a solution of diethyl (E,E)-4-oxohepta-2,5-diene-1,7-dioate 302 (50 mg, 0.22 
mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), triflic acid (33 mg, 0.22 
mmol, ƿ = 1.696 gmL-1, 19 µL, 1 equiv.) was added. The resulted solution was 
stirred at room temperature for 15 h. The resulted mixture was poured into 
water (20 mL). The aqueous layers were extracted with ethyl acetate (2 × 20 
mL), washed with saturated brine (50 mL), and then dried (MgSO4). The filtrate 
was concentrated in vacuo. Conversion was determined by analysis of the 1H-
NMR spectrum.  
The crudes from (A-E) procedures were obtained as oils with a mass recovery 
of 90-96, which were used without further purification. No characterisation of 
319 was attempted of all these methods. 
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Preparation of diethyl-4-(ethylmethylene ester)cyclopent-2-ene-1,2-
dicarboxylate 322: 
 
Procedure A:  
To a solution diethyl (E,E)-4-methylacrylate-2,5-diene-1,7-dioate 308 (50 mg, 
0.168 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL) acetonitrile (5 
mL), p-toluenesulfonic acid monohydrate (31.9 mg, 0.168 mmol, 1 equiv.) or 
zirconium tetrachloride (39.1 mg, 0.168 mmol, 1 equiv.) were added. The 
resulted solution was stirred at over diethyl ether (3 × 15 mL), washed with 
saturated brine (50 mL), then dried (MgSO4). The filtrate was concentrated in 
vacuo.  
Procedure B:  
To a solution of diethyl (E,E)-4-methylacrylate-2,5-diene-1,7-dioate 308 (50 mg, 
0.168 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL) or acetonitrile (5 
mL), ferric chloride (27.2 mg, 0.168 mmol, 1 equiv.) was added. The resulted 
solution was stirred at room temperature or 50   ͦC under a nitrogen pressure. 
After 15 hours, the reaction mixture was poured into water (20 mL). The 
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aqueous layers were extracted with ethyl acetate (3 × 15 mL), and then dried 
(MgSO4). The filtrate was concentrated in vacuo.  
The crudes from (A and B) procedures were obtained as oils with a mass 
recovery of 85-96, which were used without further purification. No 
characterisation of 322 was attempted of all these methods. 
Preparation of diethyl 4-(tert-butoxymethylene ester)cyclopent-1-ene-1,2-
dicarboxylate 323: 
 
Procedure A:  
To a solution of diethyl (E,E)-4-tert-butoxycarbonyl-2,5-diene-1,7-dioate 310 
(48 mg, 0.14 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), p-
toluenesulfonic acid monohydrate (26.6 mg, 0.14 mmol, 1 equiv.) or zirconium 
tetrachloride (32.6 mg, 0.14 mmol, 1 equiv.) were added. The resulted solution 
was stirred at room temperature or 50   ͦC under a nitrogen pressure. After 15 
hours, the reaction mixture was poured into water (20 mL). The aqueous layers 
were extracted with diethyl ether (3 × 15 mL), washed with saturated brine (50 
mL), and then dried (MgSO4). The filtrate was concentrated in vacuo. 
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Procedure B:  
To a cooled solution at 0  ͦC of diethyl (E,E)-4-tert-butoxycarbonyl-2,5-diene-
1,7-dioate 310 (48 mg, 0.14 mmol, 1 equiv.) in anhydrous dichloromethane (5 
mL), titanium tetrachloride [1M in dichloromethane] (170 µL, 0.14 mmol, 1 
equiv.) was added. The resulted solution was stirred at room temperature for 
15 hours, further heating was required. Saturated sodium bicarbonate (5 mL) 
was added. The aqueous layers were extracted with dichloromethane (3 × 5 
mL). The organic layers were combined and dried (MgSO4). The filtrate was 
concentrated in vacuo.  
Procedure c: 
To a solution of diethyl (E,E)-4-tert-butoxycarbonyl-2,5-diene-1,7-dioate 310 
(48 mg, 0.14 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), ferric 
chloride (23 mg, 0.14 mmol, 1 equiv.) was added. The resulted solution was 
stirred at room temperature or 50   ͦC under a nitrogen pressure. After 15 
hours, the reaction mixture was poured into water (20 mL). The aqueous layers 
were extracted with ethyl acetate (3 × 15 mL), and then dried (MgSO4). The 
filtrate was concentrated in vacuo.  
Procedure D:  
To a solution of diethyl (E,E)-4-tert-butoxycarbonyl-2,5-diene-1,7-dioate 310 
(48 mg, 0.14 mmol, 1 equiv.) in anhydrous dichloromethane (5 mL), 
bismuth(III) triflate (92 mg, 0.14 mmol, 1 equiv.) was added. The resulted 
solution was stirred at room temperature for 15 h, further heating was 
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required. The resulted mixture was poured into water (20 mL). The aqueous 
layers were extracted with diethyl ether (3 × 15 mL), washed with saturated 
brine (50 mL), and then dried (MgSO4). The filtrate was concentrated in vacuo. 
The crudes from (A-D) procedures were obtained as oils with a mass recovery 
of 80-95, which were used without further purification. No characterisation of 
323 was attempted of all these methods. 
7.4 Experimental procedures: Chapter 4 
7.4.1 Preparation of diols 
Preparation of 1,2-diphenylethane-1,2-diol 368: (177)   
 
To a solution of benzoin 418 (5.0 g, 35.55 mmol, 1 equiv.) in methanol (160 
mL) at 0 °C, sodium borohydride (1.36 g, 35.95 mmol, 1.01 equiv.) was added 
in several portions. The mixture was stirred for 16 h. The excess of sodium 
borohydride was poured into cold water (50 mL). Organic layer was extracted 
with (200 mL) of dichloromethane, dried (MgSO4), filtered and evaporated by 
vacuo to afford the title diol 368 as white powder (4.5 g, 21 mmol, 90%). 368: 
m.p. 137-138 °C; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 2.19 (s, 2H, H1), 4.85 (s, 
2H, H2), 7.28-7.30 (m, 4H, H5), 7.31-7.32 (m, 4H, H4), 7.33 (dd, J = 1.8, 1.0 Hz, 
2H, H6); 13C NMR (75 MHz, CDCl3, 25 °C): δ = 78.1 (C2), 127.1 (C5), 128.2 (C4), 
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128.3 (C6), 139.8 (C3); IR (KBr) : ѵmax (cm-1) = 3372,  3312,  3063,  2899,  1495,  
1450,  1279,  1034,  1022,  754,  698,  529; MS (ESI) 237 (MNa+), HRMS (ESI, 
m/z %) Calcd for C14H15O2 [(M+Na)+]: 237.0891; found 237.0894,  ̶ 3.55 ppm 
error. 
Preparation of 1,2-ditolylethane-1,2-diol 372: (177)   
 
To a solution of 4,4′-dimethylbenzil 371 (2.0 g, 8 mmol, 1 equiv.) in methanol 
(80 mL) at 0 °C, sodium tetrahydroborate (770 mg, 20 mmol, 2.5 equiv.) was 
added in several portions. The mixture was stirred for 16 h. The excess of 
sodium tetrahydroborate was quenched with cold water (50 mL). Organic layer 
was extracted with (100 mL) of dichloromethane, dried (MgSO4), filtered and 
evaporated in vacuo to afford the title diol 372 as white solid (1.10 g, 4.54 
mmol, 100%). 372: m.p. 180 °C; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 2.05 (s, 
2H, H1), 2.35 (s, 6H, H7), 4.75 (s, 2H, H2), 7.13-7.16 (m, 4H, H4), 7.19-7.22 (m, 
4H, H5); 13C NMR (75 MHz, CDCl3, 25 °C): δ = 21.2 (C7), 78.1 (C2), 127.1 (C4), 
129.1 (C5), 137.0 (C6), 137.9 (C3); IR (KBr) : ѵmax (cm-1) = 3354, 3307, 2916, 
1559, 1514, 1424, 1065, 1034, 819, 556, 519; FAB MS (m/z): Calcd for C16H18O2 
[(M+Na)+]: 265.1204; found 265.3504.  
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Preparation of 1,2-di(2-furyl)-1,2-ethanediol 374:  
 
To a solution of furoin 373 (2.0 g, 10.4 mmol, 1 equiv.) in methanol (80 mL) at 
0 °C, sodium tetrahydroborate (590 mg, 15.6 mmol, 1.5 equiv.) was added in 
several portions. The mixture was stirred for 24 h. After this time, the excess of 
sodium tetrahydroborate was quenched with cold water (50 mL). Organic layer 
was extracted with (100 mL) of dichloromethane, dried (MgSO4), then 
evaporated in vacuo to afford the title diol 374 as viscous liquid (220 mg, 21%). 
374:(178) 1H NMR (300 MHz, CDCl3, 25 °C): δ = 3.35 (s, 2H, H1), 4.97 (s, 2H, H2), 
6.22 (dd, J = 3.4, 0.8 Hz, 2H, H5), 6.30 (dd, J = 3.3, 1.8 Hz, 2H, H4), 7.35 (dd, J = 
1.9, 0.8 Hz, 2H, H6); 13C NMR (75 MHz, CDCl3, 25 °C): δ = 70.0 (C2), 108.1 (C5), 
110.4 (C4), 142.3 (C6), 152.9 (C3); IR (KBr): ѵmax (cm-1) = 3392, 2966, 2922, 
1607, 1504, 1442, 1147, 1129, 1008, 925, 812; MS (ESI) 217 (MNa+), HRMS (ESI, 
m/z %)  Calcd for C10H8O2 [(M+Na)+]:(163)  217.0477; found 217.0469.  
7.4.2 TOP reactions of diols using different phosphorane ylides 
General procedure 8:  
Activated manganese dioxide (10 equiv.) was added to a stirred solution of diol 
(1 equiv.), phosphorane ylide (2.5 equiv.) with or without 4-nitrobenzoic acid 
(0.25 equiv.) in toluene (20 mL). The resulting solution was stirred and heated 
at reflux for 24 h. The manganese dioxide was removed by filtration through a 
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celite pad, washed with THF (50 mL) and the crude was concentrated under 
higher vacuum, purified by flash chromatography on silica gel using different 
eluents gave desired products. Conversion was determined by analysis of the 
1H-NMR spectrum. 
Attempted preparation of 3-methyl-4-oxopent-2-enenitrile (389) or 3,4-
dimethyl-hexadien-2,4-dinitril (390):  
 
According to general procedure 8 using 2,3-butanediol 350 (100 mg, 1.1 mmol, 
ƿ = 1.002 gmL-1, 1 mL, 1 equiv.), manganese dioxide (950 mg, 11 mmol, 10 
equiv.) and (triphenylphosphoranylidene)acetonitrile 265 (828 mg, 2.75mmol, 
2.5 equiv.) were combined. Concentration in vacuo afforded the crude as 
yellow oil. No characterisation of 389 or 390 was attempted.  
Preparation of (E)-ethyl 3-methyl-4-oxo-2-pentenoate 376:  
 
Procedure A: 
 According to general procedure 8 using 2,3-butanediol 350 (200 mg, 2.21 
mmol, ƿ = 1.002 gmL-1, 200 µL, 1 equiv.), manganese dioxide (1.92 g, 22.1 
mmol, 10 equiv.) and ethyl (triphenylphosphoranylidene)acetate 38 (1.92 g, 
5.52 mmol, 2.5 equiv.) were combined affording the desired product as yellow 
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oil (100 mg, 0.70 mmol, 32%). 376: Rf = 0.56 (7:3 petroleum ether (b.p. 40-60 
°C)/ethyl acetate, det: KMnO4).  
Procedure B:  
According to general procedure 8 using 2,3-butanediol 350 (50 mg, 0.55 mmol, 
ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), manganese dioxide (478 mg, 5.5 mmol, 10 
equiv.), ethyl 2-(dimethoxyphosphoryl)acetate 381 (269 mg, 1.375 mmol, ƿ = 
1.186 gmL-1, 220 µL, 2.5 equiv.) and 7-methyl-1,5,7-triazabicyclo[4.4.0]-dec-5-
ene [MTBD] 89 (219 mg, 1.43 mmol, ƿ = 1.067 gmL-1, 70 µL, 2.6 equiv.) were 
combined affording the same product  as yellow oil (60 mg, 0.38 mmol, 69%). 
376:(223); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.31-1.36 (m, 3H, H8), 2.22 (d, J = 
1.3 Hz, 3H, H4), 2.40 (s, 3H, H1), 4.24 (q, J = 7.2 Hz, 2H, H7), 6.59 (q, J = 1.4 Hz, 
1H, H5); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 13.0 (C4), 14.2 (C8), 26.8 (C1), 
60.8 (C7), 126.6 (C5), 150.4 (C3), 166.2 (C6), 200.0 (C2); IR (neat): ѵmax (cm-1) = 
1725, 1690, 1640; MS (ESI), 156 (MH+), HRMS (ESI, m/z%) calcd. for C8H13O3 
[(M+H)+]: 156.0864, found 156.0820,  ̶ 1.5 ppm error. 
Attempted preparation of ethyl 2,3-dimethyl-4-oxopent-2-enoate (391) or 
1,6-dimethyl-3,4-dimethyl-1,6-dicarboethoxy-3,4-butadiene (392):  
 
According to general procedure 8 using 2,3-butanediol 350 (500 mg, 5.55 
mmol, ƿ = 1.002 gmL-1, 490 µL, 1 equiv.), manganese dioxide (4.82 g, 55.5 
mmol, 10 equiv.) and (carbethoxyethylidene)triphenylphosphorane 35 (5 g, 
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13.87 mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded the 
crude as yellow oil. No characterisation of 391 or 392 was attempted.  
Preparation (E)-tert-butyl 3-methyl-4-oxopent-2-enoate 393:  
 
According to general procedure 8 using 2,3-butanediol 350 (100 mg, 1.10 
mmol, ƿ = 1.002 gmL-1, 100 µL, 1 equiv.), manganese dioxide (956 mg, 11.0 
mmol, 10 equiv.) and (tert-butoxycarbonylmethylene)triphenylphosphorane 
304 (1.03 g, 2.75 mmol, 2.5 equiv.) were combined to afford the product as 
colorless oil (23 mg, 0.124 mmol, 12%). 393:(224) Rf = 0.57 (7:3 petroleum ether 
(b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ 
= 1.52 (s, 9H, H8), 2.17 (d, J = 1.5 Hz, 3H, H4), 2.38 (s, 3H, H1), 6.52 (d, J = 1.5 Hz, 
1H, H5); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 12.8 (C4), 28.2 (C8), 81.7 (C7), 
128.6 (C5), 148.9 (C3), 165.6 (C6), 200.3 (C2); IR (film): ѵ max (cm−1) = 2980, 
1716, 1684, 1637, 1366, 1249, 1213, 1152, 1105, 1027, 877, 858, 703; MS (ESI), 
207 (MNa+), HRMS (ESI, m/z%) calcd. for C10H16NaO3 [(M+Na)+]:(209) 207.2240, 
found 207.0990.  
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Attempted preparation of 3-methyl-4-phenyl-3-buten-2-one (395) or 1,4-
diphenyl-2,3-dimethyl-1,3-butadiene (396):  
 
According to general procedure 8 using 2,3-butanediol 350 (500 mg, 5.55 
mmol, ƿ = 1.002 gmL-1, 490 µL, 1 equiv.), manganese dioxide (4.82 g, 55.5 
mmol, 10 equiv.), benzyltriphenylphosphonium bromide 316 (5.95 g, 13.75 
mmol, 2.5 equiv.) and 7-methyl-1,5,7-triaza-bicyclo[4.4.0]-dec-5-ene [MTBD] 
89 (2.19 g, 14.3 mmol, ƿ = 1.067 gmL-1, 2.0 mL, 2.6 equiv.) were combined.  
Concentration afforded the crude as yellow oil. No characterisation of 395 or 
396 was attempted. 
Attempted preparation of 3,4-diphenyl-hexadien-2,4-dinitril 401:  
 
According to general procedure 8 using hydrobenzoin 368 (100 mg, 0.47 
mmol, 1 equiv.), manganese dioxide (408 mg, 4.7 mmol, 10 equiv.) and 
(triphenylphosphoranylidene)acetonitrile 265 (354 mg, 1.175 mmol, 2.5 equiv.) 
were combined, and concentrated in vacuo afforded the crude 401 as yellow 
oil, which used without any purification. No characterisation of 401 was 
attempted. 
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Preparation of (E)-ethyl cinnamate 397:  
 
According to general procedure 8 using hydrobenzoin 368 (200 mg, 0.95 
mmol, 1 equiv.), manganese dioxide (825 mg, 9.5 mmol, 10 equiv.) and ethyl 
(triphenylphosphoranylidene)acetate 38 (827 mg, 2.38 mmol, 2.5 equiv.) were 
combined affording the product as yellow oil (100 mg, 0.56 mmol, 30.6%). 397: 
(225) Rf = 0.63 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 
1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.34 (t, J = 7.2 Hz, 3H, H1), 4.27 (q, J = 7.2 
Hz, 2H, H2), 6.44 (d, J = 16 Hz, 1H, H4), 7.38-7.40 (m, 3H, H8, H9, H10), 7.53 (dd, J 
= 6.7, 2.3 Hz, 2H, H7, H11), 7.69 (d, J = 16 Hz, 1H, H5); 13C-NMR (100 MHz, CDCl3, 
25 °C): δ = 14.4 (C1), 60.5 (C2), 118.3 (C4), 128.1 (C8, C10), 128.9 (C7, C11), 
130.3 (C10), 134.5 (C6), 144.6 (C5), 167.1 (C3); IR (neat): ѵmax ( cm-1) = 2998, 
2942, 1713, 1638, 1311, 1177; MS (ESI), 177 (MH+), HRMS (ESI, m/z%): calcd. 
for C11H13O2 [(M+H)+]: 177.0915, found 177.0903, 4.5 ppm.  
Preparation of (E)-ethyl 2-methyl-3-phenylacrylate 403: 
 
According to general procedure 8 using hydrobenzoin 368 (100 mg, 0.47 
mmol, 1 equiv.), manganese dioxide (408 mg, 4.7 mmol, 10 equiv.) and 
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(carbethoxyethylidene)triphenylphosphorane 35 (425 g, 1.175 mmol, 2.5 
equiv.) were combined to give the product as yellow oil (107 mg, 0.28 mmol, 
59%). 403:(226) Rf = 0.70 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.32-1.37 (m, 3H, H1), 2.72 (d, J = 
1.5 Hz, 3H, H4), 4.27 (q, J = 7.2 Hz, 2H, H2), 7.30-7.33 (m, 1H, H10), 7.38-7.40 (m, 
4H, H9, H11, H8, H12), 7.69 (q, J = 1.3 Hz, 1H, H6); 13C-NMR (100 MHz, CDCl3, 25 
°C): δ = 14.1 (C4), 14.4 (C1), 60.9 (C2), 128.3 (C4), 128.1 (C10), 128.4 (C9, C11), 
129.7 (C8, C12), 136.0 (C7), 138.7 (C6), 168.7 (C3); IR (neat): ѵmax ( cm-1) =  
2980, 1708, 1446, 1253, 1112, MS (ESI), 191 (MH+), HRMS (ESI, m/z%) calcd. for 
C12H15O2 [(M+H)+]: 191.1072, found 191.1055, 5.01 ppm error. 
Preparation of (E)-tert-Butyl cinnamate 404: 
 
According to general procedure 8 using hydrobenzoin 368 (100 mg, 0.47 
mmol, 1 equiv.), manganese dioxide (408 mg, 4.7 mmol, 10 equiv.) and (tert-
butoxycarbonylmethylene)triphenylphosphorane 304 (442 g, 1.175 mmol, 2.5 
equiv.) were combined to give the product  as yellow oil (144 mg, 0.35 mmol, 
75%). 404:(227) Rf = 0.81 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.53 (s, 9H, H1), 6.37 (d, J = 16 
Hz, 1H, H4), 7.34 (d, J = 2.5 Hz, 2H, H8, H11), 7.36 (d, J = 1.1 Hz, 1H, H9), 7.48 (dd, 
J = 2.3, 0.6 Hz, 1H, H7), 7.49-7.51 (m, 1H H11), 7.59 (d, J = 16 Hz, 1H, H5); 13C-
NMR (100 MHz, CDCl3, 25 °C): δ = 28.2 (C1), 80.5 (C2), 120.2 (C4), 127.0 (C8, 
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C10), 128.8 (C7, C11), 130.0 (C9), 134.6 (C6), 143.6 (C5), 166.3 (C3); IR (neat): 
ѵmax ( cm-1) = 3060, 2978, 2931, 1704, 1637, 1577, 1496, 1328, 1315, 1145, 978, 
767, 685; MA (ESI), 204 (MH+), HRMS (ESI, m/z%) calcd. for C13H16O2 
[(M+H)+]:(227)  204.1150, found 204.1151. 
Attempted preparation of 1,2,3,4-tetraphenyl-1,3-butadiene 402: 
 
According to general procedure 8 using hydrobenzoin 368 (100 mg, 0.47 
mmol, 1 equiv.), manganese dioxide (408 mg, 4.7 mmol, 10 equiv.) and 
benzyltriphenylphosphonium bromide 316 (509 mg, 1.175 mmol, 2.5 equiv.) 
and 7-methyl-1,5,7-triaza-bicyclo[4.4.0]dec-5-ene [MTBD] 89 (187 mg, 1.22 
mmol, ƿ = 1.067 gmL-1, 170 µL, 2.6 equiv.) were combined, concentrated in 
vacuo affording the crude 402 as yellow oil, which used without any 
purification. No characterisation of 402 was attempted. 
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Attempted preparation of 3,4-ditolylhexa-2,4-diene-1,6-dinitrile 405:  
 
According to general procedure 8 using 1,2-di-(4-methylphenyl)-1,2-ethanediol 
372 (50 mg, 0.20 mmol, 1 equiv.), manganese dioxide (500 mg, 2 mmol, 10 
equiv.) and (triphenylphosphoranylidene)acetonitrile 265 (150 mg, 0.5 mmol, 
2.5 equiv.) were combined. Concentration in vacuo afforded the crude 405 as 
yellow oil. No characterisation of 405 was attempted. 
Preparation of ethyl (E)-3-(4-methylphenyl)-2-propenoate 408:  
 
Procedure A: 
 According to general procedure 8 using 1,2-di-(4-methylphenyl)-1,2-
ethanediol 372 (50 mg, 0.20 mmol, 1 equiv.), manganese dioxide (500 mg, 2 
mmol, 10 equiv.) and ethyl (triphenylphosphoranylidene)acetate 38 (174 mg, 
0.5 mmol, 2.5 equiv.) were combined affording the product as yellow oil (39 
mg, 0.20 mmol, 100%). 408: Rf = 0.57 (1:1 petroleum ether (b.p. 40-60 
°C)/ethyl acetate, det: KMnO4). 
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Procedure B: 
According to general procedure 8 using 1,2-di-(4-methylphenyl)-1,2-ethanediol 
372 (50 mg, 0.20 mmol, 1 equiv.), manganese dioxide (500 mg, 2 mmol, 10 
equiv.), ethyl 2-(dimethoxyphosphoryl)acetate 381 (98 mg, 0.5 mmol, ƿ = 1.186 
gmL-1, 80 µL, 2.5 equiv.) and 7-methyl-1,5,7-triazabicyclo[4.4.0]-dec-5-ene 
[MTBD] 89 (79.6 mg, 0.52 mmol, ƿ = 1.067 gmL-1, 0.07 mL, 2.6 equiv.) were 
combined affording the same product  as yellow oil (17 mg, 0.09 mmol, 43%). 
408:(226) Rf = 0.6 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: 
KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.31-1.36 (m, 3H, H1), 2.36 (s, H, 
H10), 4.22-4.30 (m, 2H, H2), 6.39 (d, J = 16 Hz, 1H, H4), 7.19 (d, J = 8.1 Hz, 2H, H8, 
H11), 7.41-7.43 (m, 2H, H7, H12), 7.64-7.69 (m, 1H, H5); 13C-NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.4 (C1), 21.5 (C10), 60.5 (C2), 117.2 (C4), 128.1 (C5, C12), 
128.6 (C8, C11), 131.2 (C9), 140.7 (C6),144.6 (C5), 167.3 (C3); IR (neat): ѵmax 
(cm-1) = 2980 (m), 1708 (s), 1634 (m), 1309 (m), 1163 (s), and 811 (m); MS (ESI), 
191 (MH+), HRMS (ESI, m/z%) calcd. for C12H15O2 [(M+H)+]:(226) 191.1067, found 
191.1063. 
Attempted preparation of 3,4-ditolylhexa-2,4-diene-2,5-dimethyl-1,6-diethyl 
ester 406: 
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According to general procedure 8 using 1,2-di-(4-methylphenyl)-1,2-ethanediol 
372 (50 mg, 0.20 mmol, 1 equiv.), manganese dioxide (500 mg, 2 mmol, 10 
equiv.) and (carbethoxyethylidene)triphenylphosphorane 35 (181 mg, 0.5 
mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded the crude 
406 as yellow oil. No characterisation of 406 was attempted. 
Attempted preparation of 3,4-ditolylhexa-2,4-diene-1,6-ditert-butyl ester 
407:  
 
According to general procedure 8 using 1,2-di-(4-methylphenyl)-1,2-ethanediol 
372 (50 mg, 0.20 mmol, 1 equiv.), manganese dioxide (500 mg, 2 mmol, 10 
equiv.) and (tert-butoxycarbonylmethylene)triphenylphosphorane 304 (188 
mg, 0.5 mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded the 
crude 407 as yellow gum. No characterisation of 407 was attempted. 
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Attempted preparation of 3,4-di-[2]furyl-hexa-2,4-diene-1,6-dinitril 409:  
 
According to general procedure 8 using 1, 2-di-furan-2-yl-ethane-1, 2-diol 374 
(50 mg, 0.25 mmol, 1 equiv.), manganese dioxide (217 mg, 2.5 mmol, 10 
equiv.) and (triphenylphosphoranylidene)acetonitrile 265 (188 mg, 0.625 
mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded the crude 
409 as yellow. No characterisation of 409 was attempted. 
Preparation of (E)-ethyl 3-(furan-2-yl)acrylate 410: 
 
According to general procedure 8 using 1, 2-di-furan-2-yl-ethane-1,2-diol 374 
(50 mg, 0.25 mmol, 1 equiv.), manganese dioxide (217 mg, 2.5 mmol, 10 
equiv.), ethyl (triphenylphosphoranylidene)acetate 38 (217 mg, 0.625 mmol, 
2.5 equiv.) were combined affording the same product as yellow oil (41 mg, 
0.25 mmol, 97%). 410(226) Rf = 0.6 (1:1 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.30-1.35 (m, 3H, 
H1), 4.21-4.28 (m, 2H, H2), 6.32 (dd,  J = 15.7, 0.5 Hz, 1H, H8), 6.47 (dd, J =3.5, 
1.8 Hz, 1H, H4), 6.61 (d, J = 3.2 Hz, 1H, H5), 7.43 (d, J = 15.6 Hz, 1H, H7), 7.48 
(dd, J = 1.2, 0.7 Hz, 1H, H9); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 14.3 (C1), 
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60.5 (C2), 112.3 (C4), 114.7 (C5), 115.9 (C8), 131.0 (C7), 144.7 (C9), 150.9 (C6), 
167.1 (C3); IR (neat): ѵmax (cm-1) = 2981, 1708, 1639, 1209, 1164; MS (ESI). 167 
(MH+), HRMS (ESI, m/z%) calcd. for C9H11O3 [(M+H)+]: 167.0708, found 
167.0711,  ̶ 4.04 ppm error. 
Preparation of ethyl 3-(2-furanyl)-2-methylpropenoate 411: 
 
According to general procedure 8 using 1, 2-di-furan-2-yl-ethane-1, 2-diol 374 
(50 mg, 0.25 mmol, 1 equiv.), manganese dioxide (217 mg, 2.5 mmol, 10 
equiv.) and (carbethoxyethylidene)triphenylphosphorane 35 (226 mg, 0.625 
mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded the crude 
411 as yellow oil (25 mg, 0.13 mmol, 54%). 411:(228) Rf = 0.62 (1:1 petroleum 
ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 
°C): δ = 1.31-1.36 (m, 3H, H1), 2.22 (s, 3H, H5), 4.22-4.29 (m, 2H, H2), 6.49-6.51 
(m, 1H, H8), 6.61 (d, J =3.4 Hz, 1H, H10), 7.45 (d, J = 0.9 Hz, 1H, H6), 7.53 (d, J = 
1.5 Hz, 1H, H9); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 14.1 (C5), 14.3 (C1), 60.9 
(C2), 112.0 (C8), 114.7 (C10), 125.1 (C4), 125.6 (C6), 144.0 (C9), 152.0 (C7), 
168.6 (C3); IR (film): ѵmax (cm-1) = 2979, 1705, 1634, 1475, 1372, 1269, 1209, 
1176, 1114, 1021, 740; MS (ESI), 181 (MH+), HRMS (ESI, m/z%) calcd. for 
C10H13O3 [(M+H)+]: 181.0864, found 181.0865,   ̶3.09 ppm error. 
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Preparation of (E)-tert-butyl 3-(furan-2-yl)acrylate 412: 
 
According to general procedure 8 using 1, 2-di-furan-2-yl-ethane-1,2-diol 374 
(50 mg, 0.25 mmol, 1 equiv.), manganese dioxide (217 mg, 2.5 mmol, 10 
equiv.) and (tert-butoxycarbonylmethylene)triphenylphosphorane 304 (235 
mg, 0.625 mmol, 2.5 equiv.) were combined. Concentration in vacuo afforded 
the crude 412 as yellow oil (39 mg, 0.2 mmol, 78%). 412:(227) Rf = 0.65 (1:1 
petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, 
CDCl3, 25 °C): δ = 1.52 (s, 9H, H1), 6.22-6.28 (m, 1H, H8), 6.45 (dd, J =3.4, 1.9 Hz, 
1H, H4), 6.57 (d, J = 3.4 Hz, 1H, H6), 7.33 (d, J = 15.6 Hz, 1H, H7), 7.45-7.47 (m, 
1H, H9); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 28.2 (C1), 80.4 (C2), 112.2 (C4), 
114.1 (C5), 118.0 (C8), 130.1 (C7), 144.4 (C9), 151.1 (C6), 166.4 (C3); IR (neat): 
ѵmax (cm-1) = 1705, 1639, 1153; MS (ESI), 217 (MNa+), HRMS (ESI, m/z%) calcd. 
for C11H14NaO3 [(M+Na)+]: 217.0841, found 217.0875.  
Attempted preparation of 2-phenyl-1,4-dicyanobuta-1,3-diene 413:   
 
According to general procedure 8 using 1-phenyl-1,2-ethanediol 369 (100 mg, 
0.72 mmol, 1 equiv.), manganese dioxide (625 mg, 7.2 mmol, 10 equiv.) and 
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(triphenylphosphoranylidene)acetonitrile 265 (542 mg, 1.8 mmol, 2.5 equiv.) 
were combined. Concentration in vacuo afforded the crude 413 as yellow. No 
characterisation of 413 was attempted. 
Attempted preparation of di-tert-butyl -3-phenyl-2,4-hexadienedioate 414: 
 
According to general procedure 8 using 1-phenyl-1,2-ethanediol 369 (100 mg, 
0.72 mmol, 1 equiv.), manganese dioxide (625 mg, 7.2 mmol, 10 equiv.) and 
(tert-butoxycarbonylmethylene)triphenylphosphorane 304 (677 mg, 1.8 mmol, 
2.5 equiv.) were combined. Concentration in vacuo afforded the crude 413 as 
yellow oil which was used without further purification. No characterisation of 
413 was attempted.  
Preparation of (E,Z)-deca-2,8-dienedinitrile 419: 
 
According to general procedure 8 using 1,2-cyclohexanediol 370 (50 mg, 0.43 
mmol, 1 equiv.), manganese dioxide (373 mg, 4.3 mmol, 10 equiv.) and 
(triphenylphosphoranylidene)acetonitrile 265 (323 mg, 1.075 mmol, 2.5 equiv.) 
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were combined, and concentrated in vacuo affording the title compound 419 
as yellow oil (250 mg, 1.5 mmol, 36.7%). 419: Rf = 0.64 (4:6 petroleum ether 
(b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ 
= 1.49 (s, 4H, H4, H7), 2.25 (d, J = 5.1 Hz, 4H, H5, H6), 5.35 (d, J = 16.4 Hz, 2H, H2, 
H10), 6.7 (dt, J = 16.3, 6.9 Hz, 2H, H3, H9); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 
27.0 (C4, C7), 33.0 (C5, C6), 100.4 (C2, C9), 117.3 (C1, C10), 155.0 (C3, C8); IR 
(neat): ѵmax ( cm-1) = 3058, 2934, 2925, 2861, 2220, 1630, 1229, 1073, 973, 916, 
868, 778, 746; MS (ESI), 161 (MH+), HRMS (ESI, m/z%) calcd. for C10H13N2 
[(M+H)+]: 161.1078, found 161.1.072, 0.9 ppm error. 
Attempted preparation of deca-2,8-dicarbonsaeurediethylester 415: 
 
According to general procedure 8 using 1,2-cyclohexanediol 370 (50 mg, 0.43 
mmol, 1 equiv.), manganese dioxide (373 mg, 4.3 mmol, 10 equiv.) and ethyl 
(triphenylphosphoranylidene)acetate 38 (374 mg, 1.075 mmol, 2.5 equiv.) 
were combined. The product proved to be inexistent using silica gel and NMR 
analysis. Thus, the mixture was dissolved in toluene (15 mL), 4-nitrobenzoic 
acid (17 mg, 0.107 mmol, 0.25 equiv.) added and the mixture was stirred and 
heated at reflux for 15 hours, concentrated in vacuo affording the crude 415 as 
a yellow oil. No characterisation of 415 was attempted.  
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Attempted preparation of deca-2,9-dimethyl-2,8-dicarbonsaeure-diethylester 
416: 
 
According to general procedure 8 using 1, 2-cyclohexanediol 370 (50 mg, 0.43 
mmol, 1 equiv.), manganese dioxide (373 mg, 4.3 mmol, 10 equiv.) and 
(carbethoxyethylidene)triphenylphosphorane 35 (389 mg, 1.075 mmol, 2.5 
equiv.) were combined. The product proved to be inexistent using silica gel and 
NMR analysis. Thus, the mixture was dissolved in toluene (10 mL), 4-
nitrobenzoic acid (17 mg, 0.107 mmol, 0.25 equiv.) added and the mixture was 
stirred and heated at reflux for 15 hours, concentrated in vacuo affording the 
crude 416 as a yellow oil, which was used without further purification. No 
characterisation of 416 was attempted.  
Attempted preparation of di-tert-butyl deca-2,8-dienedioate 417: 
 
According to general procedure 8 using 1,2-cyclohexanediol 370 (50 mg, 0.43 
mmol, 1 equiv.), manganese dioxide (373 mg, 4.3 mmol, 10 equiv.) and (tert-
butoxycarbonylmethylene)triphenylphosphorane 304 (404 mg, 1.075 mmol, 
2.5 equiv.) were combined, concentrated in vacuo affording the crude 417 as a 
Chapter 6                                                                                              Experimental 
252 | P a g e  
 
yellow oil, which was used without further purification. No characterisation of 
417 was attempted.  
Attempted preparation of 1,8-diphenyl-octa-1,7-diene 418: 
 
According to general procedure 8 using 1,2-cyclohexanediol 374 (50 mg, 0.43 
mmol, 1 equiv.), manganese dioxide (373 mg, 4.3 mmol, 10 equiv.) 
benzyltriphenylphosphonium bromide 316 (465 mg, 1.075 mmol, 2.5 equiv.) 
and 7-methyl-1,5,7-triaza-bicyclo[4.4.0]dec-5-ene [MTBD] 89 (171 mg, 1.11 
mmol, ƿ = 1.067 gmL-1, 160 µL, 2.6 equiv.) were combined, concentrated in 
vacuo affording the crude 418 as a yellow oil, which was used without further 
purification. No characterisation of 418 was attempted. 
Preparation of allyl 3-(1-cyclohexenyl)acrylate 362: 
 
According to general procedure 8 using (1-cyclohexenyl)methanol 357 (455 
mg, 4 mmol, 1 equiv.), manganese dioxide (1.7 g, 20 mmol, 5 equiv.), and allyl 
(triphenylphosphoranylidene) acetate 248 (1.8 g, 5 mmol, 1.25 equiv.) were 
combined, concentrated in vacuo affording the crude 362 as a yellow oil (100 
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mg, 0.52 mmol, 13%). 362: Rf = 0.38 (7:3 petroleum ether (b.p. 40-60 °C)/ethyl 
acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.62 (m, 2H, H10), 
1.69 (m, 2H, H9), 2.14 (m, 2H, H11), 2.21 (d, J = 2.7 Hz, 2H, H12), 4.66 (d, J = 5.5 
Hz, 2H, H3), 5.24 (d, J = 10.5 Hz, 1H, H1a), 5.34 (d, J = 17.4 Hz, 1H, H1b), 5.77-5.81 
(m, 1H, H5), 5.96 (d, J = 16.8 Hz, 1H, H2), 6.18 (s, 1H, H12), 7.31 (d, J = 15.7 Hz, 
1H, H6); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 22.0 (d, J = 3.7 Hz, C9, C10), 24.1, 
26.5 (C8, C11), 64.8 (C3), 114.2 (C5), 117.9 (C1), 132.6 (C12), 135.0 (C7), 139.0 
(C2), 148.5 (C6), 167.2 (C4); IR (neat): ѵmax (cm-1) = 3031, 2944, 1702, 1666, 
1606, 1581, 1475, 1425, 128, 1185, 1090, 971, 885, 817. 679; MS (ESI), 193 
(MH+), HRMS (ESI, m/z%) calcd. for C12H17O2 [(M+H)+]: 193.1228, found 
193.1242, 2.9 ppm. 
Preparation of 3'-butyen-1'-yl-3-(1-cyclohexenyl)acrylate 363: 
 
According to general procedure 8 using (1-cyclohexenyl)methanol 357 (500 
mg, 4.5 mmol, 1 equiv.), manganese dioxide (1.95 g, 22.5 mmol, 5 equiv.), and 
3'-butyen-1'-yl 2-(triphenylphosphoranylidene)acetate  254 (2.11 g, 5.62 mmol, 
1.25 equiv.) were combined, concentrated in vacuo affording the crude 363 as 
a yellow oil (100 mg, 0.04 mmol, 11%). 363: Rf = 0.50 (7:3 petroleum ether 
(b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ 
= 1.64 (d, J = 19.8 Hz, 4H, H10, H11), 2.16 (d, J = 17.7 Hz, 4H, H9, H12), 2.43 (d, J = 
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6.8 Hz, 2H, H3), 4.16-4.23 (m, 2H, H4), 5.06-5.15 (m, 1H, 2H, H1), 5.72-5.90 (m, 
2H, H2, H7), 6.16 (s, 1H, H13), 7.28 (d, J = 15.8 Hz, 1H, H6); 13C-NMR (100 MHz, 
CDCl3, 25 °C): δ = 22.0, 22.0, 24.1, 26.4 (C9, C10, C11, C12), 33.1 (C3), 63.2 (C4), 
114.3 (C1), 117.1 (C6), 134.1 (C13), 134.9 (C2), 138.8 (C8), 148.2 (C7), 167.0 
(C5); IR (neat): ѵmax (cm-1) = 2931, 2860, 1702, 1627, 1449, 1618, 1434, 1288, 
1162, 1064, 981, 871, 831, 798, 686; MS (ESI), 207 (MH+), HRMS (ESI, m/z%) 
calcd. for C13H19O2 [(M+H)+]: 207.1385, found 207.1391,  ̶ 5.12 ppm error. 
Preparation of 5-phenyl-penta-2,4-dienoic acid allyl ester 353: 
 
According to general procedure 8 using cinnamyl alcohol 346 (1 g, 7.45 mmol, 
ƿ = 1.044 gmL-1, 950 µL, 1 equiv.), manganese dioxide (3.2 g, 3.72 mmol, 5 
equiv.), and allyl (triphenylphosphoranylidene) acetate 248 (3.35 g, 9.31 mmol, 
1.25 equiv.) were combined, concentrated in vacuo affording the crude 353 as 
a yellow oil (510 mg, 2.4 mmol, 32%). 353: Rf = 0.55 (8:2 hexane/ethyl acetate, 
det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 4.64-4.67 (m, 2H,H3), 5.24 
(dq, J = 10.5, 1.3 Hz, 1H, H1), 5.34 (dq, J = 17.2, 1.6 Hz, 1H, H1), 5.89-5.97 (m, 
1H, H2), 5.99-6.02 (m, 1H, H5), 6.83 (d, J = 2.8 Hz, 1H, H7), 6.84 (1H, H8), 7.26-
7.35 (m, 3H, H11, H12), 7.40-7.44 (m, 2H. H10), 7.48 (dd, J = 6.8, 3.6 Hz, 1H, H6); 
13C-NMR (100 MHz, CDCl3, 25 °C): δ = 65.1 (C3), 118.1 (C1), 120.9 (C2, C5), 
126.2 (C7), 127.3 (C10), 128.9 (C11), 129.2 (C12), 132.5 (C9), 140.7 (C8), 145.1 
(C6), 166.6 (C4); IR (neat): ѵmax (cm-1) = 3027, 2946, 1703, 1647, 1624, 1495, 
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1449, 1362, 1170, 988, 932, 837, 750, 689; MS (ESI), 215 (MH+), HRMS (ESI, 
m/z%) calcd. for C14H15O2 [(M+H)+]: 215.1072, found 215.1066, 1.26 ppm error. 
Preparation of 5-phenyl-hexa-2,4-dienoic acid allyl ester 364: 
 
According to general procedure 8 using cinnamyl alcohol 346 (1 g, 7.45 mmol, 
ƿ = 1.044 gmL-1, 950 µL, 1 equiv.), manganese dioxide (3.2 g, 3.72 mmol, 5 
equiv.), and 3'-butyen-1'-yl2-(triphenylphosphoranylidene)acetate 254 (3.5 g, 
9.31 mmol, 1.25 equiv.) were combined, concentrated in vacuo affording the 
crude 364 as a yellow oil (534 mg, 2.3 mmol, 31%). 364: Rf = 0.57 (8:2 
hexane/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 2.39-
2.48 (m, 2H, H3), 4.21 (t, J = 6.8 Hz, 2H, H4), 5.06-5.18 (m, 2H, H1), 5.73-5.89 (m, 
1H, H2), 5.95-6.00 (m, 1H, H6), 6.85 (d, J = 4.1 Hz, 1H, H8), 6.86 (1H, H9), 7.28-
7.36 (m, 3H, H11, H12), 7.41-7.45 (m, 2H. H10), 7.47-7.52 (m, 1H, H7); 13C-NMR 
(100 MHz, CDCl3, 25 °C): δ = 33.2 (C3), 63.5 (C4), 117.3 (C1), 121.2 (C6), 126.2 
(C11), 127.3 (C8), 128.9 (C13), 129.1 (C12), 134.2 (C2), 136.0 (C9), 140.5 (C10), 
144.8 (C7), 167.0 (C5); IR (neat): ѵmax (cm-1) = 2988, 2956, 2901, 1727, 1641, 
1495, 1393, 1249, 117, 1066, 970, 866, 791, 698; MS (ESI), 229 (MH+), HRMS 
(ESI, m/z%) calcd. for C15H17O2 [(M+H)+]: 229.1228, found 229.1224,   ̶0.97 ppm 
error. 
 
 
Chapter 6                                                                                              Experimental 
256 | P a g e  
 
Preparation of methyl 5-phenyl-2,4-pentadienoate 365:  
 
According to general procedure 8 using cinnamyl alcohol 346 (49.6 mg, 0.37 
mmol, ƿ = 1.044 gmL-1, 47 µL , 1 equiv.), manganese dioxide (160 mg, 1.9 
mmol, 5 equiv.), bis(2,2,2-trifluoroethyl)(methoxycarbonylmethyl)phosphonate 
361 (150 mg, 0.46 mmol, ƿ = 1.504 gmL-1, 100 µL, 1.25 equiv.) and 7-methyl-
1,5,7-triaza-bicyclo[4.4.0]-dec-5-ene [MTBD] 89 (71.4 mg, 0.46 mmol, ƿ = 1.067 
gmL-1, 70 µL, 1.26 equiv.) were combined, concentrated in vacuo affording the 
crude 365 as a yellow oil, which was used without further purification. No 
characterisation of 365 was attempted. 
7.4.3 Wittig reactions with and without 4-nitrobenzoic acid (Lewis acid) 
General procedure 9:  
A solution of diketone (1.0 equiv.), ylide (1-3 equiv.) and 4-nitrobenzoic acid 
(0.2-0.4 equiv.) [required] in different solvents like dichloromethane, 
anhydrous benzene and toluene (20 mL) was heated at reflux for 15 hours, the 
mixture was cooled to room temperature and then concentrated in vacuo. The 
crude residue was purified by flash chromatography on silica using different 
eluents to afford the products. Conversion was determined by analysis of the 
1H-NMR spectrum. 
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Attempted preparation of 3,4-dimethyl-hexadien-2,4-dinitril 390:  
 
According to general procedure 9 using 2,3-butanedione 375 (50 mg, 0.58 
mmol, ƿ = 0.981 gmL-1, 50 µL, 1 equiv.), 
(triphenylphosphoranylidene)acetonitrile 265 (524 mg, 1.74 mmol, 3 equiv.) 
and 4-nitrobenzoic acid (0.2 or 0.4 equiv.) were combined. Concentration in 
vacuo afforded the crude 390 as faint yellow oil, which was used without 
further purification.  No characterisation of 390 in both reactions was 
attempted. 
Run 4-nitrobenzoic acid 
 (Catalyst) 
Solvent/ conditions 
/15 h 
Yield
% 
equiv. mmol mg  
1 - - - Anhydrous benzene/rt NR 
2 0.2 0.116 19 Toluene/rt Dec. 
3 0.4 0.232 39 Toluene/reflux NR 
 
Preparation of (E,Z)-ethyl 3-methyl-4-oxo-2-pentenoate 376:  
 
Procedure A:  
According to general procedure 9 using 2,3-butanedione 375 (100 mg, 1.16 
mmol, ƿ = 0.981 gmL-1, 100 µL, 1 equiv.), ethyl 
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(triphenylphosphoranylidene)acetate 38 (401 mg, 1.375 mmol, 1 equiv.) in 
dichloromethane were combined, concentrated in vacuo affording the crude 
367 as faint yellow oil (97 mg, 0.57 mmol, 100%). 376: Rf = 0.59 (2.5:7.5 diethyl 
ether/hexane, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.33 (t, J = 
7.2 Hz, 3H, H8), 2.22 (d, J = 1.5 Hz, 3H, H4), 2.40 (s, 3H, H1), 4.25 (q, J = 7.2 Hz, 
2H, H7), 5.32 (1H, H5, (Z)-isomer), 6.59 (q, J = 1.4 Hz, 1H, H5, (E)-isomer); 13C-
NMR (100 MHz, CDCl3, 25 °C): δ = 13.0 (C4), 14.2 (C8), 26.8 (C1), 60.8 (C7), 
126.6 (C5), 150.4 (C3), 166.2 (C6), 200.0 (C2); IR (neat): ѵmax (cm-1) = 1725, 
1690, 1640; MS (ESI),156 (MH+), HRMS (ESI, m/z%) calcd. for C8H13O3 [(M+H)+]: 
156.0864, found 156.0820, 1.5 ppm error. 
Procedure B:  
According to general procedure 9 using 2,3-butanedione 375 (50 mg, 0.58 
mmol, ƿ = 0.981 gmL-1, 50 µL, 1 equiv.), ethyl 
(triphenylphosphoranylidene)acetate 377 (341 mg, 1.74 mmol, 3 equiv.) and 7-
methyl-1,5,7-triaza-bicyclo[4.4.0]dec-5-ene [MTBD] 89  (275 mg, 1.79 mmol, ƿ 
= 1.067 gmL-1, 250 µL, 3.1 equiv.) in toluene (20 mL) were combined, 
evaporated the solvent under higher vacuum affording the crude 376, which 
was used without further purification. No characterisation of 376 was 
attempted (no reaction).  
Procedure C:  
According to general procedure 9 using 2,3-butanedione 375 (100 mg, 1.16 
mmol, ƿ = 0.981 gmL-1, 100 µL, 1 equiv.), ethyl 
(triphenylphosphoranylidene)acetate 38 (900 mg, 2.6 mmol, 2.2 equiv.) in 
anhydrous benzene (10 mL) were combined, evaporated the solvent under 
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higher vacuum affording the crude 376, a 95:5 mixture of (E)/(Z) isomers, as a 
colourless oil (170 mg, 1.08 mmol, 94%). 376: Rf = 0.61 [E], 0.44 [Z] (5:5 diethyl 
ether/hexane, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): (E) isomers δ = 
1.33 (q, J = 7.2 Hz, 3H, H8), 2.21 (d, J = 0.7 Hz, 3H, H4), 2.40 (s, 3H, H1), 4.25 (q, J 
= 7.1 Hz, 2H, H7), 6.59 (s, 1H, H5);  13C-NMR (100 MHz, CDCl3, 25 °C): δ = 13.0 
(C4), 14.1 (C8), 26.1 (C1), 60.7 (C7), 126.5 (C5), 150.4 (C3), 166.1 (C6), 199.8 
(C2); MS (ESI), 156 (MH+),HRMS (ESI+ m/z%): calcd for C8H13O3 [M+H]+: 
157.0864, found 156.0861, -1.43 ppm error; (Z) isomers δ = 1.25-1.29 (m, 3H, 
H8), 1.99 (d, J = 0.7 Hz, 3H, H4), 2.37 (d, J = 0.5 Hz, 3H, H1), 4.16 (q, J = 7.0 Hz, 
2H, H7), 5.69 (d, J = 0.5 Hz 1H, H5); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 14.1 
(C8), 20.2 (C4), 28.6 (C1), 60.7 (C7), 117.1 (C5), 157.1 (C3), 165.2 (C6), 206.2 
(C2); IR (neat): ѵmax (cm-1) = 1725, 1690, 1640; MS (ESI), 156 (MH+),HRMS (ESI, 
m/z%) calcd. for C8H13O3 [(M+H)+]: 156.0864, found 156.0860,  ̶ 1.44 ppm 
error. 
Preparation of diethyl (E,E) and (E,Z)-3,4-dimethylmuconate (378) and (379):  
 
To a cooled 0 °C solution of sodium hydride (28.8 mg, 1.20 mmol, 1.94 equiv.) 
in anhydrous benzene (3 mL) under nitrogen pressure, followed by adding 
ethyl 2-(dimethoxyphosphoryl)acetate 38 (239 mg, 1.22 mmol, ƿ = 1.186 gmL-1, 
200 µL, 1.97 equiv.). A solution of 376 (97 mg, 0.62 mmol, 1 equiv.) was added 
dropwise to the solution, stirred at room temperature for 15 hours, poured 
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into water (10 mL), extracted with diethyl ether (50 mL) and dried (MgSO4). 
The filtrate was concentrated under higher vacuum affording the crude 378 
and 379, a 95:5 mixture of (E,E)/(E,Z) isomers, as a yellow oil (130 mg, 0.57 
mmol, 92.8%). 378 and 379: Rf = 0.50 [E,E], 0.25 [E,Z] (0.5:9.5 diethyl 
ether/hexane, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): (E,E) isomers δ = 
1.30 (q, J = 7.1 Hz, 3H, H1), 2.32 (s, 3H, H6), 4.19 (q, J = 7.1 Hz, 2H, H2), 6.04 (s, 
2H, H4); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 14.2 (C1), 15.8 (C6), 60.1 (C2), 
118.9 (C4), 155.3 (C5), 166.5 (C3); MS (ESI), 227 (MH+), HRMS (ESI, m/z%) calcd. 
for C12H19O4 [(M+H)+]: 227.1283, found 227.1282, -1.69 ppm error; (E,Z) 
isomers δ = 1.22-1.26 (m, 3H, H1), 1.28 (t, J = 7.5 Hz, 3H, H1/), 1.98 (s, 3H, H6), 
2.32 (d, J = 0.5 Hz, 3H, H6/), 4.10-4.14 (m, 3H, H2), 4.14-4.19 (m, 2H, H2/), 5.56 
(s, 1H, H4), 5.64 (s, 1H, H4/); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 14.1 (C1), 
14.3 (C1/), 17.9 (C6), 24.5 (C6/), 59.8 (C2), 60.1 (C2/), 115.4 (C4), 116.6 (C4/), 
157.6 (C5), 158.3 (C5/), 165.1 (C3), 166.3 (C3/); MS (ESI), 227 (MH+),HRMS (ESI, 
m/z%) calcd. for C12H19O4 [(M+H)+]: 227.1283, found 227.1285,   ̶ 3.34 ppm 
error. 
Preparation of 4-oxo-3,4-phenylbut-2-enoic acid ethyl ester 421:  
 
According to general procedure 9 using benzil 318 (50 mg, 0.23 mmol, 1 
equiv.), ethyl (triphenylphosphoranylidene)acetate 38 (200 mg, 0.575 mmol, 
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2.5 equiv.) in toluene (25 mL) were combined, concentrated in vacuo, purified 
twice by flash chromatography on silica gel using 3:7 ethyl acetate/hexane as 
the eluent affording the crude 421 as faint yellow oil (20 mg, 0.06 mmol, 31%). 
421:(229) Rf = 0.5 (PTLC, 3:7 diethyl ether/hexane, det: KMnO4); 1H-NMR (300 
MHz, CDCl3, 25 °C): δ = 1.10-1.16 (m, 3H, H1), 4.02-4.15 (m, 2H, H2), 6.26 (s, 1H, 
H4), 7.36-7.39 (m, 5H, H7, H8, H9), 7.46-7.48 (m, 2H, H12), 7.55-7.58 (m, 1H, H14), 
7.91-7.95 (m, 2H, H13); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 13.9 (C1), 60.9 
(C2), 124.0 (C4), 128.2 (C7), 128.5 (C8), 128.7 (C9), 128.9 (C12), 130.1 (C13), 
133.7 (C14), 134.3 (C6), 135.7 (C11), 152.2 (C5), 165.4 (C3), 195.7 (C10); IR 
(neat): ѵmax ( cm-1) = 2998, 2943, 1713, 1669, 1448, 1375, 1254, 1203, 1066, 
918, 812, 737, 677; MS (ESI), 281 (MH+), HRMS (ESI, m/z%) calcd. for C18H17O3 
[(M+H)+]: 281.1177, found 281.1178,  ̶ 1.83 ppm error.  
No effect was noticed when 4-nitrobenzoic acid (15 mg, 0.09 mmol, 0.4 equiv.) 
added to the reaction under the same conditions above. 
 Preparation of 4-oxo-3,4-tolylbut-2-enoic acid ethyl ester 382:  
 
Procedure A:  
According to general procedure 9 using 1,2-di(4-methylphenyl)-1,2-
ethanedione 371 (50 mg, 0.2 mmol, 1 equiv.), ethyl 
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(triphenylphosphoranylidene)acetate 38 (174 mg, 0.5 mmol, 2.5 equiv.) and 4-
nitrobenzoic acid (13.3 mg, 0.08 mmol, 0.4 equiv.) in toluene (20 mL) were 
combined, concentrated in vacuo affording the crude 382 as faint yellow oil (22 
mg, 0.07 mmol, 34%). 382: Rf = 0.60 (7:3 petroleum ether (b.p 40-60 °C) /ethyl 
acetate, det: KMnO4). 
Procedure B:  
According to general procedure 9 using 1,2-di(4-methylphenyl)-1,2-
ethanedione 371 (100 mg, 0.42 mmol, 1 equiv.), ethyl 
(triphenylphosphoranylidene)acetate 38 (320 mg, 0.924 mmol, 2.2 equiv.) in 
anhydrous benzene were combined, concentrated in vacuo affording the 382 
product as faint yellow oil (90 mg, 0.29 mmol, 70%). 382: Rf = 0.50 (5:5 diethyl 
ether/hexane, det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25 °C): δ = 1.17 (t, J = 
7.0 Hz, 3H, H1), 2.34 (s, 3H, H10), 2.40 (s, 3H, H16), 4.14 (q, J =6.7 Hz, 2H, H2), 
6.17 (s, 1H, H4), 7.24 (d, J = 7.6 Hz, 2H, H8), 7.30 (d, J = 7.6 Hz, 2H, H14), 7.82 (d, 
J = 7.3 Hz, 2H, H7), 7.86 (d, J = 7.3 Hz, 2H, H13); 13C-NMR (100 MHz, CDCl3, 25 
°C): δ = 14.0 (C1), 21.4 (C10), 21.7 (C16), 60.7 (C2), 122.4 (C4), 129.3 (C8), 129.7 
(C14), 130.0 (C13), 130.3 (C7), 133.2 (C9), 139.0 (C15), 144.6 (C6), 146.1 (C12), 
152.8 (C5), 165.5 (C3), 194.5 (C11); IR (neat): ѵmax ( cm-1) = 2988, 2970, 2901, 
1724, 1663, 1373, 1252, 1066, 9018, 818, 737, 731, 708; MS (ESI), 309 (MH+), 
HRMS (ESI, m/z%) calcd. for C20H21O3 [(M+H)+]: 309.1490, found 309.1492,   ̶
2.32 ppm error.  
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Attempted preparation of 4,5-dimethylocta-3,5-dienedioic acid 385: 
 
Procedure A:(230)   
A mixture of 2,3-butanedione 375 (100 mg, 1.16 mmol, ƿ = 0.981 gmL-1, 100 
µL, 1 equiv.) in triethylamine (3 mL), malonic acid 384 (241 mg, 2.32 mmol, 2 
equiv.) was added. The resulted mixture was stirred and heated at 98   ͦC for an 
hour. After the mixture had been cooled to room temperature, the solution 
was poured into 10% ice hydrochloric acid solution (10 mL), extracted with 
diethyl ether (10 mL), washed with 5% sodium hydroxide solution (10 mL). The 
aqueous layer was extracted with diethyl ether (10 mL), washed with 10% 
hydrochloric acid solution (10 mL), and then extracted further with diethyl 
ether (10 mL). The extract was washed with brine (10 mL), dried (MgSO4), and 
concentrated in vacuo affording the crude 385 as white solid, which was used 
without further purification. No characterisation of 385 was attempted.  
Procedure B: (231)   
To a stirred solution of malonic acid 384 (241 mg, 2.32 mmol, 2 equiv.) and 
triethylamine (305 mg, 3.01 mmol, ƿ = 0.726 gmL-1, 420 µL, 2.6 equiv.) in 
toluene (10 mL), a solution of 2,3-butanedione 375 (100 mg, 1.16 mmol, ƿ = 
0.981 gmL-1, 100 µL, 1 equiv.) in piperidine (35.5 mg, 0.417 mmol, ƿ = 0.862 
gmL-1, 40 µL, 0.36 equiv.) was added. The resulted mixture was stirred and 
heated at 70 ͦC for overnight. After the mixture had been cooled to room 
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temperature, the solution was extracted with 5 mL of 5% saturated sodium 
bicarbonate solution for 10 min., and then washed with 10 mL of ethyl acetate. 
The aqueous layer was cooled the acidified with drops of 10% hydrochloric 
acid solution until white solid precipitated. The solid was filtered and dried 
under higher vacuum to afford the crude 385 as white solid, which was used 
without further purification. No characterisation of 385 was attempted. 
7.4.4 Attempts of Diels-Alder reactions  
Attempted preparation of 5-phenyl-3,3a,4,5,7a-hexahydroisobenzofuran-1-
one 355:   
 
Procedure A:  
Allyl (triphenylphosphoranylidene) acetate 354 (20 mg, 0.05 mmol, 1.0 equiv.) 
was dissolved in xylene (10 mL) or mesitylene (10 mL). To the solution was 
added hydroquinone (270 mg, 2 mmol, 0.05 equiv.) and heated at reflux for 
overnight. The reaction mixture was concentrated in vacuo to give the crude 
product as thick oil, which was used without further purification. No 
characterisation of 355 was attempted. 
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Procedure B:  
A solution of allyl (triphenylphosphoranylidene) acetate 354 (41 mg, 0.113 
mmol, 1 equiv.) in diphenyl ether (7 mL) was stirred and heated at reflux for 
overnight, and then concentrated in vacuo. A 50 g of silica gel was weighed in 
prepared column, added petroleum ether (100 mL), and then added the 
reaction after dissolving with petroleum ether (100 mL) through this column, 
and washed with ethyl acetate (50 mL). The collected crude was concentrated 
in vacuo, which was used without further purification.  No characterisation of 
355 was attempted. 
Procedure C: 
To a solution of allyl (triphenylphosphoranylidene) acetate 354 (20 mg, 0.05 
mmol, 1 equiv.) in anhydrous benzene (10 mL) was added lithium 
tetrafluoroborate solution [1.0 M in MeCN] (60 µL, 0.06 mmol, 1.1 equiv.), 
stirred and heated at reflux. After 15 hours, the reaction mixture was washed 
with dichloromethane (50 mL). The dichloromethane layer was extracted with 
water (50 mL), dried (MgSO4), filtered, and concentrated in vacuo to afford the 
crude as yellow oil, which was used without further purification. No 
characterisation of 355 was attempted. 
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Attempted preparation of 6-phenyl-3,4,4a,5,6,8a-hexahydro-1H-2-
benzopyran-1-one 366:  
 
Procedure A:  
To a solution of 3'-butyen-1'-yl 2-(triphenylphosphoranylidene)acetate 364 (30 
mg, 0.08 mmol, 1 equiv.) in toluene (10 mL) was added bismuth(III) triflate (57 
mg, 0.087 mmol, 1.1 equiv.) or p-toluenesulfonic acid monohydrate (16.5 mg, 
0.087 mmol, 1.1 equiv.) or triflic acid (12.7 mg, 0.087 mmol, ƿ = 1.696 gmL-1, 7 
µL, 1.1 equiv.), stirred and heated at reflux for overnight. After this time, the 
reaction mixture was quenched with saturated sodium bicarbonate solution 
(20 mL), extracted with dichloromethane (15 mL). The extract was washed with 
brine (30 mL), dried (MgSO4), filtered, and concentrated in vacuo to afford the 
crude as yellow oil, which was used without further purification. No 
characterisation of 366 was attempted. 
Procedure B:  
A solution of 3'-butyen-1'-yl-2-(triphenylphosphoranylidene)acetate 364 (48 
mg, 0.127 mmol, 1 equiv.) in diphenyl ether (7 mL) was stirred and heated at 
reflux for 15 hours, and then concentrated in vacuo. A 50 g of silica gel was 
weighed in prepared column, added petroleum ether (100 mL), and then 
added the reaction after dissolving with petroleum ether (100 mL) through this 
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column, and washed with ethyl acetate (50 mL). The collected crude was 
concentrated in vacuo, which was used without further purification. No 
characterisation of 366 was attempted. 
Procedure C:  
To a solution of 3'-butyen-1'-yl-2-(triphenylphosphoranylidene)acetate 364 (20 
mg, 0.053 mmol, 1 equiv.) in anhydrous benzene (10 mL) was added lithium 
tetrafluoroborate solution [1.0 M in MeCN] (53 µL, 0.053 mmol, 1.1 equiv.), 
stirred and heated at reflux. After 15 hours, the reaction mixture was washed 
with dichloromethane (50 mL). The dichloromethane layer was extracted with 
water (50 mL), dried (MgSO4), filtered, and concentrated in vacuo to afford the 
crude as yellow oil, which was used without further purification. No 
characterisation of 366 was attempted. 
7.4.5 TOP reactions using different oxidants 
General procedure 10: TOP for the preparation of dienes with SO3Py 
To a solution of diol (1 equiv.), ylides (2.5 equiv.) and triethylamine (20 equiv.) 
was dissolved in dichloromethane (1 mL) at 0  ͦC and then treated with a 
solution of pyridine sulfur trioxide complex (10 equiv.) in dichloromethane (2 
mL) and DMSO (3 mL), stirred for 16 hours at room temperature and 50   ͦC, 
poured into water (50 mL) and extracted with dichloromethane (4 × 100 mL). 
The extracts were washed sequentially with saturated brine (20 mL), dried 
(MgSO4), and filtered through a pad of celite, concentrated to provide the 
product of sufficient purity for subsequent use with further purification.  
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General procedure 11: TOP for the preparation of dienes with iodoxybenzoic 
acid (IBX) 
To a cooled 0   ͦC solution of diol (1 equiv.) and ylides (2.5 equiv.) was dissolved 
in dichloromethane (5 mL), and a solution of IBX (20 equiv.) in DMSO (3 equiv.) 
was added slowly, stirred for 2 hours at room temperature. This resultant 
solution was filtered through celite, extracted with diethyl ether (50 mL), 
washed sequentially with water (20 mL), saturated brine (20 mL), dried 
(MgSO4), concentrated in vacuo to afford the crude product. Conversion was 
determined by analysis of the 1H-NMR spectrum. 
General procedure 12: TOP for the preparation of dienes with Dess-Martin 
periodinane (DMP)  
Diol (1 equiv.) and ylide (2.5 equiv.) were dissolved in anhydrous 
dichloromethane or toluene (10 mL). Dess-Martin periodinane (3 equiv.) was 
added, and the mixture turned orange-red brown within seconds. The 
resultant solution was stirred at room temperature for three hours, followed 
by a further 15 hours at 90   ͦC.  The crude was extracted with diethyl ether (50 
mL) and washed with saturated NaHCO3 solution (50 mL). After stirring for an 
hour, the mixture was filtered, separated. The organic layer was dried (MgSO4) 
and concentrated in vacuo. The crude was used in the next step. Conversion 
was determined by analysis of the 1H-NMR spectrum. 
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Attempted preparation of 3,4-dimethyl-hexadien-2,4-dinitril 390:  
 
Procedure A: 
According to general procedure 10 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), triethylamine (1.11 g, 11 mmol, ƿ = 
0.727 gmL-1, 1.53 mL, 20 equiv.), (triphenylphosphoranylidene)acetonitrile 265 
(414 mg, 1.375 mmol, 2.5 equiv.) and pyridine sulfur trioxide complex (873 mg, 
1.43 mmol, 10 equiv.) were combined. Concentration in vacuo afforded the 
crude 390 as faint yellow oil. No characterisation of 390 was attempted (no 
reaction).  
According to general procedure 10 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), triethylamine (1.11 g, 11 mmol, ƿ = 
0.727 gmL-1, 1.53 mL, 20 equiv.), diethyl 1-cyano-methylphosphonate 420 (243  
mg, 1.375 mmol, ƿ = 1.095 gmL-1, 220 µL, 2.5 equiv.) and 7-methyl-1,5,7-
triazabicyclo[4.4.0]-dec-5-ene [MTBD] 89 (219 mg, 1.43 mmol, ƿ= 1.067 gmL-1, 
70 µL, 2.6 equiv.) and pyridine sulfur trioxide complex (873 mg, 5.5  mmol, 10 
equiv.) were combined. No characterisation of 390 was attempted. 
Procedure B: 
According to general procedure 11 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), Iodoxybenzoic acid (231 mg, 0.825 
mmol, 1.5 equiv.), (triphenylphosphoranylidene)acetonitrile 265 (414 mg, 
1.375 mmol, 2.5 equiv.) and DMSO (128 mg, 1.65 mmol, ƿ = 1.1 gmL-1, 110 µL, 
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3 equiv.) were combined. Concentration in vacuo afforded the crude 390 as 
red oil. No characterisation of 390 was attempted.  
 Procedure C: 
According to general procedure 12 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), DMP (699 mg, 1.65 mmol, 3 equiv.), 
(triphenylphosphoranylidene)acetonitrile 265 (414 mg, 1.375 mmol, 2.5 equiv.) 
were combined. Concentration in vacuo afforded the crude 390 as faint yellow 
oil. No characterisation of 390 was attempted.  
Preparation of (E)-ethyl 3-methyl-4-oxo-2-pentenoate 376:  
 
Procedure A: 
 According to general procedure 10 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), triethylamine (1.11 g, 11 mmol, ƿ = 
0.727 gmL-1, 1.53 mL, 20 equiv.), ethyl (triphenylphosphoranylidene)acetate 38 
(479 mg, 1.375 mmol, 2.5 equiv.) and pyridine sulfur trioxide complex (873 mg, 
5.5 mmol, 10 equiv.) were combined to give the product as a yellow oil. No 
characterisation of 376 was attempted (no reaction). 
According to general procedure 10 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), triethylamine (1.11 g, 11 mmol, ƿ = 
0.727 gmL-1, 1.53 mL, 20 equiv.), ethyl 2-(dimethoxyphosphoryl)acetate 381 
(269 mg, 1.375 mmol, ƿ = 1.186 gmL-1, 220 µL, 2.5 equiv.) and 7-methyl-1,5,7-
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triazabicyclo[4.4.0]-dec-5-ene [MTBD] 89 (219 mg, 1.43 mmol, ƿ = 1.067 gmL-1, 
70 µL, 2.6 equiv.) and pyridine sulfur trioxide complex (873 mg, 5.5  mmol, 10 
equiv.) were combined, concentrated under higher vacuum affording the 
crude 376 as faint yellow oil. No characterisation of 376 was attempted. 
Procedure B: 
According to general procedure 11 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1,50 µL, 1 equiv.), IBX (385 mg, 1.375 mmol, 2.5 equiv.), 
ethyl (triphenylphosphoranylidene)acetate 38 (479 mg, 1.375 mmol, 2.5 
equiv.) and in DMSO (6 mL) were combined to give the product as red oil.  No 
characterisation of 376 was attempted. 
Procedure C: 
According to general procedure 12 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), DMP (699 mg, 1.65 mmol, 3 equiv.), 
ethyl (triphenylphosphoranylidene)acetate 38 (479 mg, 1.375 mmol, 2.5 
equiv.) in toluene were combined, concentration in vacuo afforded the alkene 
product 376 as faint yellow oil (10 mg, 0.064 mmol, 11%). 376: Rf = 0.70 (7:3 
petroleum ether (b.p. 40-60 °C)/ethyl acetate, det: KMnO4); 1H-NMR (300 MHz, 
CDCl3, 25 °C): δ = 1.31-1.36 (m, 3H, H8), 2.22 (d, J = 1.3 Hz, 3H, H4), 2.40 (s, 3H, 
H1), 4.24 (q, J = 7.2 Hz, 2H, H7), 6.59 (q, J = 1.4 Hz, 1H, H5); 13C-NMR (100 MHz, 
CDCl3, 25 °C): δ = 13.0 (C4), 14.2 (C8), 26.8 (C1), 60.8 (C7), 126.6 (C5), 150.4 
(C3), 166.2 (C6), 200.0 (C2); IR (neat): ѵmax (cm-1) = 1725, 1690, 1640; MS (ESI), 
156 (MH+), HRMS (ESI, m/z%) calcd. for C8H13O3 [(M+H)+]: 156.0864, found 
156.0820, 1.5 ppm error. 
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Attempted preparation of 1,3-dimethyl-4-dimethyl-1,4-dicarboethoxy-1,3-
butadiene 392:  
 
According to general procedure 12 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), DMP (699 mg, 1.65 mmol, 3 equiv.) 
and (carbethoxyethylidene)triphenylphosphorane 35 (498g, 1.375 mmol, 2.5 
equiv.) were combined. Concentration in vacuo afforded the crude 392 as 
yellow oil. No characterisation of 392 was attempted.  
Attempted preparation 1,4-ditertbutyl ester-2,3-dimethyl-1,3-butadiene 394:  
 
According to general procedure 12 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), DMP (699 mg, 1.65 mmol, 3 equiv.) 
and (tert-butoxycarbonylmethylene)triphenylphosphorane 304 (517 g, 1.375 
mmol, 2.5 equiv.) were combined, concentrated in vacuo afforded the crude 
394 as yellow oil. No characterisation of 394 was attempted.  
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Attempted preparation of 1,4-diphenyl-2,3-dimethyl-1,3-butadiene 396:  
 
According to general procedure 12 using 2,3-butanediol 350 (50 mg, 0.55 
mmol, ƿ = 1.002 gmL-1, 50 µL, 1 equiv.), DMP (699 mg, 1.65 mmol, 3 equiv.), 
benzyltriphenylphosphonium bromide 316 (595 mg, 1.375 mmol, 2.5 equiv.) 
and 7-methyl-1,5,7-triaza-bicyclo[4.4.0]dec-5-ene [MTBD] 89 (219 mg, 1.43 
mmol, ƿ = 1.067 gmL-1, 200 µL, 2.6 equiv.) were combined, concentration in 
vacuo afforded the crude 396 as yellow oil. No characterisation of 396 was 
attempted. 
Preparation of 4-oxo-3,4-diphenylbut-2-enoic acid ethyl ester 421:  
 
Procedure A: 
According to general procedure 10 using hydrobenzoin 368 (50 mg, 0.23 
mmol, 1 equiv.), triethylamine (465 mg, 4.6 mmol, ƿ = 0.727 gmL-1, 640 µL, 20 
equiv.), ethyl (triphenylphosphoranylidene)acetate 38 (200 mg, 0.575 mmol, 
2.5 equiv.) and pyridine sulfur trioxide complex (366 mg, 2.3 mmol, 10 equiv.) 
were combined affording the product as yellow oil (39 mg, 0.14 mmol, 60%). 
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421:(229) Rf = 0.60 (7:3 hexane/ diethyl ether, det: KMnO4); 1H-NMR (300 MHz, 
CDCl3, 25 °C): δ = 1.10-1.16 (m, 3H, H1), 4.02-4.15 (m, 2H, H2), 6.26 (s, 1H, H4), 
7.36-7.39 (m, 5H, H7, H8, H9), 7.46-7.48 (m, 2H, H12), 7.55-7.58 (m, 1H, H14), 
7.91-7.95 (m, 2H, H13); 13C-NMR (100 MHz, CDCl3, 25 °C): δ = 13.9 (C1), 60.9 
(C2), 124.0 (C4), 128.2 (C7), 128.5 (C8), 128.7 (C9), 128.9 (C12), 130.1 (C13), 
133.7 (C14), 134.3 (C6), 135.7 (C11), 152.2 (C5), 165.4 (C3), 195.7 (C10); IR 
(neat): ѵmax ( cm-1) = 2998, 2943, 1713, 1669, 1448, 1375, 1254, 1066, 1025, 
918, 812, 737, 677; MS (ESI), 281 (MH+), HRMS (ESI, m/z%) calcd. for C18H17O3 
[(M+H)+]: 281.1177, found 281.1178,  ̶ 1.83 ppm error. 
Procedure B: 
According to general procedure 11 using hydrobenzoin 368 (50 mg, 0.23 
mmol, 1 equiv.), IBX (161 mg, 0.575 mmol, 2.5 equiv.), ethyl 
(triphenylphosphoranylidene)-acetate 38 (200 mg, 0.575 mmol, 2.5 equiv.) in 
DMSO (6 mL) were combined, concentrated in vacuo to afford the crude as red 
oil.  No characterisation of 421 was attempted (no reaction). 
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7.5 Experimental procedures: Chapter 5 
Preparation of (S)-2-amin-3-(1H-indol-3-yl)-N-methylpropanamide 432: 
 
Procedure A: 
Methylamine 431a (40 ml, 2.0 M in THF, 20 equiv.) was added to a suspension 
of L-tryptophan methyl ester hydrochloride 430 (500 mg, 1.96 mmol, 1 equiv.) 
in THF (10 ml) and then stirred at room temperature. After 24 h, the solvent 
was evaporated in vacuo, and the crude was purified by column 
chromatography 20% methanol/dichloromethane to give the product as a 
yellow solid (150 mg, 35%). 432:(192); Rf = 0.57 (8:2 dichloromethane/methanol, 
det: KMnO4); m.p. 120-122   ͦC; 1H-NMR (300 MHz, CD3OD, 25   ͦC): δ = 3.12 (s, 
3H, H1), 2.94-3.01 (m, 1H, H4a), 3.11-3.18 (m, 1H, H4b), 3.54-3.59 (m, 1H, H3), 
6.97-7.03 (m, 1H, H8), 7.07 (s, 1H, H12). 7.08-7.11 (m, 1H, H9), 7.33 (dt, J = 8.1, 
1, 1H, H10), 7.57 (dt, J =7.7, 1.1 Hz, 1H, H7); 13C-NMR (75 MHz, CD3OD, 25   ͦC): δ 
= 26.3 (C1), 32.2 (C4), 56.9 (C3), 111.2 (C5), 112.3 (C8), 119.5 (C10), 119.8 (C7), 
122.5 (C12), 124.7 (C9), 128.8 (C6), 138.2 (C11), 17.7 (C2); IR (NaCl disk): ѵmax 
(cm-1) = 3282, 1650, 1537, 1457, 1411, 1342, 1232, 1101; MS (ESI), 218 (MH+), 
HRMS (ESI, m/z %) calcd. for C12H16N3O [(M+H)+]: 218.1293; found: 218.1295,   ̶
4.1 ppm error. 
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Procedure B: 
L-tryptophan 144 (4.85 g, 23.8 mmol, 1 equiv.) was added to a cooled solution 
of thionyl chloride (8.15 g, 67 mmol, ƿ = 1.631 gmL-1, 5 mL, 2.8 equiv.) in 
methanol (130 mL) at 0   ͦC. The solution was stirred for 24 hours at room 
temperature then evaporated by vacuo. The crude reaction was washed with 
ethyl acetate (200 mL) and petroleum ether (100 mL). the solid was 
concentrated to afford a white solid. This solid was stirred at room 
temperature in an ethanolic solution of methylamine 431 (35 mL [33% in 
EtOH], 12 equiv.) for 4 days then evaporated, washed with saturated sodium 
bicarbonate solution (100 mL). The aqueous layer was extracted with 
chloroform (4 × 10 mL), and then chloroform extracts were combined to dry 
over (MgSO4). The filtrate was evaporated to give the product 432, as a yellow 
solid (4.5 g, 21 mmol, 87%). 432: Rf  = 0.60 (8:2 CH2Cl2/MeOH, det: KMnO4). 
Data as recorded above in procedure A. 
Preparation of 2-acetamino-5-chlorbenzaldehyde 452:   
 
To a solution of 2-amino-5-chlorbenzaldehyde 451 (500 mg, 3.21 mmol, 1 
equiv.) in pyridine (5 mL) under N2 pressure, acetic anhydride (5.4 g, 52.8 
mmol, ƿ = 1.08 gmL-1, 5 mL, 16 equiv.) was added dropwise, then stirred at 
room temperture overnight. The resulted solution was concentrated in vacuo, 
and re-dissolved in  dichloromethane (20 mL). Further evaporated the solution 
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in vacuo was required twice. The crude was extracted with dichloromethane 
(20 mL) and water (20 mL), washed with 2 M hydrochloric acid (20 mL) and 
then saturated sodium bicarbonate (5 mL). The organic layer was washed with 
saturated  brine (20 mL), dried (MgSO4), filtered, and concentrated in vacuo. 
Purification of the residue via flash chromatography on silica using 9.5:0.5 
dichloromethane/diethyl ether to afford the product as a thick yellow oil (470 
mg, 2.4 mmol, 75%). 452: Rf = 0.56 (9.5:0.5 dichloromethane/diethyl ether, 
det: KMnO4); 1H-NMR (300 MHz, CDCl3, 25   ͦC): δ = 2.24 (s, 1H, H10), 7.61 (d, J = 
18.6 Hz, 2H, H3, H4), 8.73 (s, 1H, H8), 9.84 (d, J = 18.1 Hz, 1H, H6), 11.01 (s, 1H, 
H7); 13C-NMR (75 MHz, CDCl3, 25   ͦC): δ =  25.4 (C10), 121.5 (C6), 122.4 (C5), 
127.9 (C2), 135.0 (C3), 136.0 (C4), 139.4 (C1), 169.6 (C9), 194.4 (C7); MS (ESI), 
198 (MH+), HRMS (ESI, m/z %) calcd. for C9H935ClNO2 [(M+H)+]: 198.0321; 
found: 198.0323,  ̶ 4.92 ppm error.   
7.5.1 Pictet spengler reaction 
General Procedure 13:  
L-Trp-NHMe 432 (1 equiv.) was dissolved in anhydrous dichloromethane (20 
mL) and 3 Aͦ  molecular  sieves (10 mg) were placed under atmosphere of 
nitrogen and the aldehyde (1.1 equiv.) was added via cannula over a period of 
5 min or a anhydrous dichloromethane  solution if it is solid. The mixture was 
lef the stir overnight to allow the imine to form. Trifluoroacetic acid (2 equiv.) 
was added via needle and the solution stirred for further three hours at room 
temperature. Saturated aqueous sodium bicarbonate (20 mL) was added to 
quench the reaction. The layers were separated and the aqeous layer was 
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further extracted with dichloromethane (2 × 30 mL). The combined organic 
extracts were washed with saturated brine (20 mL), dried (MgSO4), filtered and 
solvent evaporated in vacuo. The crude was purified by column 
chromatography.  
Preparation of (1S,3S)- 1-([4-trifluoromethyl]phenyl)-3-acetamide-1,2,3,4-
tetrahydro-β-carboline  436: 
 
According to general procedure 13 L-Trp-NHMe 432 (390 mg, 1.79 mmol, 1 
equiv.), 3 Aͦ   molecular  sieves (10 mg), 4-(trifluoromethyl)benzaldehyde 435 
(342 mg, 1.96 mmol, ƿ = 1.275 gmL-1, 260 µL, 1.1 equiv.) and trifluoroacetic 
acid (408 mg, 3.58 mmol, ƿ = 1.478 gmL-1, 270 µL, 2 equiv.) were combined to 
afford white solid (90 mg, 0.24 mmol, 13%). 436: Rf = 0.55 (7:3 
dichloromethane/diethyl ether, det: KMnO4); m.p. 192-194   ͦC; 1H-NMR (300 
MHz, CDCl3, 25   ͦC): δ = 1.79 (br.s, 1H, H2), 2.82 (d, J = 5.1 Hz, 3H, H1), 2.83-2.86 
(m, 1H, H5a), 3.37 (ddd, J = 15.6, 4.2, 1.8 Hz, 1H, H5b), 3.72 (dd, J = 11.1, 4.3 Hz, 
1H, H4), 5.25 (s, 1H, H15), 7.10-7.19 (m, 2H, H9, H10), 7.22-7.24 (m, 1H, H11), 7.45 
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(d, J = 8.1Hz, 2H, H19,  H22), 7.55 (dd, J = 6.1, 2.0 Hz, 1H, H8), 7.62-7.65 (m, 3H, 
H18, H23, H13).13C-NMR (75 MHz, CDCl3, 25   ͦC): δ =  25.6 (C1), 25.9 (C5), 58.1 
(C15), 110.5 (C6), 111.1 (C11), 118.5 (C8), 119.9 (C9), 122.4 (C10), 126.0 (q, J = 
3.8 Hz) (C19, C22), 127.0 (C21), 129.0 (C18, C23), 130.7 (C7), 131.1 (C14), 133.3 
(C20), 136.3 (C12), 144.7 (C17), 173.0 (C3); IR (neat): ѵmax (cm-1) = 2972, 1661, 
1608, 1584, 1460, 739, 687; MS (ESI), 374 (MH+), HRMS (ESI, m/z %) calcd. for 
C20H19F3N3O [(M+H)+]: 374.1480; found: 374.1511,   ̶5.91 ppm error. 
Preparation of (1S,3S)- 1-([3-trifluoromethyl]phenyl)-3-acetamide-1,2,3,4-
tetrahydro-β-carboline  438:  
 
According to general procedure 13 L-Trp-NHMe 432 (1.2 g, 5.6 mmol, 1 
equiv.), 3 Aͦ   molecular  sieves (10 mg), 3-(trifluoromethyl)benzaldehyde 437 ( 
1.07 g,  6.16 mmol, ƿ = 1.301 gmL-1, 820 µL, 1.1 equiv.) and trifluoroacetic acid 
(1.27 g, 11.2 mmol, ƿ = 1.478 gmL-1, 860 µL, 2 equiv.) were combined to afford 
white-off oil (99 mg, 0.26 mmol, 5%). 438: Rf = 0.39 (9:1 
dichloromethane/diethyl ether, det: KMnO4); m.p. 188-190   ͦC; 1H-NMR (300 
MHz, CDCl3, 25   ͦC): δ = 2.05 (br.s, 1H, H2), 2.82-2.83 (m, 3H, H1), 2.87-2.91 (m, 
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1H, H5a), 3.32-3.39 (m, 1H, H5b), 3.73 (dd, J = 11.1, 4.3 Hz, 1H, H4), 5.23 (t, J = 
2.2 Hz, 1H, H15), 7.13-7.14 (m, 1H, H9), 7.16-7.17 (m, 1H, H10), 7.23 (d, J = 2.0 
Hz, 1H, H11), 7.48 (s, 1H, H18), 7.49-7.51 (m, 1H, H23), 7.54-7.57 (m, 1H, H8), 
7.62-7.64 (m, 2H, H22, H21), 7.66 (br.s, 1H, H13); 13C-NMR (75 MHz, CDCl3, 25   ͦC): 
δ =  25.6 (C1), 26.0 (C5), 58.1 (C15), 110.5 (C6), 111.1 (C11), 118.5 (C8), 119.9 
(C9), 122.4 (C10), 125.5 (q, J = 3.8 Hz) (C21, C22), 127.0 (C20), 129.6 (C18), 
130.2 (C7), 131.6 (C14), 133.9 (C19), 136.3 (C12), 141.8 (C17), 173.1 (C3); IR 
(neat): ѵmax (cm-1) = 2990, 1652, 1531, 1443, 769, 701, 683; MS (ESI), 374 
(MH+), HRMS (ESI, m/z %) calcd. for C20H19F3N3O [(M+H)+]: 374.1480; found: 
374.1512,  ̶ 7.27 ppm error.  
Preparation of (1S,3S)- 1-(2,4-dichlorophenyl)-3-acetamide-1,2,3,4-
tetrahydro-β-carboline 440: 
 
According to general procedure 13 L-Trp-NHMe 432 (1.2 g, 5.6 mmol, 1 
equiv.), 3 Aͦ  molecular  sieves (10 mg), 2,4-dichlorobenzaldehyde 439 ( 1.07g,  
6.16 mmol, 1.1 eqiv.) and trifluoroacetic acid (1.27 g, 11.2 mmol, ƿ = 1.478 
gmL-1, 860 µL, 2 equiv.) were combined to afford white solid (135 mg, 0.36 
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mmol, 6.75%). 440: Rf = 0.46 (9:1 dichloromethane/diethyl ether, det: KMnO4); 
m.p. 183-185   ͦC; 1H-NMR (300 MHz, CDCl3, 25   Cͦ): δ = 1.77 (br.s, 1H, H16), 2.80 
(d, J = 4.9 Hz, 3H, H1), 2.84 (dd, J = 11.2, 2.5 Hz, 1H, H5a), 3.27-3.35 (m, 1H, H5b), 
3.68 (dd, J = 11.1, 4.2 Hz, 1H, H4), 5.68 (br.s, 1H, H15), 6.93 (d, J = 4.9 Hz, 1H, 
H2), 7.10 (d, J = 1.3 Hz, 1H, H8), 7.12-7.13 (m, 1H, H10), 7.14 (d, J = 1.3 Hz, 1H, 
H21), 7.16 (d, J = 1.9 Hz, 1H, H19), 7.22 (s, 1H, H11), 7.44-7.45 (m, 1H, H22), 7.62 
(d, J = 6.8 Hz, 1H, H9), 7.95 (br.s, 1H, H13); 13C-NMR (75 MHz, CDCl3, 25   Cͦ): δ =  
25.6 (C1), 26.0 (C5), 54.7 (C15), 58.0 (C4), 110.6 (C6), 111.1 (C11), 118.4 (C9), 
119.8 (C8), 122.3 (C10), 127.0 (C7), 127.9 (C19), 129.8 (C22), 130.7 (C21), 132.9 
(C14), 134.8 (C20), 135.1 (C12), 136.3 (C18), 137.0 (C17), 173.1 (C3); IR (neat): 
ѵmax (cm-1) = 2985, 2967, 2911, 1661, 1617, 1584, 1464, 1182, 755; MS (ESI), 
374 (MH+), HRMS (ESI, m/z %) calcd. for C19H1835Cl2N3O [(M+H)+]: 374.0826; 
found: 374.0837,  ̶ 0.5 ppm error. 
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Preparation of (1S,3S)- 1-(4-fluorophenyl)-3-acetamide-1,2,3,4-tetrahydro-β-
carboline 442: 
 
According to general procedure 13 L-Trp-NHMe 432 (500 mg, 2.3 mmol, 1 
equiv.), 3 Aͦ molecular  sieves (10 mg), 4-fluorobenzaldehyde 441 ( 313 mg,  
2.53 mmol, ƿ = 1.157 gmL-1, 270 µL, 1.1 equiv.) and trifluoroacetic acid (524 
mg, 4.6 mmol, ƿ = 1.478 gmL-1, 350 µL, 2 equiv.) were combined to afford 
white solid (55 mg, 0.17 mmol, 7.43%). 442: Rf = 0.39 (9:1 
dichloromethane/diethyl ether, det: KMnO4); m.p. 235-237   ͦC; 1H-NMR (400 
MHz, CD3OD, 25   ͦC): δ = 2.79 (s, 3H, H1), 2.90-2.97 (m, 1H, H5a), 3.19 (dt, J = 13, 
2.3, 2.3, 2.3 Hz, 1H, H5b), 3.80 (dd, J = 11, 4.2 Hz, 1H, H4), 5.69 (s, 1H, H15), 6.98-
7.06 (m, 3H, H9, H10, H19), 7.18 (d, , J = 7.8 Hz, 1H, H11), 7.47 (d, J = 7.3 Hz, 1H, 
H18), 7.66 (d, J= 8.1 Hz, 1H, H21), 7.88 (d, J = 7.8 Hz, 1H, H22), 8.06 (s, 1H, H8); 
13C-NMR (100 MHz, CD3OD, 25   Cͦ): δ =  24.9 (C1), 25.4 (C5), 53.4 (C15), 58.7 
(C4), 108.7 (C6), 110.8 (C11), 117.4 (C18), 118.7 (C19), 121.3 (C9, C10), 122.4 
(C8), 126.6 (C7), 129.0 (C21), 130.0 (C14), 132.1 (C22), 133.1 (C12), 137.1 (C20), 
145.0 (C17), 174.6 (C3); IR (neat): ѵmax (cm-1) = 2985, 9850, 1650, 1586, 1473, 
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1280, 1118, 746, 696; MS (ESI), 324 (MH+), HRMS (ESI, m/z %) calcd. for 
C19H19FN3O [(M+H)+]: 324.1512; found: 324.1540,  ̶ 7.59 ppm error. 
Preparation of (1S,3S)- 1-(4-chlorophenyl)-3-acetamide-1,2,3,4-tetrahydro-β-
carboline 444: 
 
According to general procedure 13 L-Trp-NHMe 432 (500 mg, 2.3 mmol, 1 
equiv.), 3 Aͦ  molecular  sieves (10 mg), 4-chlorobenzaldehyde 443 ( 355 mg, 
2.53 mmol, 1.1 equiv.) and trifluoroacetic acid (524 mg, 4.6 mmol, ƿ = 1.478 
gmL-1, 250 µL, 2 equiv.) were combined to afford white solid (53 mg, 0.15 
mmol, 6.8%). 444: Rf = 0.33 (diethyl ether, det: KMnO4); m.p. 177-178   ͦC; 1H-
NMR (400 MHz, CDCl3, 25   ͦC): δ = 1.90 (s, 1H, H16), 2.82 (d,  J = 4.9 Hz, 3H, H1), 
2.85-2.87 (m, 1H, H5a), 3.33 (d, J = 3.2 Hz, 1H, H5b), 3.70 (dd, J = 11, 4.3 Hz, 1H, 
H4), 5.17 (s, 1H, H15), 6.94 (d, J = 4.2 Hz, 1H, H2), 7.11-7.17 (m, 2H, H9, H10), 7.25 
(d, J = 8.6 Hz, 3H, H11, H19, H21), 7.32-7.34 (m, 2H, H18, H22), 7.54 (d, J = 7.3 Hz, 
1H, H8), 7.68 (s, 1H, H13); 13C-NMR (100 MHz, CDCl3, 25   Cͦ): δ =  23.7 (C1), 24.1 
(C5), 56.3 (C4), 56.5 (C15), 108.5 (C6), 109.2 (C11), 116.6 (C8), 118.0 (C10), 
120.4 (C9), 125.3 (C7), 127.4 (C19, C21), 128.1 (C18, C22), 132.0 (C12), 132.7 
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(C14), 134.5 (C20), 137.4 (C17), 171.2 (C3); IR (neat): ѵmax (cm-1) = 3002, 2950, 
1644, 1540, 1489, 1140, 1066, 794, 741; MS (ESI), 340 (MH+), HRMS (ESI, m/z 
%) calcd. for C19H1935ClN3O [(M+H)+]: 340.1216; found: 340.1243,   ̶ 6.25 ppm 
error. 
Preparation of (1S,3S)- 1-(3-chlorophenyl)-3-acetamide-1,2,3,4-tetrahydro-β-
carboline 446: 
 
According to general procedure 13 L-Trp-NHMe 432 (500 mg, 2.3 mmol, 1 
equiv.), 3 Aͦ    molecular sieves (10 mg), 3-chlorobenzaldehyde 445 ( 355 mg, 
2.53 mmol, ƿ = 1.241 gmL-1, 290 µL, 1.1 equiv.) and trifluoroacetic acid (524 
mg, 4.6 mmol, ƿ = 1.478 gmL-1, 350 µL, 2 equiv.) were combined to afford 
white solid (104 mg, 0.33 mmol, 13%). 446: Rf = 0.45 (diethyl ether, det: 
KMnO4); m.p. 196-198   Cͦ; 1H-NMR (400 MHz, CDCl3, 25   ͦC): δ = 1.85 (s, 1H, 
H16), 2.85 (d, J = 4.5 Hz, 3H, H1), 2.88-2.90 (m, 1H, H5a), 3.39 (dd, J = 15.7, 4.2 
Hz, 1H, H5b), 3.76 (dd, J = 11.1, 4.3 Hz, 1H, H4), 5.20 (s, 1H, H15), 6.93 (d, J = 4.2 
Hz, 1H, H2), 7.12-7.18 (m, 2H, H9, H10), 7.22-7.24 (m, 2H, H20, H21), 7.31-7.35 (m , 
3H, H18, H22, H11), 7.52 (s, 1H, H13), 7.57 (d, J = 7.6 Hz, 1H, H8); 13C-NMR (100 
MHz, CDCl3, 25  ͦC): δ =  25.6 (C1), 25.9 (C5), 58.2 (C4), 58.6 (C15), 110.6 (C6), 
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111.0 (C20), 118.6 (C8), 119.9 (C9), 122.4 (C10), 126.6 (C21), 127.1 (C7), 128.7 
(C22), 129.0 (C11), 130.4 (C18), 133.5 (C14), 135.1 (C19), 136.3 (C12), 142.8 
(C8), 173.0 (C3); IR (neat): ѵmax (cm-1) = 3545, 3050, 2988, 1666, 1592, 1570, 
1518, 1263, 1138, 1077, 60, 746, 696; MS (ESI), 340 (MH+), HRMS (ESI, m/z %) 
calcd. for C19H1935ClN3O [(M+H)+]: 340.1216; found: 340.1243,  ̶ 6.25 ppm error.  
Preparation of (1S,3S)- 1-([2,4-bis[trifluoromethyl]phenyl)-3-acetamide-
1,2,3,4-tetrahydro-β-carboline 448: 
 
According to general procedure 13 L-Trp-NHMe 432 (300 mg, 1.38 mmol, 1 
equiv.), 3 Aͦ   molecular  sieves (10 mg), 2,4-bis(trifluoromethyl)benzaldehyde 
447 ( 417 mg, 1.72 mmol, ƿ = 1.470 gmL-1, 280 µL, 1.25 equiv.) and 
trifluoroacetic acid (314 mg, 2.76 mmol, ƿ = 1.478 gmL-1, 210 µL, 2 equiv.) were 
combined to afford white solid (33 mg, 0.07 mmol, 5.5%). 448: Rf = 0.36 
(diethyl ether, det: KMnO4); m.p. 215-217   ͦC; 1H-NMR (300 MHz, CDCl3, 25   ͦC): 
δ = 1.65 (br.s, 1H, H16), 2.86 (d, J = 4.9 Hz, 3H, H1), 2.90 (s, 1H, H5a), 3.40 (d, J = 
15.7 Hz, 1H, H5b), 3.77 (dd, J = 11.1, 4.3 Hz, 1H, H4), 5.22 (s, 1H, H15), 6.95 (s, 
1H, H2), 7.08 (t, J = 8.4 Hz, 2H, H9, H10), 7.16 (t, J =7.7 Hz, 2H, H20, H23), 7.30-7.33 
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(m, 1H, H11, H8), 7.45 (s, 1H, H13), 7.57 (d, J =7.6 Hz, 1H, H24); 13C-NMR (75 MHz, 
CDCl3, 25   ͦC): δ =  25.6 (C1), 25.9 (C5), 58.2 (C4), .58.4 (C15), 110.5 (C11), 111.9 
(C11), 115.9 (C10), 116.2 (C9), 118.5 (C24), 119.9 (C20), 122.3 (C23), 126.4 (C7), 
1327.2 (C14), 130.2 (C8), 130.3 (C21), 134.0 (C12), 136.2 (C18), 136.5 (C17), 
173.1 (C3); IR (neat): ѵmax (cm-1) = 3010, 2943, 1652, 1604, 1508, 1459, 1163, 
763, 750, 691; MS (ESI), 442 (MH+), HRMS (ESI, m/z %) calcd. for C21H18F6N3O 
[(M+H)+]: 442.1354; found: 442.1388,  ̶ 7.61 ppm error.  
Preparation of (1S,3S)- 1-([4-methoxyphenyl)-3-acetamide-1,2,3,4-
tetrahydro-β-carboline 450: 
 
According to general procedure 13 L-Trp-NHMe 432 (200 mg, 0.9 mmol, 1 
equiv.), 3 Aͦ   molecular  sieves (10 mg), 4-methoxybenzaldehyde 449 (134 mg, 
0.99 mmol, ƿ = 1.119 gmL-1, 120 µL, 1.25 equiv.) and trifluoroacetic acid (205 
mg, 1.8 mmol, ƿ = 1.478 gmL-1, 140 µL, 2 equiv.) were combined to afford the 
crude as yellow oil. No characterisation of 450 was attempted. 
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Preparation of (1S,3S)- 1-([2-acetamino-5-chlorophenyl)-3-acetamide-1,2,3,4-
tetrahydro-β-carboline 453: 
 
According to general procedure 13 L-Trp-NHMe 432 (200 mg, 0.9 mmol, 1 
equiv.), 3 Aͦ   molecular  sieves (10 mg), 2-acetamino-5-chlorbenzaldehyde 452 
(200 mg, 1.0 mmol, 1.1 equiv.) and trifluoroacetic acid (205 mg, 1.8 mmol, ƿ = 
1.478 gmL-1, 140 µL, 2 equiv.) were combined to afford the crude as yellow oil. 
No characterisation of 453 was attempted. 
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